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Abstract 
Probing microRNA Activity in vitro and inside Cells  
Using Single Molecule Microscopy 
 
By 
 
Sethuramasundaram Pitchiaya 
 
Chair: Nils G. Walter 
 
 Non-coding RNAs (ncRNAs) outnumber their protein-coding counterparts, 
yet their presumably diverse functions are still ill-understood. This thesis reports 
the development of two novel single-molecule methods to probe the activity of 
microRNAs (miRNAs), a class of regulatory ncRNAs, in pursuit of their elusive 
mechanism of action.  
miRNAs associate with components of the RNA induced silencing 
complex (RISC) to assemble on messenger RNA (mRNA) targets and regulate 
protein expression in higher eukaryotes. Here, I describe a method for the 
intracellular single molecule, high resolution localization and counting (iSHiRLoC) 
of miRNAs. Microinjected, singly fluorophore labeled, functional miRNAs were 
tracked within diffusing particles, a majority of which contained single miRNA 
molecules. Observed mobility and mRNA dependent assembly changes support 
a model of multiple target turnovers by miRNAs, revealing the dynamic nature of 
an important gene regulatory pathway and paving the way towards its single 
molecule systems biology. 
x 
 
miRNAs accumulate in processing bodies (PBs), sub-cellular foci enriched 
in RNA processing enzymes, as a cause or consequence of post-transcriptional 
gene silencing. Despite numerous observations, quantitative analysis of miRNA 
localization within PBs has been lacking. iSHiRLoC of miRNAs revealed that only 
a small fraction of miRNAs localized to PBs and majority of PBs contained only 
one or two fluorophore labeled miRNA molecules. Moreover, miRNAs resided in 
PBs only for a few hundred milliseconds, suggesting the preponderance of 
unstable interactions. Heterogeneous distribution of miRNAs in PBs coupled with 
the observation that miRNAs docked onto PBs either stably or transiently 
suggests an underlying diversity in the composition of these two complexes. 
Some mRNAs contain multiple binding sites for a specific miRNA, 
presumably for enhanced regulation. To quantify the binding stoichiometry 
between miRNAs and such mRNAs, I developed a single-molecule in vitro assay 
based on the step-wise photobleaching of fluorescent probes. Our data, in two 
different cell extracts, showed that a majority of mRNAs are either bound by zero 
or a single miRNA under conditions of maximal repression. Computational mRNA 
structure analysis predicted low accessibility of miRNA binding sites. Together, 
these data suggest that a higher number of binding sites corresponds to a higher 
probability of binding, not multiple occupancy. 
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Chapter 1 
Surveying the RNA World: One Molecule at a Time 
 
1.1 Introduction 
Following its isolation in 1869 by Friedrich Miescher (1), research on ―nuclein‖, 
now known as DNA, took a meteoric leap. Seminal work, including the 
elucidation of its composition and double-helix structure, the Avery-Mcleod-
Mcarthy transformation experiment, and the Hershey-Chase hereditary 
experiments, soon followed and culminated in the central dogma of biology as we 
know it; DNA, not protein, is the carrier of genetic information, which is 
transferred to functional proteins by way of RNA. Since then, the line separating 
science fiction from science has been blurred, largely owing to the advent of 
molecular cloning and genetic engineering. The possibility that ‗life‘ can be 
created or tweaked within a test-tube (2-4), as exemplified by the cloning of a 
mammal - ‗dolly‘ the sheep – from adult somatic cells by Wilmut and coworkers 
(3), has made the word ‗DNA‘ commonplace in every household. 
The insight that DNA is the storehouse of (inheritable) genetic information 
holds the promise of explaining disease susceptibility and progression, genetic 
variation and human complexity. Initially proteins, built from a more diverse set of 
20 amino acids as compared to the 4 building blocks of nucleic acids, are 
complementarily deemed the workhouse of the cell that catalyzes all biochemical 
reactions. RNA was merely considered an information messenger involved in the 
transcription of the genetic information stored in DNA into proteins. The discovery 
of independently functioning catalytic RNAs or ribozymes (5) shattered this 
misconception and thus heralded an era wherein RNA takes more of a ‗center 
stage‘. The emergence of ribozymes also gave rise to the hypothesis of a 
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primordial RNA world, according to which RNA was the original genetic material 
that could both self-replicate and catalyze the enzymatic reactions necessary to 
sustain life.  
 
1.2 Non-coding RNAs at the Forefront of Biology 
Despite the fact that the human genome is 30-fold larger than that of C. elegans, 
the number of protein coding genes in humans is only ~1.2-fold larger than in the 
worm (6, 7). In addition, sequencing of the human genome has shown that only 
~1.5% of the entire human genetic material codes for proteins (6, 7). These 
observations lead to an interesting and important question; what criteria 
distinguish organisms that are as complex as humans from relatively simpler 
ones such as the worm? The answer lies in the other 98.5% of the human 
genome that does not encode proteins and previously was perceived as ‗junk‘. 
The complexity of organisms, i.e. a qualitative measure of the intricacy involved 
in organismal development, body plan organization and cellular diversity, is now 
known to be related to the amount of non-protein coding sequences within the 
genome (Fig. 1.1). Furthermore, the fundamental reason behind complexity is 
not the mere presence of such sequences, but also their transcription into RNA. 
Current estimates place the fraction of the mammalian genome that is 
transcribed at ~30–60% (6-8). Considering that only ~1.2% of the entire genome 
is protein coding, non-coding RNAs (ncRNAs) are predicted to be one of the 
most abundant molecular species within a eukaryotic cell. As they do not code 
for proteins, these ncRNAs were initially thought of as ‗transcriptional noise‘, i.e. 
a basal amount of erroneous transcription accompanying the fruitful synthesis of 
protein-coding messenger RNAs (mRNAs), but at least some of them were later 
found to exhibit profound regulatory roles (6-8), thus forming the basis for cellular 
homeostasis rather than constituting an aberration. 
 ncRNAs are a diverse group of RNA molecules, both structurally and 
functionally. These RNAs also vary in size from several kilo bases (kb), as in the 
case of long ncRNAs (9) and intronic regions of precursor messenger RNAs (pre-  
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Figure 1.1. Percent of genomic DNA not coding for proteins plotted against the 
complexity of organisms. Reprinted from reference (10) with permission from 
Scientific American, Inc.  
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mRNAs), to small silencing or microRNAs (siRNAs or miRNAs) that are ~22 
nucleotides (nt) in length (11, 12). Moreover, they perform a combination of 
structural, catalytic and regulatory roles, and are widely distributed through all life 
forms. Structural ncRNAs include small nuclear RNAs (snRNA), small nucleolar 
RNAs (snoRNAs), transfer RNAs (tRNAs) and ribosomal RNAs (rRNA). These 
RNAs act as structural scaffolds for the organization of large RNA protein 
complexes, often referred to as ribonucleoproteins (RNPs), which as a complex 
elicit a biological function. For instance, snRNAs associate with several proteins 
to form the spliceosome (13), which catalyzes the removal of non-coding intronic 
regions from a pre-mRNA in eukaryotes, resulting in a mature mRNA bearing the 
appropriate information for protein synthesis. Based on similar principles of 
ordered assembly, the ribosome also forms a functional RNP from greater than 
50 proteins and 3 or 4 rRNAs, which with assistance from tRNAs (molecules that 
are enzymatically ‗charged‘ with amino acids and decode the genetic information 
of mRNAs) synthesize cellular proteins (14). As the active sites of both of these 
machineries contain RNA, they have often been described as ribozymes that 
require protein cofactors (13-15) .  
The first functional ribozymes were discovered in the 1980‘s by Tom Cech 
and Sidney Altman, who were investigating the functions of Tetrahymena group I 
introns (5) and bacterial RNase P (16), respectively, for which they shared the 
1989 Nobel Prize in Chemistry. Group I introns catalyze their own excision from 
between protein coding regions in pre-mRNAs, whereas RNase P mediates the 
5`trimming of precursor-tRNAs to produce the functional tRNA. To date, several 
other self-cleaving catalytic RNAs have been identified, initially in sub-viral 
particles and now also more broadly through all life forms (17, 18). The hairpin, 
hammerhead, hepatitis delta virus (HDV) and the Neurospora crassa Varkud 
satellite (VS) ribozymes are the four classical examples of such self-cleaving 
catalytic RNAs (19). These ribozymes undergo a series of conformational 
changes (20-22) and eventually dock into a catalytically active structure to cleave 
their own backbone. In sub-viral particles, self-cleavage causes the 
monomerization of longer multi-copy genomes synthesized via rolling circle 
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replication (19). More recently, a variant of the HDV ribozyme termed the CPEB3 
ribozyme, has been discovered in the human transcriptome (23, 24). This and 
similar discoveries suggest that evolutionary remnants or precursors of viral 
ribozymes appear to be buried within the mammalian genome.  
In contrast to other self-cleaving RNA enzymes, the glmS ribozyme, which 
is present in the 5`untranslated region (UTR) of genes responsible for 
glucoseamine-6-phosphate (GlcN6P) biosynthesis in bacteria, catalyzes self- 
cleavage of its backbone only when bound by GlcN6P as a cofactor (25, 26). 
Under conditions of elevated GlcN6P concentration, the ribozyme binds this 
cofactor and catalyzes its own cleavage, resulting in the destabilization of the 
GlcN6P synthesis genes (26). In this fashion, the ribozyme senses cellular 
GlcN6P abundance and creates a negative feedback loop to regulate GlcN6P 
biosynthetic enzymes. Such metabolite-binding ncRNAs, which regulate the 
activity of mRNAs in which they are embedded, are called riboswitches (27). The 
vast majority of riboswitches, however, lack catalytic activity and mediate gene 
regulation by inhibiting transcription or translation of their host mRNA (27). The 
S-adenosyl methionine (SAM), thiamin pyrophosphate (TPP), pre-queuosine-1 
(PreQ1) and glycine riboswitches are a few examples of gene regulatory 
bacterial ncRNAs (27). 
Conceptionally related to riboswitches, 5` and 3`UTRs of mRNAs as well 
as intronic regions in pre-mRNAs can similarly be classified as cis-acting 
regulatory ncRNAs (7). These ncRNAs, unlike riboswitches, are present only in 
eukaryotes and act in cis as receivers of trans-acting signals, by forming 
secondary structures that recruit regulatory proteins. In addition to serving 
regulatory roles, introns can have significant sequence diversity and can mediate 
alternative splicing, recombination of exons in multiple ways, to increase protein 
diversity.  Interestingly, the length of UTRs (28) and the fraction of alternatively 
spliced genes (29) scale with the developmental complexity in animals, indicative 
of the greater sophistication of mRNA regulation in higher organisms.  
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Long ncRNAs (lncRNAs) (9), also known as long-intervening ncRNAs 
(lincRNAs), are regulatory RNA molecules greater than 500 nt in length. These 
ncRNAs can function as cis- or trans-acting elements to elicit epigenetic 
regulation by recruiting chromatin remodeling factors at appropriate genomic foci. 
Classical examples of lncRNAs include XIST (30) and HOTAIR (31), the former 
silences one of the two X chromosomes in all eutherian females to achieve 
proper X-linked gene dosage, whereas the latter is proposed to promote cancer 
metastasis.  
In summary, we are in the midst of a fundamental revolution in our 
understanding of cellular gene expression.  Small (<500 nucleotides) regulatory 
ncRNAs have only over the past 10 years been recognized as abundant key 
elements of the cellular machinery responsible for the maintenance, regulation, 
and modification of genetic information (9, 32, 33). At the forefront of this 
revolution stand two classes of small regulatory ncRNAs; silencing RNAs 
(siRNAs) and microRNAs (miRNAs).  
 
1.3 Small RNAs, Big Impact: miRNA Mediated Gene Regulation 
In 1993, two research groups independently arrived at the conclusion that protein 
coding genes are regulated by endogenously expressed, non-protein coding 
genes, via the hybridization of their complementary RNAs (34, 35). Within a few 
years, Andrew Fire and Craig Mello published a pair of seminal articles (36, 37) 
that provided an explanation for the previously observed suppression (38, 39) of 
endogenous genes, which they found to be mediated by the introduction of 
homologous RNA. These and several other key findings (40-43) marked the 
inception of the RNA silencing or RNA interference (RNAi) field. 
RNA silencing is an evolutionarily conserved cellular phenomenon 
wherein small non-coding RNA fragments act as triggers to either repress or 
destroy complementary mRNA targets (12). Consequently, RNAi has become a 
tool that exploits the introduction of exogenous siRNAs into the cellular RNA 
silencing pathway to mediate mRNA cleavage (44). As a tool, RNAi provides a 
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rapid means of depleting specific mRNAs by introducing double-stranded RNA 
homologous to a particular message leading to its sequence-specific degradation 
with profound implications in functional genomics and therapeutics. Additionally, 
the observation that viral RNAs can be targeted effectively via RNAi (45) 
implicates this pathway as an evolutionarily ancient, intracellular antiviral immune 
response.  
By contrast, miRNAs are endogenously expressed and processed small 
RNAs, ~20-30 nt in length, that bind to short (6-8 nt) so-called ―seed‖ sequences 
in the 3‘UTRs of target mRNAs to typically downregulate the gene expression of 
target mRNAs at the post-transcriptional level (11, 12).  As abundant high-level 
gene regulators they play key roles in almost all cellular processes (11, 12, 46, 
47), and their aberrant expression has been associated with several human 
pathologies, including cancer (48, 49).  About 50% of all human genes (~11,000) 
are computationally predicted to be controlled by ~1,000 different miRNAs, while 
the rest of the human genes appear to evolve to avoid such control (47, 50, 51).  
As an additional layer of complexity, a single miRNA is thought to typically 
regulate several hundred mRNAs, whereas a single mRNA is predicted to often 
be regulated by multiple miRNAs of the same or different sequence.  A picture 
thus emerges of a complex regulatory network that allows for rapid adaptation of 
the whole transcriptome to changing environmental cues during, for example, cell 
development or cancer onset.  However, tools to experimentally verify this 
regulatory network are only slowly emerging. 
Biosynthesis of functional miRNAs follows a tightly regulated multi-step 
pathway (Fig. 1.2) (47). Bioinformatic annotations show that most miRNA genes 
are located in intergenic regions with their own promoters and are transcribed as 
primary transcripts (pri-miRNA) by RNA polymerase II (RNAPII) or RNAPIII (52, 
53). It was also observed that 50% of known miRNAs are in close proximity to 
other miRNAs, leading to the proposition that clustered miRNAs might be 
transcribed from a single polycistronic transcription unit (54). Pri-miRNAs fold into 
one or several stem-loop structures containing imperfectly base-paired stems,  
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Figure 1.2. miRNA biogenesis pathway. Reprinted from reference (47) with 
permission from the Nature publishing group.   
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which are cleaved in the nucleus by a protein complex that contains Drosha (an 
RNAse III type endonuclease) and DGCR8 (the microprocessor). This enzymatic 
reaction results in the formation of precursor-miRNAs (pre-miRNA) that are ~70 
nt long and contain a 2-nt overhang on their 3`end. Some pre-miRNAs are 
produced from very short introns (mirtrons) of protein coding pre-mRNAs as a 
result of splicing and debranching, thereby bypassing the Drosha–DGCR8 step 
(55). pre-miRNAs contain a single stem-loop and are transported by Exportin-5 
via the nuclear pore complex (NPC) into the cytoplasm, where they are cleaved 
by protein complexes containing the enzyme Dicer to yield ~22-bp miRNA 
duplexes. In general, this product of Dicer has 2-nt overhangs on the 3`end of 
each strand, with the overhang on one end resulting from Drosha cleavage. In 
mammals, the protein argonaute 2 (AGO2), which has robust RNaseH-like 
endonuclease activity, can support Dicer processing by cleaving the 3′ arm of 
some pre-miRNAs, thus forming an additional processing intermediate called 
AGO2-cleaved precursor miRNA (ac-pre-miRNA) (56). Processing of pre-miR-
451 also requires cleavage by AGO2, but is independent of Dicer cleavage and 
its 3′ end is generated by exonucleolytic trimming (57, 58). Following processing, 
one strand of the miRNA duplex (the guide strand) is preferentially incorporated 
into the miRNA-induced silencing complex (miRISC), whereas the other strand 
(passenger or miRNA*) is released and degraded. Generally, the retained strand 
is the one that has the less stably base-paired 5′ end in the duplex. Passenger 
strands are not always byproducts of miRNA biogenesis; they can also be loaded 
into miRISC to function as miRNAs (59-61). 
As part of miRISC, miRNAs base pair with target mRNAs to mediate their 
repression (Fig. 1.3) (62). In the relatively rare case where the miRNA binds with 
complete complementarity, the mRNA target is endonucleolytically cleaved by 
Ago2, leading to a complete knockdown of protein expression as expected for 
RNAi. In contrast, mRNAs bound by partially complementary miRNAs are 
repressed via translational repression or deadenylation and degradation. Initially, 
translational repression was considered a hallmark of gene regulation mediated 
by only partially base-paired miRNAs (63, 64). Translation repression is thought  
10 
 
 
Figure 1.3. Possible mechanisms of miRNA mediated gene regulation in 
mammals. Adapted from reference (65) with permission from nature publishing 
group. 
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to occur via inhibition of translation initiation or elongation. It was first observed 
that only m7G-capped, not ApppN capped or IRES containing, mRNAs 
underwent miRNA-mediated repression. Polysome gradient analyses have also 
shown that m7G-capped miRNAs containing a functional let-7 miRNA binding site 
move up the gradient, indicating reduced or no ribosome loading onto the mRNA 
and thus supporting suppression at the translation-initiation step (66, 67). 
Moreover, there is substantial evidence that proteins of miRISC disrupt the 
essential eIF4E-eIF4G interaction or bind directly to the 5`cap, thus impeding the 
formation of the translation initiation complex. One of the proteins that disrupt 
initiation complex formation is believed to be from the AGO family, which are 
core components of miRISC, as it contains a domain of (limited) homology to the 
cap-binding domain of eIF4E (68). This suggests that AGO may compete with 
eIF4E for cap binding, thus preventing effective PABP-eIF4G interaction. In 
addition, it was shown that either the 40S subunit (66, 69) or 60S (70, 71) subunit 
are inhibited from binding to repressed mRNAs, further corroborating the 
initiation block model. In contrast to earlier reports, studies in C. elegans showed 
that lin14 and lin28 mRNAs, which are targets of lin4 miRNA, remained 
associated with polysomes even though the protein level was strongly repressed 
(72). Additionally, miRNAs and AGO proteins co-sedimented with their mRNA 
targets and polysomes in human cells (73-75). These results show that 
ribosomes can still be associated with the miRISC-mRNA complex, thus instead 
supporting a post-initiation repression model.  
The notion that mRNA destabilization and decay is a mode of miRNA-
mediated repression was initially supported by microarray analysis of transcript 
levels in cells and tissues (76). The miRNA pathway was inhibited in these cells, 
resulting in a marked increase in the abundance of several mRNAs validated as 
miRNA targets. Since then several groups have found evidence that miRNAs act 
by predominantly degrading their targets (77, 78). These results recently were 
further validated using high throughput sequencing and ribosome profiling, which 
showed that only 7% of all miRNA targets were translationally repressed (79). 
However, mRNA degradation is initiated by a gradual decrease in the length of 
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the poly-A-tail and can either proceed by 3` to 5` decay or by decapping followed 
by 5` to 3` decay (80); AGO hypothetically can bind to the 5`cap, preventing 
circularization of the mRNA, which in turn can render the poly-A tail vulnerable to 
cleavage.   
Sequestration of miRNA-bound mRNA complexes to processing bodies 
(PBs) (67, 81), intracellular foci enriched in RNA degrading enzymes (82), was 
initially deemed an attractive mechanism of miRNA mediated gene regulation, in 
part because the hypothesis exemplifies spatial organization of cellular function. 
However, it still remains possible that repressed targets localize to PBs only as a 
consequence of other modes of repression (83).  
In summary, a number of competing hypothesis regarding the mechanism 
of miRNA-induced gene repression have been proposed (Fig. 1.3). It is a distinct 
possibility that this divergence simply arises from the fact that experiments on 
different systems (cells, cell-free extracts, etc.) using different methodologies 
give different answers. In addition, it is not yet clear whether miRNAs repress 
their target in a specific cell either by a single mechanism or by several parallel 
mechanisms. These questions arguably can be answered only by direct 
observation of the repression of single mRNA targets in real-time. To this end, I 
resorted to single molecule fluorescence microscopy in live cells and in vitro.  
 
1.4 Single Molecule Fluorescence Microscopy 
The cell is a complex mixture of single molecules that function in a highly 
organized and concerted manner to forge life. Conversely, each molecule within 
the cell is, in principle, a local reporter on the nature and dynamics of its 
surroundings. Yet studies of biomolecules, such as probing their structure, 
measuring their reaction kinetics or determining their intracellular distribution, 
have mostly been conducted on the ensemble level, reporting the ―average‖ 
structure, mechanism or cellular organization. Important information hidden 
within this average, as a seemingly homogenous population of molecules can, in 
fact, be composed of surprising heterogeneity. This fact is exemplified by the 
recent realization that the flow of genetic information is spatially and temporally 
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organized through the transport of single mRNA molecules to discrete regions in 
an organ (84) or even a single cell (85, 86) to synthesize proteins in the region 
where they are needed most. For example, as seen by live-cell fluorescence 
microscopy, a significant fraction of the mRNA encoding the cytoskeletal protein 
actin localizes to the leading edge of the cell. Upon tracking the diffusion of single 
actin mRNA molecules, multidirectional movements with net displacement 
vectors pointing towards the leading edge of the cell were observed, thus 
rationalizing the average cellular organization of the mRNA (87). 
Single-molecule fluorescence microscopy (SMFM) generally reveals rare 
events and transient species or intermediates on a reaction pathway, like those 
found in protein (88, 89) or RNA folding landscapes (20, 90), without the need to 
perturb or synchronize the molecules of the system to generate a signal. Such 
information is easily lost by averaging in regular ensemble measurements. 
According to the ergodic theorem, the time average of any observable obtained 
from visualizing a single molecule is equivalent to the population average, 
provided the molecule is visualized over a sufficiently long period of time. Yet, 
single-molecule studies have also shown that some RNA and protein enzymes 
exhibit so-called static heterogeneity with conformationally and functionally 
distinguishable molecular species that only slowly exchange on an experimental 
time scale (20-22, 91). The types of information obtained from SMFM thus 
provide unprecedented insights into the functional mechanisms, dynamic 
properties, and sub-cellular localization of biomolecules, with only limited 
perturbation of the underlying biology. 
Two major aspects of microscopy, accuracy and resolution, define the quality 
of imaging in a quantitative manner. On one hand, accuracy describes the radius 
of the circle (or sphere in the case of three-dimensional localization) within which 
it is certain that an object is localized (i.e., the error associated with localizing an 
object). On the other hand, resolution is the distance below which two closely 
located objects cannot be distinguished as separated from one another. In 1873, 
Ernst Abbe observed the failure of a lens-based optical microscope to distinguish 
two features closer than half of the wavelength of the illumination light on the 
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lateral plane. This imposes a theoretical limit on the resolution of fluorescence 
microscopy of 200–300 nm (using visible, ~500-nm illumination light). This 
relationship is more accurately described by: 
  
    

sin2n  
                                                                                               (Eq. 1)  
 
where Δd is the distance between two closely located spots, λ is the wavelength 
of light used for illumination, n is the refractive index of the medium in which the 
lens is working and α is the half-angle of the maximum cone of light that enters or 
exits the lens. The obtainable axial resolution as then described by:  
 


2sin2n
z                                                                                                  (Eq. 2)  
  
is almost threefold higher than the resolution limit in the lateral dimension (~500–
600 nm).  
For over a century, Abbe‘s law (also referred to as ―Rayleigh‘s resolution 
limit‖) was considered a fundamentally limiting factor in intracellular imaging. This 
problem is exacerbated for single molecules: their intracellular density is often 
much higher than that commonly used in SMFM, leading to severe overlap of 
their images. Given that a typical human cell contains ~1010 protein molecules 
(92) of ~2.5-nm radius and the cell by itself has a volume of ~4x1012 nm3, a 
conservative estimate of ~20% of the total cell volume is filled with just proteins. 
Factoring in other molecules, such as lipids, nucleic acids, inorganic ions and 
small metabolites, the density of molecules, in general, within a cell is 
astoundingly high. Even in such a crowded environment biomolecules often 
diffuse at speeds of several nanometers per second, frequently colliding with 
other molecules and changing direction. Studying single molecules under such 
conditions necessitates the need for higher accuracy and resolution than that 
obtained from conventional optical microscopy.  
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Single-molecule techniques can be broadly classified into two groups, those 
based on optical observation, which encompasses all SMFM approaches 
including single molecule fluorescence resonance energy transfer (SM-FRET) 
(93), and others based on mechanical interaction, such as manipulation by 
optical tweezers and imaging by atomic force microscopy (AFM) (94). Of these, 
SMFM has especially proven to be valuable in probing molecular properties in 
environments as complex and dense as those within cells. Currently available 
ultra-high-resolution microscopy methods can be categorized as: 1.) methods 
pertaining to localization of a few single molecules with nanometer-scale 
precision (super-accuracy imaging (95)); and 2.) methods resolving many single 
molecules within a densely populated sample by localizing only a sparse subset 
of them at a time through repeated super-accuracy imaging (often termed super-
resolution imaging (95)). With a focus on super-accuracy imaging, a general 
outline of the important requirements for performing single-molecule 
experiments, in addition to a broad overview of well-established single-molecule 
techniques that localize molecule with nanometer scale precision, is given in the 
following. 
 
Experimental Design in Single-Molecule Fluorescence Microscopy. The 
sensitivity required to detect single molecules is achieved by carefully selecting 
the sample concentration, instrumentation, and probe used to label the molecule. 
The concentration of molecules should be kept low enough, in the nanomolar to 
picomolar range, to distinguish one molecule from another. While controlling 
sample concentration in vitro is relatively easy, it presents a major challenge in 
vivo. Another important parameter to be optimized in SMFM is the signal-to-noise 
ratio (SNR) (i.e., the ratio of useful signal (photons) emitted by single molecules 
and unwanted, spurious background signal (noise)). Noise can arise from 
impurities in the sample, from fluorescent molecules in the sample that are not in 
focus, or from shot noise (dark counts) of the detector. From its definition, it is 
clear that having a high SNR is preferred, but several factors can markedly affect 
this value (as discussed under section ―Probes‖). A whole arsenal of solutions, in 
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the form of improved optical configurations (illumination methods, light sources, 
and detectors) and fluorescent probes, is currently available and constantly being 
refined to overcome low SNR.  
Modes of illumination. Schemes to illuminate a sample can be primarily divided 
into two categories: far-field illumination and near-field illumination. In far-field 
imaging, the distance between the objective lens and sample is at least an order 
of magnitude greater than the wavelength of light used. Conversely, in near-field 
imaging, the sample is separated from the illuminating focusing lens or fiber 
optics by a distance much smaller than the illumination wavelength. Additionally, 
the diameter of the lens or fiber is smaller than the wavelength of light used 
(typically ~80 nm) (96, 97). Such a configuration ensures that the light interacts 
with the sample before effects of diffraction come into play, leading to higher 
resolution. Near-field illumination requires very flat samples for the lens or fiber 
optics to scan over it, making it less useful for intracellular imaging. In the 
following, we focus on some of the more popular far-field illumination schemes 
used in SMFM imaging (Fig. 1.4).  
Wide-field epi-illumination. In wide-field epi-illumination schemes, light passes 
through the objective‘s optical axis, illuminating all molecules in the light path. 
Although a specific plane of the sample can be focused, molecules present in 
other focal planes also get excited, contributing significant background. This 
illumination method is suitable for SMFM only when bright molecules are 
sparsely distributed, such that background contribution from out of focus 
molecules is negligible.  
Total internal reflection (TIR) illumination. TIR was first used in 1981 by Daniel 
Axelrod in conjunction with fluorescence (TIRF) and fluorescence microscopy 
(TIRFM) to image the lipid probe 3,3´-diocta-decyclindocarbocyanine (diI) in 
human skin fibroblasts (98). When light is transmitted through a medium of 
higher refractive index (ni; e.g., glass) into one of lower refractive index (nr; e.g., 
water) at incident angles (θi) greater than the critical angle given by θc = sin
-
1(nr/ni) (Snell‘s Law), light is totally reflected within the first medium. However, 
because of its wave properties, some light will be transmitted into the medium of  
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Figure 1.4. Wide-field Illumination methods. In live cell imaging, typically, OTIRF 
(a), HILO (b) or wide-field epi-illumination (c) is used. By simply moving the 
excitation light away from the optical axis, one can switch from wide-field epi-
illumination to HILO or OTIRF. In all three cases, the incident light and the 
fluorescent light pass through the same objective. By contrast, in PTIRF (d) the 
incident light is directed to the sample through a prism. The fluorescent light 
passes through the depth of the sample and the coverslip before being collected 
by the objective. As the sample has to be sandwiched between the slide and the 
coverslip, PTIRF is not suitable for live cell imaging, which demands frequent 
media change and precise control of O2/CO2 gas. 
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lower refractive index in the form of a ―standing‖ or ―evanescent‖ wave. The 
intensity of this light field decreases exponentially from the interphase, 
establishing only a thin lamina of ~150-nm depth within the aqueous sample, 
effectively reducing background fluorescence from outside regions. TIR can be 
achieved by illumination through either a high numerical aperture (NA) objective 
(objective-type TIRFM, or OTIRFM) or a quartz prism that couples the incident 
light into the glass surface (prism-type TIRFM, or PTIRFM). In OTIRFM, the 
incident laser light is focused onto the back focal plane (BFP) of the objective so 
that it is away from and parallel to the optical axis, thus θc is achieved without 
needing an inclined light source. Since the incident light and the fluorescent light 
are focused by the same objective, scattering of laser light within the objective 
leads to some background in the image. PTIRFM avoids this background, but 
poses geometric constraints due to the greater challenge to couple the incident 
light at the right angle and the fact that both sides of the sample need to be 
optically accessed. TIRFM is especially useful in imaging surface immobilized 
molecules or, in the case of (intra)cellular imaging, the basal plasma membrane 
and ~100 nm of the adjacent cytoplasm. 
Highly inclined and laminated optical sheet (HILO) illumination. Although TIRFM 
provides image quality greatly improved over that obtained by traditional epi-
illumination, it is restricted to imaging molecules near an optically transparent 
surface. HILO microscopy (HILOM), also termed variable angle epi-fluorescence 
microscopy (VAEM) or near-TIRFM, overcomes this limitation by greater 
penetration into the sample without significantly compromising the signal-to-noise 
ratio (SNR) (99, 100). Similar to OTIRF, the light source is focused onto the BFP 
of the objective but at a smaller radial distance from the optical axis so that the 
incident angle does not exceed the critical angle. This way, light is refracted into 
the sample at high inclination from the optical axis, thus illuminating a small 
lamina within the sample, the width of which is dependent on the diameter of the 
field of view (FoV) and the angle of incidence. The laminar width of the beam is 
maintained by using a field stop, essentially decreasing the FoV, to prevent 
excessive divergence of the incident beam. Due to the transmission of the 
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refracted beam through the objective into the sample, as in epi- and narrow-field 
illumination, any movement of the objective along the optical axis results in 
focusing on a different plane in the sample along the z-dimension, enabling 
imaging in 3D (99, 100). The excitation beam path for epi-illumination, OTIRFM 
and HILOM are relatively similar so that a single microscope can be used to 
implement all three schemes. 
Narrow-field epi-illumination. In narrow-field epi-illumination light is focused onto 
a small volume element within the sample, thus exciting only molecules in the 
excitation volume and not those outside of it. Confocal laser scanning 
microscopes work by this principle, wherein focusing of light to a specific volume 
is achieved by introducing pinholes (or apertures) in the excitation and emission 
paths. Higher resolution as compared to wide-field illumination can be achieved 
by decreasing the width of the pinholes, but this comes at the cost of lower 
photon collection. The method also suffers from slow sample readout rates as 
scanning an entire specimen occurs at one volume element at a time. A 
significant improvement in the scanning rate can be achieved by using spinning-
disc or Nipkow-disc confocal microscopy. A disk consisting of several 
microlenses spins at typically 3,500 rpm to create virtual pinholes for confocal 
detection (101), essentially exciting several distinct regions of the sample 
simultaneously.  
Light sources and detectors. Lasers are preferred over lamps for high-
resolution optical microscopy because of their monochromatic, coherent and 
collimated light. Laser power should be high enough to excite all molecules 
optimally without damaging the sample. The wavelength of light spans anywhere 
from the far ultra-violet (UV) to the near-infra-red (NIR) region of the electro-
magnetic spectrum (350–1000 nm), depending on the nature of the fluorescent 
probe and sample used. However, wavelengths from the visible part of the 
spectrum (450–680 nm) are used most frequently, mainly for two reasons. First, 
the transmission properties of available optics are best in the visible range, and 
second, most well-documented fluorescent probes (fluorophores) have their 
spectral properties in this region of the electromagnetic spectrum. Moreover, UV 
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light is not suitable for imaging living cells: it induces DNA damage and 
sometimes even apoptosis (102). IR lasers are slowly gaining popularity, 
however, because they scatter the least, thus significantly improving sample 
penetration depth.  
Charge coupled devices (CCDs) and avalanche photodiodes (APDs) or 
photomultiplier tubes (PMTs) are most commonly used in SMFM, and depending 
on the type of imaging performed, one or the other is preferred. In wide-field 
illumination, CCDs are the detectors of choice, whereas for narrow-field 
illumination where photons from only a small region of the entire sample are 
collected, APDs or PMTs are used. CCDs contain a large matrix of 
photosensitive elements (or pixels) that simultaneously collect photons over the 
entire detector surface. Photon flux information at each pixel is stored as an 
electronic charge (photoelectron) that is first converted to an analog voltage by 
an amplifier, and then digitized. Intensified (I-)CCDs and electron-multiplying 
(EM-)CCDs amplify the number of photoelectrons through an external amplifier 
and on-chip, respectively, such that the digital number is (marginally) linearly 
dependent on the number of photons collected, making intensity values semi-
quantitative at the (sub-)pixel level. APDs and PMTs are point detectors sensitive 
enough to detect and accurately count single photons, but have to be used in 
laser scanning microscopes to generate images of two-dimensional samples, 
limiting their time resolution. The time resolution obtainable with CCDs is 
primarily limited by the frame rate (number of frames or images per unit time), 
whereas the spatial resolution is dependent on the number of pixels and the 
quantum efficiency (i.e., the fraction of detected versus collected photons). A 
typical CCD used in SMFM has 512 x 512 pixels. While CCDs with higher 
numbers of pixels are available (e.g., 1024 x 1024), they are often less sensitive 
due to lower quantum yields.  
Probes. The sample or the single molecule(s) under inquiry must be conjugated 
to a (fluorescent) probe or carry strong inherent fluorescence to be visualized. 
Synthetic dyes (Cy dyes, Alexa dyes, various forms of rhodamine dyes), 
fluorescent beads, quantum dots, and fluorescent proteins (FPs) are among the 
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common fluorescent probes used in SMFM. FPs are the mainstay of intracellular 
fluorescence microscopy. The cloning and expression of fluorescent proteins 
fused to cellular targets have become routine practices. However, this method of 
labeling comes at the cost that the protein fusion must be expressed 
exogenously, often resulting in overexpression as compared to endogenous 
copies. Using inducible expression systems (103) is one of the many possible 
tricks that can be employed to mitigate overexpression. Non-fluorescent beads, 
especially ones of large size, can be imaged with high precision even using 
microscopes with simple optics, making them an attractive alternative to synthetic 
dyes and FPs in single particle tracking (SPT). Conjugating biomolecules to 
beads and to a certain extent FPs, however, comes with the caveat that the 
attachment of a bulky load could skew the molecule‘s function, localization, 
and/or diffusion. The development of various bioorthogonal labeling strategies 
(104) and fluorogenic photo-affinity probes (105, 106) has made the specific 
labeling of single molecules with small fluorescent probes a viable option, even in 
living cells. A more detailed description and comparison of conjugation 
chemistries and the different organic dyes and FPs used in SMFM can be found 
in several reviews (107-109). 
A fluorophore suitable for SMFM should have high brightness, favorable 
photophysical properties and sufficient inertness so that the label does not 
interfere with the function of the molecule to be tagged. The first two criteria have 
a direct impact on the localization accuracy of single molecules. Brightness, a 
value of photon output that is calculated as the product of a fluorophore‘s 
extinction coefficient and quantum yield, should be high enough to delineate 
signal from noise. Undesirable photophysical processes, such as intersystem 
crossing (triplet state excitation) and photobleaching, markedly affect the quality 
and length of a single-molecule recording. Although the precise mechanism is 
unclear, molecular oxygen is thought to be primarily responsible for 
photobleaching via photo-oxidation of the fluorophore. Several chemical agents 
(e.g., cyclooctatetraene (COT), trolox and 4-nitobenzyl alcohol (110)) and 
enzymatic oxygen scavenging systems (e.g., those containing glucoseoxidase 
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and catalase (22) or protocatechiuc acid and protocatechuate-3,4-dioxygenase 
(111)) can be used to prevent fast photobleaching and quench triplet state 
excitation. Attaching multiple fluorophores per molecule can also increase 
brightness and fluorescence longevity, but it also increases the risk of rendering 
the molecule non-functional. 
Imaging living biological samples presents a unique set of problems, including 
phototoxicity and autofluorescence. Fluorophores, in their excited states, react 
with molecular oxygen in the cell, resulting in the accumulation of phototoxic free 
radicals that can compromise sub-cellular compartments or even the entire cell‘s 
livelihood (112). Thus, a balance has to be struck between the excitation laser 
power (and wavelength) used and the time for which the sample is illuminated, 
especially for long time-lapse experiments. In addition, naturally fluorescent 
molecules present inside cells, such as NADH, FADH and heme, absorb visible 
light and fluoresce, contributing to a high background level of autofluorescence 
during imaging. One way to circumvent autofluorescence and simultaneously 
enhance photostability of FPs is by using cell culture media that do not contain 
any fluorescent molecules, especially vitamins (113). Arguably the best solution 
is, however, to use fluorophore probes that absorb light in the far-red visible or 
NIR part of the spectrum where cellular components show minimal absorption 
(114, 115). 
 
Imaging Single Molecules with Nanometer Scale Localization Accuracy. 
Even before the advent of single-molecule detection methods, there was a 
widespread interest in tracking the movement or diffusion of molecules, 
especially membrane proteins and motor proteins, in solution and in living cells. 
Ensemble methods to calculate molecular velocities and diffusion coefficients 
have existed in the form of fluorescence correlation spectroscopy, or FCS (116), 
and fluorescence recovery after photobleaching, or FRAP (117). Tracking the 
movement of individual molecules with high spatio-temporal resolution seemed 
like a logical extension.  
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During the late 1980s, three different groups independently tracked the 
displacement of single beads over time by high-speed video microscopy both in 
vitro (118) and within living cells (119, 120) with ~10–100 nm lateral accuracy 
and sub-second temporal resolution. Around the same time, the optical 
absorption spectrum of single pentacene molecules was recorded in p-terphenyl 
crystalline matrices at liquid-helium temperature (121). Single-molecule 
fluorescence detection of cryo-cooled pentacene molecules soon followed (122-
124). In an effort to enhance resolution and extend single molecule detection to 
the 3rd dimension, Van Oijen et al. (125) used a combination of confocal 
microscopy and spectrally selective imaging (SSI) to localize single pentacene 
molecules embedded in p-terphenyl crystals. SSI involves sequentially exciting 
individual pentacene molecules of distinct absorption maxima (caused by matrix 
effects), so that each molecule can be localized independent of the presence of 
another within a densely populated, otherwise un-resolvable region. The abilities 
to track beads with high accuracy and to visualize single fluorescent molecules 
with high resolution, together with a continual expansion of the available 
repertoire of optical instrumentation, have converged over the past two decades 
into what is now termed super-accuracy and super-resolution imaging. 
A single fluorescent probe (or a cluster of closely positioned probes) can be 
considered to be a point source of emitted light whose image is, due to 
diffraction, spread over a much larger area on the detector than the actual size of 
the object. Such an image, referred to as a diffraction limited spot, appears as an 
airy disc, composed of a central bright spot surrounded by concentric rings of 
diminishing intensities. The intensity distribution of such an image can be 
mathematically described by what is termed a point spread function (PSF). By 
approximating the PSF with a simple two-dimensional (2D) Gaussian function, 
the intensity maximum, that is, the center of the Gaussian curve, can be localized 
with an accuracy similar in magnitude to the size of the fluorescent emitter, 
effectively breaking the diffraction barrier and Abbe‘s law.  
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Fluorescence imaging with one nanometer accuracy (FIONA). FIONA is a 
super-accuracy method that is used to localize and track single, typically 
fluorescently labeled, molecules with nanometer accuracy in the x-y plane (126). 
Fluorescence from single emitters is detected by a CCD and the intensity is 
plotted as a function of the spatial coordinates x and y (Fig. 1.5A). The resulting 
PSF is fit with a 2D Gaussian function:  
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where z0 is a constant term due to background fluorescence, A is the amplitude 
or maximal signal, x0 and y0 are the coordinates of the center of the distribution, 
and sx and sy are the standard deviations along the axes. The full width at half-
maximum (FWHM) of the Gaussian depicts the variance of the PSF, and the 
(central) peak pinpoints the mean (Fig. 1.5A). The variance divided by the 
number of photons collected results in the most simplistic form of the standard 
error of the mean (s.e.m.), or the precision by which the molecule can be 
localized (127, 128): 
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where Δx is the error in localization, ‹(Δx)2› is the s.e.m., s2 is the variance and N 
is the number of photons. The s.e.m. also depends on other important 
parameters, including the detector noise, background noise and the effective 
pixel size (128): 
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where a is the effective pixel size, which is simply the CCD pixel size divided by 
the overall magnification used, and b represents noise of any form. This equation 
shows that greater localization accuracy can be achieved by increasing the 
number of photons collected, decreasing the noise, and/or reducing the effective 
pixel size. High (1.2–1.65) NA objectives and back-thinned CCDs are typically 
used to collect as many photons as possible with minimal detector noise. 
Decreasing the effective pixel size requires a corresponding increase in 
magnification, which in turn reduces the number of photons collected per unit 
square area of the detector, significantly compromising the SNR. Therefore, a 
localization precision of 1–2 nm can be achieved under ideal conditions by 
collecting 5,000–10,000 photons using a CCD with effective pixel size of 80–120 
nm. The same principles can be applied to each frame of a movie (or series of 
multiple frames), tracking the movement of a single molecule with ~1-nm 
accuracy, hence the name FIONA. Depending on the frame rate at which the 
movie is recorded, a temporal resolution of up to 1 ms can be achieved (126).  
Perhaps one of the most convincing proof-of-concepts for FIONA and a 
spearhead for the broader adoption of single molecule techniques, originated 
from the investigation of motor protein movements. The mechanism by which 
motor proteins translocate on a cytoskeletal ―path‖ was under debate for several 
years. Myosin V is a dimeric-motor protein that contains a catalytic (―head‖) 
domain, a light chain ―arm‖ that is composed of six calmodulins, and a cargo 
binding domain on each of its monomers that is held together by a coiled-coil 
―stalk‖ (Fig. 1.5B). One study (129) postulated that kinesin, another motor 
protein, moves over microtubules by an ―inchworm‖-type mechanism, where one 
of the arms always leads, while another study (130) hypothesized a hand-over-
hand mechanism, in which the two heads alternately move past one another. 
Yildiz et al. (126) resorted to FIONA to resolve the controversy. They used a 
similar myosin-light-chain-domain labeling strategy to that used by Goldman and 
coworkers (130). Rhodamine-labeled calmodulin was added to myosin V 
monomers so that each dimeric motor protein contained a single fluorophore  
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Figure 1.5. FIONA and its application. (A) CCD image of a single Cy5 labeled 
RNA (left inset) and its corresponding PSF fit to a 2D Gaussian. Residuals from 
the fit, which depicts the deviation of data points from the fitted curve, are also 
shown (right inset). (B) The hand-over-hand translocation model of myosin V as 
evident from single molecule step traces of myosin V labeled with bifunctional 
rhodamine on one of the twelve calmodulin light chains (126). On average, the 
protein alternates between 52 nm and 23 nm steps as it moves. This stepping 
pattern suggests that X, the distance along the direction of motion between the 
center of the coiled-coil stalk and labeled calmodulin, is 7.5 nm, i.e., the third 
calmodulin from the top is labeled. Sometimes, the speed of myosin V 
translocation is much faster than the frame rate of image acquisition, due to 
which, some 52 nm and 23 nm steps combine to yield ~74 nm apparent steps. A 
histogram of six myosin V molecules taking a total of 92 steps, representing the 
frequency of occurrence of specific step-sizes, is shown in the inset. (Panel C 
reproduced with permission from (126)). 
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(i.e., one fluorophore per two arms). The labeled arm is expected to take 
alternative 37-2X nm and 37+2X nm steps if it translocates by a hand-over-hand 
mechanism, where X is the distance of the fluorophore from the stalk. For a 
labeled calmodulin closest to the head, X would be ~18.5 nm, and hence, the 
motor should take alternating 74 nm and 0 nm steps. Alternatively, if the motor 
moves by an inchworm type mechanism, the step size should be a constant ~37 
nm. Not only could the authors convincingly show that the protein moved via a 
hand-over-hand mechanism by plotting the position of the fluorophore with time, 
they could also distinguish between molecules that had the labeled calmodulin at 
different positions with respect to the stalk (Fig. 1.5C). Similarly, FIONA has also 
been used to track the path taken by kinesin as it ―walks‖ over microtubules in 
vitro (131).  
 
Multi-label imaging and particle tracking. In an effort to extend the use of 
FIONA to densely populated samples in which the PSFs overlap, both Paul 
Selvin‘s group (132) and Norbert Scherer‘s group (133) developed a method that 
exploits the quantized photobleaching behavior of single fluorophores to perform 
FIONA localization, and termed it Single-molecule high-resolution imaging with 
photobleaching (SHRImP) and nanometer localized multiple single molecules 
(NALMS), respectively.  
The principle of SHRImP/NALMS can be explained by considering a sample 
that contains two molecules A and B whose PSFs overlap (PSFA + PSFB). If both 
fluorophores photobleach, the signal reduction in a plot of intensity over time will 
typically be in the form of two consecutive steps, each step representing the 
photobleaching of a single fluorophore, since it is highly unlikely for multiple 
fluorophores to photobleach at the same time. This step-wise photobleaching can 
be used to count the number of fluorophores with overlapping PSFs (134, 135). 
Once A has photobleached, the image only contains PSFB, which can now be 
localized with high accuracy using FIONA. The resultant image can then be 
subtracted from the original image (PSFA + PSFB) to derive PSFA, another single 
PSF to which the FIONA can be applied, thus localizing both molecules with high 
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accuracy in different images of a movie. The same concept can be applied to a 
sample that contains more than two overlapping PSFs, enabling localization of 
molecules that are separated by as low as ~10 nm (132, 133). 
Gordon et al. (132) used SHRImP to resolve double-stranded (ds) DNA 
molecules each labeled with one Cy3 at both 5´ends. Upon imaging immobilized 
biotin-tagged DNA molecules of different lengths (30–50 bp) with TIRF, they 
deduced the expected length for each molecule of 3.4Å per base pair. Qu et al. 
(133) used NALMS to arrive at a similar conclusion, but in addition to using short 
dsDNA also used long λ-DNA hybridized to multiple Cy3-PNA conjugates to 
resolve up to ~20 serially overlapping PSFs, each separated by ~7 nm.  
Single-molecule high-resolution colocalization (SHREC), on the other hand, 
resolves overlapping PSFs originating from molecules labeled with spectrally 
distinct fluorescent dyes. Unlike SHRImP/NALMS, SHREC does not depend on 
photobleaching of fluorescent probes so that the observation window for imaging 
can be significantly extended (136). However, it requires the precise mapping of 
images from channels of distinct spectral range (color) onto one another, which is 
non-trivial due to chromatic aberrations of the optics. Spudich and coworkers 
therefore developed a mapping calibration for SHREC that uses fiduciary 
markers to measure the registration between the color detection channels. To 
this end, surface immobilized beads of sub-diffraction (100 nm) diameter labeled 
with both Cy3 and Cy5 (fiduciary markers) were imaged at such a low density 
that only a single bead was visible per FoV. This bead was then moved in 0.5-µm 
steps in the pattern of a 12x26 grid with a piezoelectric stage. The resultant 312 
images were stacked to create a single image containing 614 regularly spaced 
PSFs (312 each in the Cy3 and Cy5 channels). Each PSFs in each channel was 
independently fit with a 2D Gaussian function and localized by a FIONA-like 
algorithm. Combining all locations thus determined, a local weighted mean 
transformation (137) was calculated to map any point in the Cy5 channel 
precisely onto its corresponding point in the Cy3 channel. The resultant map is 
used as a template to localize single dual-labeled molecules.  
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To benchmark their SHREC technique, the authors used Cy3/Cy5 doubly-
labeled dsDNA similar to that used in the SHRImP and NALMS studies and 
obtained very similar results (136). They then went on to use SHREC to 
concomitantly visualize the movement of both legs of myosin V in real-time. To 
this end, they exchanged the native calmodulines with a mixture of either Cy3- or 
Cy5 labeled calmodulins so that, on occasion, the two legs of a myosin would 
carry each a different fluorophore. As expected, they observed leg step sizes of 
~74 nm, shifted by ~37 nm between the two color channels (136). More recently, 
Singer and coworkers have used a similar super-registration approach to track 
the transport of β-actin mRNAs through the nuclear pore complex (NPC). By 
achieving an unprecedented ~20-nm lateral accuracy at ~20-ms time resolution 
in living cells, they observed and measured the kinetics of a fast three-step 
mRNA transport process taking no more than 200-ms total time (138).  
Of note, the multi-fluorophore super-accuracy imaging methods SHRImP, 
NALMS and SHREC are closely related to and likely inspired the super-
resolution imaging techniques, such as Stochastic optical reconstruction 
microscopy (STORM) and Photo-activation localization microscopy (PALM) 
(REF). The primary goal of the former methods is to localize and track single a 
few molecules over time with high precision, whereas the latter tools aim to 
resolve ~103 times higher densities of single molecules over consecutive imaging 
cycles where only few molecules are turned on at any given time, accumulating 
data for a super-resolution image over time.  
Localization and tracking of single molecules in 3D. Initial efforts in SPT 
involved systems that were either two-dimensional in nature, such as labeled 
lipid molecules in the basal membrane of a cell, or the information obtained were 
2D projections of objects moving in 3D. Verkman and co-workers developed a 
unique method for 3D SPT by introducing a cylindrical lens in the optical path of 
an epi-fluorescence microscope (139). The PSF of a particle in focus then is 
circular in shape and becomes larger and more ellipsoidal when the particle 
moves out of the focal plane. The major axis of the ellipsoid formed when the 
particle is above the focal plane is perpendicular to that formed when the particle 
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is below the focal plane. Using this method, the authors localized red fluorescent 
beads of 100-nm diameter in living cultured cells with ~5-nm lateral and ~12-nm 
axial accuracy at ~500 ms time resolution (139).  
Another powerful method for tracking particles in 3D is off-focus or defocused 
imaging. Developed by Florin and coworkers this method is based on the 
principle that the diameter and pattern of a PSF varies as the object is defocused 
(140). Particles that are slightly out-of-focus have a larger PSF diameter than 
when in focus and those even further from the focal plane give rise to a complex 
ring patterned PSF. The distance of the particle from the image plane can be 
deduced from the intensity pattern of the rings (i.e., the number, diameter, and 
relative intensity of rings). Schutz et al. used this method to record the trajectory 
of single potassium channels labeled with Cy5-tagged hongotoxin ligands in 
living T-lymphocyte cells (141). Although the method yielded lower axial accuracy 
than bead tracking (~40 nm versus ~3 nm), it was the first report of 3D SPT of 
molecules tagged with small fluorescent probes. Toprak et al. (142) used a 
variation of the above method to track phagocytosed beads with ~2.7 nm lateral 
accuracy and ~3.7-nm accuracy along the optical axis at 50-ms time resolution. 
In this technique, termed bifocal imaging, only 30% of the emitted light is 
focused, leaving the other 70% defocused, both of which are then split onto 
different regions of a CCD camera. The focused and defocused PSFs of a single 
particle are first mapped onto one another and then used to record the trajectory 
of the particle in the x-y plane and the z-axis, respectively. 
Another approach for 3D SPT is based on the relative displacement of a pair 
of split images of the PSF onto distinct regions of the CCD. Appropriately named 
Parallax by Goldman and coworkers, either a wedge prism (143) or two closely 
spaced, parallel mirrors (144) are introduced at the back-focal-plane of the 
objective to view a fluorescent particle from two sides of the optical axis of the 
objective. With this optical configuration, the image of a particle moving in only 
the x-y plane is equally displaced in the x and y directions on either region of the 
CCD. By contrast, movements along the z-direction are reflected by the two 
images moving towards or away from each other in the x- (143) or y-direction 
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(144). The authors localized fluorescent particles with ~3-nm accuracy along the 
optical axis, including glucose-transporter containing vesicles in living adipocytes 
and single myosins walking along actin filaments (144, 145). 
Finally, Moerner and coworkers recently introduced a so-called 4f imaging 
system composed of two achromatic lenses and a reflective liquid crystal phase-
only spatial light modulator that convolves the microscope image with a double-
helical PSF (146, 147). As a result, the camera image obtained of a single 
fluorescent particle shows two spots whose relative x,y-positions will twist around 
each other as the z-position of the tracked particle changes (like the two 
backbones of a dsDNA viewed along the double-helical axis). The authors were 
able to localize brightly fluorescent 200-nm beads with ~5–10-nm precision in the 
z-dimension and weaker emitters with up to ~30-nm precision (147). 
 
Super-Resolution Microscopy – Hardware (Optics)-Based Methods. 
Beginning with confocal microscopy, several imaging techniques were developed 
starting in the 1990‘s with the vision of increasing resolution by reducing the focal 
spot size. These methods use specialized optical setups and can be considered 
‗hardware-based‘ solutions for super-resolution imaging, as opposed to 
‗software-based‘ methods like STORM/PALM/F-PALM, which rely instead on 
mathematical processing of a series of acquired diffraction limited images. Spot-
scanning 4Pi microscopy (4PiM) (148) and wide-field I5M (149) are two 
hardware-based techniques that can achieve ~3-7-fold greater axial resolution 
than traditional confocal microscopy. 4PiM uses two opposing high-NA objective 
lenses to illuminate a single focal spot. The coherent addition of wavefronts from 
both lenses narrows the focal dimension across the optical axis, resulting in 
higher resolution. I5M implements the same opposing lens aperture 
enhancement for the detection of fluorescence but uses plane-parallel standing 
waves to illuminate the entire FoV. 
 
Reversible saturable optical fluorescence transitions (RESOLFT) 
techniques. RESOLFT techniques utilize sophisticated excitation configurations 
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to physically decrease the width of the excitation volume and thus decrease the 
size of the PSF below theoretical limits of diffraction (150). These techniques can 
be described as targeted illumination/readout methods that do not require 
detection of single molecules, whereas STORM/PALM/F-PALM are stochastic 
readout methods based on the very features of single molecule detection. 
Implementation of RESOLFT can be loosely divided into three categories—
stimulated emission depletion (STED) (151), ground state depletion (GSD) (152, 
153), and saturated pattern excitation microscopy (SPEM)/saturated structured 
illumination microscopy (SSIM) (154, 155). In STED, two laser beams are used 
(Fig. 1.6A), an excitation beam and a comparatively red-shifted ―depletion‖ 
beam. The excitation laser is first applied, followed immediately (within 
picoseconds) by a doughnut-shaped depletion beam that depletes the excited 
state of all fluorophores except those at the very centre of the original excitation 
beam. Fluorescence from the remaining molecules in the centre of the focal 
volume is then detected. The intensity of the depletion beam can be increased to 
―squeeze‖ the final detection volume to a smaller size. The two beams are raster-
scanned across the entire sample to form the complete image, as is generally 
done in scanning laser confocal fluorescence microscopy (94). Using STED 
microscopy, GFP-labeled viruses and endoplasmatic reticulum were imaged in 
fixed PtK2 cells with a lateral resolution of ~70 nm (156). Recently, Hell and 
coworkers implemented STED in a 4Pi microscope to achieve 40–45 nm in all 
three spatial dimensions by generating a spherical focal spot of the same 
diameter (157). Axial scanning of fixed Vero cells with this configuration revealed 
that immunologically labeled Tom20 (a subunit of the TOM complex) formed 
distinct clusters on the mitochondrial membrane. The group also implemented a 
dual-color imaging scheme in which they used a combination of two excitation-
one depletion events to image both Tom20 and mtHsp70 (a mitochondrial matrix 
protein) simultaneously with ~40-nm resolution in 3D. 
As in STED, GSD requires reversible switching between on- and off-states of 
the fluorophore. However, one of the major differences between the two methods 
lies in the nature of the off-state. Rather than by stimulated depletion, the off- 
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Figure 1.6. STED and GSD. (A) A 2D cross section of the excitation, depletion 
and resultant beams used in STED microscopy. The doughnut shape of the 
depletion beam can be achieved by placing a phase mask in the light path. (B) 
Jablonski diagram depicting STED and GSD. In STED, the depletion beam 
(labeled STED) de-populates the excited state (S1). Fluorescence from very few 
fluorophores, which still remain in the excited state, is then recorded. In contrast, 
GSD works by ‗optical shelving‘. The electronic ground state (S0) of fluorophores 
is depleted by pumping electrons into either the first triplet state (T1) or other dark 
states. Electronic relaxations from these dark states occur at durations that are 
several orders of magnitude higher than that of fluorescence. At any given time, 
the ground state is thus sparsely populated, allowing only a few fluorophores to 
get excited. 
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state in GSD is induced via ground state depletion through increasing the triplet 
state population (Fig. 1.6B). Another difference between the two RESOLFT 
techniques is the use of a single continuous-wave laser for both excitation and 
depletion in GSD. A lateral resolution of ~50 nm has been demonstrated by 
applying GSD to the imaging of microtubules (152, 153) and to aggregates of 
SNAP-25 (152) or integrin-β proteins (153) in fixed cells. SPEM/SSIM is a wide-
field super-resolution technique that excites a fluorescent sample by structured or 
patterned illumination (154, 155). This way unresolved information is first visible 
in the form of low-resolution moiré fringes, which are then computationally 
processed to obtain the final high-resolution image. Similar to other RESOLFT 
techniques, SSIM relies on the non-linear relationship between the fluorescence 
emission rate and excitation intensity, and the practical resolving power is 
determined by the SNR. The improvement in resolution is, however, only twofold 
over that obtained by conventional fluorescence microscopy, which is almost an 
order of magnitude less than that obtained by STORM/PALM/F-PALM. 
Nevertheless, SIM is currently the only subdiffraction high-resolution imaging 
technique that can produce multicolor 3D images of whole cells with 
enhancement of resolution in both lateral and axial directions while using 
conventional fluorescent probes and low intensity light sources. Upon 
implementing 3D-SIM to visualize interphase chromatin architecture and nuclear 
pore complex structure in formaldehyde-fixed cells, never-before seen details of 
these macromolecular structures were unraveled in their native nuclear milieu 
(158). In another report, Kner et al. (159) used a combination of speckle 
microscopy and SIM to observe the evolution of microtubules in living cultured 
cells with ~100-nm lateral resolution and ~100-ms time resolution. Recently, 
impressive time-lapsed 3D images of zebrafish and Drosophila embryos 
undergoing development were recorded using SIM based on a tunable light 
sheet, taking the potential of SIM to new heights (160). By utilizing multiple 
fluorescent tags and imaging embryos at multiple angles the group was able to 
generate a ‗digital‘ fly embryo, highlighting the morphological changes of the 
entire embryo as it develops. 
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The theoretical resolution limit of RESOLFT techniques can be described 
by an extension of Abbe‘s law:  
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where Imax is the intensity of light bordering the centre and Is is the saturation 
intensity required to outperform competing spectroscopic transitions (161). When 
Imax/Is  ∞, in theory ―infinite‖ resolution can be achieved (i.e., down to a single 
molecule or even smaller), but this comes at the cost of using very high intensity 
beams that might damage sensitive samples like living cells. Due to this risk, 
RESOLFT is still generally implemented as an ensemble imaging technique, 
although single molecule detection is definitely possible (162). 
 
Bridging the gap. The gap in attainable limits of resolution between traditional 
microscopy and electron microscopy (EM) has recently been bridged by several 
high-resolution imaging techniques. Ultra-high resolution microscopy, which for a 
long time was thought to be the realm of EM, near-field imaging or negative 
refractive index superlenses (163), has now become commonplace using 
microscope that bear conventional optics. Importantly, the ultimate contribution 
that these optical techniques will have to science depends on their accessibility 
to researchers. To this end, several ‗out of the box‘ microscopes that implement 
PALM, and other high resolution microscopic techniques have recently been 
commercialized by manufacturers like Zeiss and Leica. Additionally, user-friendly 
software packages, both commercial and open-source (such as ImageJ), have 
made it easier to implement these powerful techniques without the need for 
technical proficiency or prior experience.  
SMFM techniques are mainly limited by the number of observables 
accessible per experiment, imposing the need to perform multiple assays to 
study complex biological processes. The future of SMFM lies in the ability to 
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combine multiple tools into one adaptive instrument, such that the wealth of 
information obtained from a single sample is broadened. Techniques like 3D 
correlated EM (164), which combines the technical prowess of EM with the non-
invasive nature of fluorescence microscopy, and SPT/single molecule FRET 
(165), have emerged as powerful tools to study the spatiotemporal evolution of 
molecules during various stages of cellular processes at very high resolution. 
The latter method can particularly probe conformational changes of proteins as 
they diffuse inside living cells.  
Realizing the true potential of any technique relies on understanding its scope 
and limitations. However, factors considered as a bane in certain methods can 
be a boon in others. For instance, reactive oxygen species produced by 
fluorescent probes, which are considered to be toxic to living cells, can be used 
to oxidize certain contrast-enhancing agents to improve image quality in EM 
(166). Even non-fluorescent chromophores like heme, which typically contribute 
to high background in intracellular fluorescence imaging, can be imaged by 
STED microscopy to provide unique details on sub-cellular super-structures 
(167). In this fashion, molecules can be visualized label-free in their native 
cellular environment without the need for fluorophore conjugation. 
Chu and coworkers recently improved the precision of wide-field imaging of 
biological samples by a factor of two through correcting for microscope drift with 
active feedback control, reaching sub-nm accuracy and resolution (168, 169). At 
such resolutions, it should become possible to obtain structural information of 
single molecules, for instance the distance between two subunits of a protein, 
even at very low molecule abundance and without the need to cool the sample 
below ambient temperatures (as required for EM and X-ray diffraction). The near 
future of SMFM will involve the implementation of such image acquisition and 
processing algorithms to spatially resolve the complex biological processes that 
enable life. Spatial resolution is, however, just one side of the coin since 
sufficient temporal resolution is also necessary; and both types of resolution are 
typically inversely related. Reaching higher (sub-millisecond) temporal resolution 
during biological imaging is mainly impeded by hardware limitations (e.g., the 
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maximal frame rate of the camera), limited photon collection at high frame rates, 
decreasing SNR, and fast diffusion of molecules inside the cell, which leads to 
image blurring. Stroboscopic imaging techniques, where laser excitation pulses 
are synchronized with the camera frame rate, have emerged as tools to address 
these limitations (170). Development of faster and more sensitive cameras may 
in the future enable higher resolution also during single-particle tracking based 
on simple optical and excitation schemes. Considering the large strides that 
SMFM has taken over the past two decades, one can easily envision that large-
scale multiplexed imaging of biomolecules (e.g., proteins, DNA, RNA) at sub-
nanometer and sub-millisecond spatiotemporal resolution within live cells or even 
animals will become possible within the next two decades.  
 
1.5. Thesis Overview 
The pervasive nature of miRNAs and the lack of an incisive tool to differentiate 
the various intracellular pathways these small ncRNAs follow warranted the 
utilization of SMFM; an unparalleled tool that has exposed molecular 
heterogeneities and short-lived and/or rare intermediates otherwise masked in 
the ensemble average. In Chapter 2, a novel single-molecule method was 
developed to visualize the diffusion and distribution of miRNAs in human cells. A 
combination of microinjection, HILO microscopy, SPT and stochastic 
photobleaching of fluorescent probes was used to measure the intracellular 
assembly and disassembly of fluorophore labeled miRNAs and their associated 
complexes. Single particles containing single or multiple miRNA molecules were 
visualized in live and formaldehyde-fixed cells. Their molecular stoichiometry, 
based on our single miRNA counting experiments, and diffusive behavior, based 
on SPT, is concordant with a heterogenous population of miRNA complexes 
bearing different molecular masses and following different cellular pathways. 
Moreover, time dependent changes in diffusive behavior and assembly states are 
suggestive of a miRNA-multiple turnover model. To the best of my knowledge, 
these data represent the first reported observation of intracellular miRNA 
complex assembly. 
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 Next, I sought to further characterize the observed heterogeneous 
behavior of miRNA complexes using two-color single molecule (or particle) 
fluorescence microscopy as described in Chapter 3. The extent of colocalization 
(or interaction) between organic-fluorophore labeled miRNAs and fluorescent-
protein labeled PBs, subcellular foci enriched in RNA degrading enzymes that 
are known to associate with miRNAs, were quantified with single molecule 
sensitivity. As reported by our single molecule counting experiments, only a small 
fraction of the total miRNA pool localized in PBs, with varying numbers of miRNA 
molecules per PB. Two-color SPT experiments in live cells showed that miRNAs 
either associated with PBs in a transient or stable fashion. Put together, these 
results predict the presence of a diverse set of miRNA complexes and PBs inside 
cells.   
 In chapter 4, I developed a single-molecule method to observe the 
interaction of miRNAs with mRNAs in an effort to quantify their binding 
stoichiometry in vitro. Mammalian cell extracts were used to assemble functional 
miRISC and miRISC-mRNA complexes. The number of miRNA molecules per 
mRNA was counted in a fashion similar to the miRNA counting experiments of 
chapters 2 and 3, which utilize the stochastic photobleaching of fluorescent 
probes. To our surprise, we found that a majority of mRNAs were either not 
bound or only bound by a single miRNA, even under conditions that led to 
maximum repression. This prompted us to hypothesize a low-probability binding 
model for miRNA-mRNA interaction as well. We further suggest that the relatively 
poor association of miRNAs with mRNAs could be mediated by mRNA structure 
and/or waek binding energies of miRNAs. These data, together with those in 
Chapter 3, seem to provide the molecular basis for the relatively weakly 
repressive capabilities of miRNAs as compared to siRNAs, which directly lead to 
target degradation. Finally, chapter 5 contains a summary of all salient results 
and future directions to be embarked upon by an upcoming student. 
 The data presented here advance our understanding of how miRNAs, 
ubiquitous small regulatory ncRNAs with profound implications in cellular 
sustenance and disease progression, function inside cells and assemble on their 
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mRNA targets to mediate gene regulation. The techniques developed for this 
purpose also provide a fundamental framework to probe other ncRNAs within the 
confines of the cell. In summary, this thesis provides the broader scientific 
community with new methods to visualize macromolecular complex assembly 
both in vitro and inside cells with single molecule sensitivity. 
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Chapter 2 
 
Development of a Single-molecule Method to Probe miRNA Activity in 
Human Cells1 
 
2.1 Introduction 
Gene regulation by microRNAs (miRNAs) is an evolutionarily conserved RNA 
interference (RNAi) pathway wherein ~22-nucleotide-short non-coding RNAs 
assemble with components of the RNA induced silencing complex (RISC) so that 
their guide strand can bind partially complementary sequences in mRNA 3‘ 
untranslated regions (UTRs) to repress protein expression (11, 12). To date, over 
1,000 mammalian miRNAs, generated from miRNA genes that account for over 
1% of the entire genome (54), have been identified that are predicted to regulate 
over 50% of all protein coding genes (47). The ubiquitous nature of miRNAs 
implicates their involvement in all aspects of multi-cellular life (11, 12, 47), from 
general cellular processes such as cell differentiation and survival to pathologies 
such as cancer, thus creating an urgent need to understand the mechanism(s) by 
which miRNAs function.  
While standard ensemble assays, including intracellular fluorescence 
microscopy (67, 171), have revealed a wealth of information (11, 12), the 
mechanism of gene repression by miRNAs is still debated (47). A major reason 
for this controversy is that an incisive tool for differentiating the various 
                                                          
1  Sethuramasundaram Pitchiaya performed all experiments and analysis except for the 
fluorescence repression assay. John R. Androsavich created fluorescence reporter plasmids, 
performed the fluorescence repression assay and assisted with the bioinformatic analysis. 
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intracellular pathways that miRNAs follow so far has been lacking. We have 
therefore developed a unique approach to studying these molecules; by utilizing 
single molecule tools to investigate the location and mobility of single miRNAs 
within their native environment in pursuit of their still elusive mode of action. 
Single molecule fluorescence microscopy (SMFM) has emerged as a 
powerful tool to quantify properties of biomolecules not accessible to 
conventional ensemble-averaging techniques (94, 172). In particular, SMFM has 
been applied to living cells to assess diffusive properties by single particle 
tracking (SPT) and the stoichiometry of molecular complexes by stepwise 
photobleaching (173). The main strategies for SPT in living cells either decorate 
the target molecule with endogenously expressed fluorescent protein(s) (138) or 
endocytosed nanoparticles (174), leading to high-molecular weight appendices 
that may impede function, or employ microinjection of target particles externally 
labeled with multiple fluorophores (175). These approaches so far have been 
applied to proteins, protein assemblies and large RNA:protein complexes. 
Complementary methods have recently been developed to assess the number 
and location of single intracellular molecules by fixing and permeabilizing a cell 
and incubating it with probes that are labeled with multiple fluorophores or 
nanoparticles (176), limiting this approach to the detection of relatively large 
protein and RNA molecules. Our intracellular single molecule high resolution 
localization and counting (iSHiRLoC) method overcomes these caveats by 
combining microinjection, optimal illumination, SPT and stepwise photobleaching 
of fluorophores to visualize the diffusive motions and distribution of singly 
fluorophore labeled functional small RNAs inside cells. Importantly, our data 
demonstrates the potential of iSHiRLoC to unravel both the dynamic nature and 
kinetics of intracellular complex assembly associated within an important gene 
regulatory pathway at single molecule sensitivity. 
 
2.2 Materials and Methods 
Plasmids, DNA and RNA olignucleotides. Luciferase reporter plasmids pmG-
mH3U (wt) and pmG-mH3UM (mut) were engineered by inserting the wild-type 
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and mutant mouse HMGA2 3‘ UTR sequences, respectively, downstream of the 
firefly luciferase ORF in the pmirGLO dual-luciferase expression vector 
(Promega). The wild-type and mutant 3‘ UTRs were PCR amplified from plasmid 
templates received as a gift from David Bartel (Whitehead Institute, MIT) (48) 
using primers containing at their 5‘ ends  XhoI and NotI or XhoI and XbaI 
restriction sequences, respectively. Following restriction digestion, the amplicon 
insert was ligated to complementary ends in the pmirGLO vector. Fluorescence 
reporter plasmid pEF6-mCherry-mH3Um was constructed by first subcloning the 
mCherry ORF from the pRSET-mCherry vector, a gift from Roger Tsien (UCSD), 
into the multiple cloning site of the pEF6-myc-His-B (Invitrogen) vector using 
BamHI and EcoRI restriction sites. Then, using PCR cloning, the mutant HMGA2 
3‘ UTR was inserted downstream of the mCherry ORF between XhoI and NotI 
sites. pEGFP-C1 was purchased from Clontech.  
Negative control siRNA used in transfection experiments was purchased 
from Ambion. SiLuc2 siRNA, a positive control siRNA, was designed towards the 
coding sequence of the firefly luciferase gene (luc2) and purchased from 
Dharmacon as a duplex.  All other RNA oligonucleotides were purchased from 
the Keck Biotechnology Resource Laboratory at the Yale University School of 
Medicine with a 5‘ phosphate (P) and, in the case of amine modified RNA, a 3‘ 
amino group on a C7 carbon linker. RNA was purified as described (177) and the 
3‘ amine groups were labeled with Cy3 or Cy5 succinimidyl ester as described 
(177, 178). RNA sequences were as follows: 
let-7-a1 guide: P-UGAGGUAGUAGGUUGUAUAGUU 
let-7-a1-passenger: P-CUAUACAAUCUACUGUCUUUCC 
let-7-a1 mut guide: P-UGCGUUAGUAGGUUGUAUAGUU 
let-7-a1 mut passenger: P-CUAUACAAUCUACUGUCGUUCC 
cxcr4 guide: P-UGUUAGCUGGAGUGAAAACUU 
cxcr4 passenger: P-GUUUUCACAAAGCUAACACA 
siLuc2 guide: GAAGUGCUCGUCCUCGUCCUU 
siLuc2 passenger: GGACGAGGACGAGCACUUCUU 
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Guide and passenger strands were heat-annealed in a 1:1 ratio, resulting in 
duplex miRNAs, and frozen for further use. DNA oligonucleotide MS2 with four 
internal amine modifications was purchased from the Keck Biotechnology 
Resource Laboratory at the Yale University School of Medicine, purified and 
labeled as described above. A DNA oligonucleotide completely complementary 
to MS2 (C-MS2) with a 5‘ phosphate (P) was purchased from Invitrogen. The 
labeled and complementary strands were annealed in a 1:1 ratio and frozen for 
further use. DNA sequences were as follows: 
MS2: AXGTCGACCTGCAGACAXGGGTGATCCTCAXGTTTTCTAGGCAATXA 
(X represents an amine modified deoxy-uridine) 
C-MS2:TAATTGCCTAGAAAACATGAGGATCACCCATGTCTGCAGGTCGACAT 
Cell culture and media.  HeLa cells (CCL-2, ATCC) were cultured in DMEM 
(GIBCO, Invitrogen) supplemented with 10% (v/v) fetal bovine serum (FBS) and 
non-essential amino acids (NEAA) at 37 oC. 1 - 1.25 x 105 cells were seeded 
onto delta-T dishes (Bioptechs) one day before microinjection, such that they 
were ~80% confluent at the time of microinjection. Regular medium was replaced 
with phenol red-free medium 4 h prior to microinjection and subsequently with a 
minimal medium (HBS), without serum and vitamins, but containing 20 mM 
HEPES-KOH pH 7.4, 135 mM NaCl, 5 mM KCl, 1 mM MgCl2, 1.8 mM CaCl2 and 
5.6 mM glucose, immediately before microinjection. After microinjection, cells 
were incubated in phenol red-free DMEM containing 2% (v/v) FBS and 1x NEAA 
and in the presence of a 5% CO2 atmosphere for the indicated amounts of time 
prior to imaging. For long incubations (4 h and greater), the medium was 
replaced every 4 h with fresh growth medium containing 2% (v/v) FBS. We found 
that cellular autofluorescence was a function of serum concentration; higher 
serum concentrations resulted in higher background and medium with no serum 
exhibited the least background. We used 2% (v/v) FBS to prevent conditions of 
serum starvation and simultaneously minimize cellular autofluorescence. 
Microinjection. Microinjections were performed using a Femtojet pump 
(Eppendorf) and a microscope mounted Injectman NI2 micromanipulator 
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(Eppendorf). Solutions to be microinjected were centrifuged at 16,000 x g for 15 
min at 4oC just prior to microinjection. For a majority of the tracking and fixed cell 
experiments, the micropipette (Femtotips, Eppendorf) was loaded with 1.5 µM 
fluorophore labeled miRNA and 0.05% 10 kDa Fluorescein dextran (Invitrogen) in 
PBS. Fluorescein, which is spectrally distinct from Cy5, served as a marker to 
locate microinjected cells, mainly because Cy5 photobleached relatively quickly 
(within ~1.5 s). The focal plane to be imaged was adjusted during 488 nm 
(fluorescein) excitation and then quickly switched to 640 nm (Cy5) excitation for 
image acquisition. For (negative) control experiments, the miRNA was omitted 
and either 0.05% Fluorescein dextran (Invitrogen) in PBS or plain PBS were 
used. Microinjection of fluorescein dextran only resulted in very low background 
and false-positive particles. In some experiments, the fluorescein dextran was 
omitted and 2 µM Cy3 labeled miRNA in PBS was used. Although Cy3 labeled 
particles were visible for a longer time than those of Cy5, the majority of 
experiments were performed with Cy5 labeled miRNAs in conjunction with 
fluorescein dextran for two reasons: (i) cellular autofluorescence was higher upon 
532 nm (Cy3) excitation as compared to 640 nm excitation; and (ii) it was easier 
to choose microinjected cells and check for microinjector clogging without 
photobleaching the dye conjugated to the miRNA. Co-microinjecting let-7-a1-Cy3 
along with either fluorescein dextran or Alexa-647 dextran resulted in high 
background fluorescence and strong Cy3 fluorescence quenching, respectively, 
when illuminated with at 532 nm. The former background is largely contributed by 
the spectral overlap between fluorescein and Cy3. For MS2 DNA microinjections, 
0.5 µM duplex DNA mixed with 0.05% (w/v) of 10 kDa fluorescein dextran was 
microinjected. All microinjections were performed at 100 hPa microinjection 
pressure for 0.5 s with 20 hPa compensation pressure. Using these conditions, 
microinjection volume was estimated to be ~0.02 pL or ~0.5% - 5% of the total 
cell volume, which translates to ~18,000 molecules of miRNA (at 1.5 µM working 
concentration). For plasmid microinjections, compensation pressure was 
increased to 40 hPa and plasmids were microinjected at a working concentration 
of 0.1 µg/µl in PBS (see Repression Assays for further details). 
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Fluorescence microscopy. Imaging was performed using a cell-TIRF system 
based on an Olympus IX81 microscope equipped with a 60x 1.45 NA oil-
immersion objective (Olympus), nanometer-precision motorized stage (ASI 
Imaging), focal drift control module (zero drift control, Olympus), 1x – 4x 
magnification changer (Olympus) and an EM-CCD camera (Evolve, 
Photometrics). Solid state lasers with wavelengths of 488 nm (25 mW), 532 nm 
(100 mW) and 640 nm (100 mW), were directed through an acousto-optical 
tunable filter, split into different fiber-optic cables and then coupled to the cell-
TIRF module. All laser lines had 10 nm bandwidth clean-up filters to ensure 
monochromatic illumination. Net powers of ~1.2 mW, 7 mW and 8 mW were 
achieved at the objective for the 488 nm, 532 nm and 640 nm laser lines, 
respectively. Laser beams were focused on the back-focal plane of the objective 
and made to travel parallel to the optic axis such that changing the distance from 
the optic axis controlled incident angle at the dish-media interface. Highly inclined 
laminar optical sheet (HILO) microscopy (100) was used to achieve deeper 
penetration into cells without compromising on signal-to-noise ratio. A dual band 
filter cube consisting of a z491/639rpc dichroic filter (Chroma) and z491/639m 
emission filter (Chroma) was used to detect fluorescein and Cy5 emission. Cy3 
emission was detected using a Q570LP dichroic filter (Chroma) and HQ610/75m 
emission filter (Chroma). All videos were recorded at 100 ms camera exposure 
time using 120x magnification (60x objective and 2x additional magnification 
using the magnification changer) unless otherwise mentioned. Cells were 
maintained at 37 oC on the microscope stage while imaging using the DeltaT 
open dish system (Bioptechs) and a heated lid (Bioptechs). 5% CO2 was 
supplemented to cells using the side port of the heated lid. 
 Live cell imaging and data analysis. The dish was washed several times with 
HBS immediately after microinjection. Cells were imaged in HBS consisting of 
0.3 U/mL Oxyfluor (Oxyrase), 20 mM sodium succinate, 2 mg/mL ascorbic acid 
and 200 µM trolox (HBS-OSS). Oxyfluor and its substrate succinate act as an 
oxygen scavenging system, whereas ascorbic acid and trolox served as strong 
triplet state quenchers, effectively increasing the lifetime of the fluorophores 
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inside the cells. Single particle were tracked using the tracking module of Imaris 
(Bitplane). Only particles that lasted for more than 9 frames, in which case the 
error in the calculated diffusion coefficient will be ~50% (179), were used for 
further analysis. All tracks were visually inspected to ensure that they arose from 
well-isolated particles. In-house MATLAB routines were then used to calculate 
the mean squared displacement (MSD) and diffusion coefficients. Brownian 
diffusion coefficients were calculated by fitting the mean squared displacement 
for the first three time intervals to the equation (180): 
                 
An offset was used to account for the error in localization at t = 0. Localization 
precision was measured by tracking the variation in position of fixed miRNA 
particles (Supplementary Fig. 2). Relative deviation analysis (181) was 
performed on individual trajectories, based on the equation: 
   
       
     
 
where D is the instantaneous diffusion coefficient and n is a data point at a later 
time lag, not included in the original calculation of D. An RD value of 1 
corresponds to pure Brownian motion. If the MSD time course were to deviate 
from linearity, such as those in anomalous, directed and corralled motions, RD 
values will deviate from 1. Thus, by comparing the distribution of RD values 
between multiple sample sets, we can gauge if a change in mobility of particles is 
due to the preponderance of one type of diffusive pattern over another.   
 The analytical forms of MSD time courses for different forms of motion: 
                                                                                 (Brownian motion) 
         
        
           
                                             (Corralled motion) 
                                         (Biased / directed motion with diffusion) 
were used to derive diffusion coefficients from data points in Fig. 1e respectively. 
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 Calculation of background intensity was done using ImageJ software 
(NIH). Briefly, a binary mask, using the background subtracted-thresholded 
image created by our intensity analysis software (see Fixed cell imaging and 
data analysis), was used to subtract all miRNA particles from an image and the 
total intensity from the resultant image was used to calculate the average 
background intensity. Intensity of regions outside the cell was used as the 
baseline to calculate the relative average background intensity. The 1 h and 32 h 
datasets were background subtracted, thresholded and deconvolved to 
accurately localize single particles. These images were subsequently also used 
to calculate the average number of particles visible for at least nine consecutive 
frames.  
Fixed cell imaging and data analysis. Cells were first washed five times with 
PBS, fixed using 4% (w/v) paraformaldehyde in PBS for 20 min, washed five 
times with PBS after fixing and imaged in PBS consisting of the same OSS-
antioxidant mix as mentioned above (PBS-OSS). Intensity analysis to determine 
number of photobleaching steps was performed using a custom written LabView 
(National Instruments) code (182). A Chung-Kennedy non-linear filter (183) was 
used to effectively average out the noise within intensity traces, yet preserving 
fast and sudden transitions, which aided in better visualization of photobleaching 
steps. The number of fluorophores per spot was estimated based on the number 
of photobleaching steps. The density of spots within cells was low enough (~0.1 - 
0.25 spots/µm2) to be confident that single particles were discerned. 
Repression assays. For transfection repression assays 24 h prior to 
transfection, 100 µL of 15,000 HeLa cells were seeded per well of a 96 well plate. 
Cells were transfected with 60 ng of the indicated plasmid, 10 nM of the indicated 
dsRNA, 0.4 µL of Lipofectamine 2000 (Invitrogen) and 50 μL of OptiMEM 
(GIBCO). 6 h after transfection the growth medium was replaced with fresh 
medium. 24 h after transfection, medium was replaced with phenol red-free 
DMEM. Dual luciferase assays were performed using the Dual-Glo luciferase 
assay reagents (Promega) as per the manufacturer‘s protocol and luminescence 
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was detected using a Genios Pro (Tecan) plate reader. For microinjection 
repression assays, 0.1 μg/ul of both pEF6-mCherry-mH3UM and pEGFP-C1 
plasmids were microinjected with 1.5 μM WT or MUT let-7 miRNA and 0.025% 
Alexa647 dextran (Invitrogen) in PBS. Following microinjection, cells were 
maintained under normal growth conditions for 24 h prior to imaging. 
Fluorescence signal were quantified using ImageJ software (NIH). The 
background subtracted mCherry signal was normalized with that of GFP for 
individual cells, which was then averaged over all cells. Using our filter sets (refer 
to Microscopy) we observed a small amount of mCherry bleed-through signal, 
~14%, while imaging GFP. This bleed through was corrected for in our 
calculations. Repression was measured by normalizing the average relative 
intensity of mutant let-7-a1 injections with respect to that of wild-type let-7-a1 
injections.  
Cellular abundance of mRNA targets for let-7 and cxcr4. We first used 
targetscan 5.2© to identify potential mRNA targets of both let-7 and cxcr4 
miRNAs. These targets were then compared to data from a HeLa cell mRNA 
expression profiling array (184) (dataset accessible at NCBI GEO database 
(185), accession GSM650992) using a custom written MATLAB code to identify 
endogenously expressed targets of both miRNAs. We found that ~10% of all 
predicted targets in either datasets were not expressed in HeLa cells. Comparing 
mRNA abundances of all potential targets for both miRNAs we deduced that let-7 
is predicted to have ~10-fold more expressed target molecules than cxcr4. 
Calculation of miRNA copy number in HeLa cells. We calculated the number 
of let-7 miRNA molecules per cell based on miRNA expression profiling data 
(186) and previously reported abundance of let-7a (187) and miR-21 (188) in 
HeLa cells. Fluorescence (187) and qRT-PCR (188) assays have estimated the 
copy number of let-7a and miR-21 to be ~4,000 copies and ~20,000 copies per 
cell, respectively. Deep sequencing data (186) (http://www.mirz.unibas.ch/ 
cloningprofiles/) have predicted that let-7a, whose cellular fraction is 16.5% of the 
total let-7 population, and miR-21 are 1.6% and 13.2%, respectively, of the total 
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miRNA pool (~150,000 copies) in HeLa cells. Taking both these data sets into 
consideration, we calculated the abundance of let-7 to be approximately between 
15,000 and 24,000 copies per HeLa cell. 
 
2.3 Results 
iSHiRLoC – a biologically relevant, intracellular, single-molecule method. In 
order to understand intracellular miRNA transport and localization, we 
microinjected mature double-stranded let-7-a1 or an artificial cxcr4 miRNA, 
labeled on the 3‘-end of the guide strand with one Cy3 or Cy5 fluorophore, into 
human HeLa cervical cancer cells. Let-7-a1 miRNA is a member of the highly 
conserved, tumor suppressing let-7 family whose function is critical to cell 
proliferation (48). Let-7-a1 and cxcr4 have ~700 and ~70 predicted mRNA 
targets in HeLa cells, respectively (Materials and Methods) and both miRNAs 
have been reported to localize to processing bodies (PBs) (67, 189), sub-cellular 
ribonucleoprotein (RNP) complexes enriched in RNA processing enzymes. 
Microinjection allowed us to control the number of molecules introduced into the 
cytoplasm (~18,000) to be similar to the endogenous levels of let-7 miRNAs 
(Materials and Methods), minimizing cell perturbation and facilitating single 
miRNA detection as distinct point-spread functions upon imaging by highly 
inclined laminar optical sheet (HILO) microscopy (100). We supplemented cell 
medium with an oxygen scavenger system to delay photobleaching (Materials 
and Methods). Microinjected cells divided normally after 24 h and remained 
viable for at least 32 h, attesting to the low invasiveness of iSHiRLoC.  
 We further sought to ensure that microinjected, fluorophore-labeled 
miRNAs retain functionality. Transfection experiments showed that a luciferase 
reporter gene with seven let-7 target sequences was strongly repressed even 
without adding exogenous let-7-a1, most likely due to the fact that let-7 is one of 
most abundant miRNA families in HeLa cells. Accordingly, repression was 
moderately enhanced (by ~14%) upon co-transfection with let-7-a1 (Fig. 2.1A).  
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Figure 2.1.  Effect of fluorophore modification and microinjection on miRNA 
function. (A) Luciferase reporter assays of HeLa cells co-transfected with 
luciferase reporter plasmids bearing the wild-type (wt) or a mutant (mut) 3`UTR 
of mouse HMGA2, and either a negative control siRNA (-ve‘s), wild-type let-7-a1 
(WT‘s) or mutant let-7-a1 (MUT‘s) miRNA. An siRNA, Siluc2, was used as a 
positive control for repression. Renilla luciferase activity was used for internal 
normalization of each sample. All samples were normalized with respect to -ve. 
Results presented are from four replicates. Error bars, standard deviations. (B) 
Representative images of GFP fluorescence (top) and mCherry fluorescence 
(bottom) in cells co-injected with an mCherry reporter plasmid, a GFP control 
plasmid and, either the wild-type (WT) or mutant let-7-a1 (MUT) miRNA are 
shown. Scale bar, 20 μm. (C) Quantification of fluorescence data from panel B, 
normalized with respect to the WT sample. Results presented here are from 
duplicate experiments (n = 50 cells per experiment). Error bars, standard error of 
the mean.  
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To enhance the sensitivity of our assay, we included a mutant let-7-a1 that was 
previously shown to specifically repress a compensatory mutant of the target 
sequence (48). As expected, the repression of mutant target by mutant let-7-a1 
was strong (~70%) and specific, consistent with previous observations (48). In 
this more sensitive assay, we then showed that attaching either a single Cy3 or 
Cy5 to the 3‘-end of the let-7-a1 guide strand does not significantly compromise 
repression (Fig. 2.1A). Finally, we microinjected either mutant or wild-type let-7-
a1 along with a mutant target and control fluorescent reporter gene plasmid and 
found that the intended target protein was specifically and strongly repressed, 
supporting the biological relevance of iSHiRLoC results (Fig. 2.1B, C).  
Upon RNP assembly, microRNAs diffuse within well-resolved single 
particles. We next analyzed SPT trajectories of miRNA particles in cells injected 
with let-7-a1-Cy3 or let-7-a1-Cy5 (Fig. 2.2A, B) and found individual particles to 
undergo (at least) four distinct diffusive patterns (Fig. 2.2C-E). Control 
experiments showed that microinjection of PBS buffer alone or fluorescein-
conjugated dextran, used as a marker for microinjection, contributed neither to 
the fluorescence signal (Materials and Methods) nor impacted the function and 
mobility of miRNA particles (Fig. 2.1B  and Fig. 2.2F). Our SPT analysis reached 
a super-accuracy of ~30 nm at 100 ms temporal resolution (Fig. 2.3) with an 
observation window of, on average, ~3 s for let-7-a1-Cy3 (and cxcr4-Cy3) and 
~1.5 s for let-7-a1-Cy5, before an individual particle went out of focus or 
photobleached (Fig. 2.4). Time-averaged mean squared displacement (MSD) 
analysis of individual SPT trajectories allowed us to characterize the distinct 
diffusive patterns as biased, corralled, fast or very slow Brownian diffusion, 
leading to a wide range of diffusion coefficients (Materials and Methods, Fig 
2.2E-G and Fig. 2.5). Analysis of a large number of trajectories (Table 2.1) 4 h 
after microinjection revealed two distinct Gaussian distributions of diffusion 
constants, with average diffusion coefficients of ~0.26 µm2/s and ~0.034 µm2/s 
for both let-7-a1-Cy3 (Fig. 2.2F) and let-7-a1-Cy5 miRNA (Fig. 2.2G). These 
diffusion coefficients closely resemble those of messenger RNPs (87) and PBs 
(190), respectively, which are thought to be mechanistic intermediates of miRNA  
52 
 
Live cell analysis 
Experiment No. cells (no. 
particles*) 
 Initial no. 
particles*/frame 
No. frames/video 
Cy3 labeled miRNAs 4 h post-injection   
Let-7a-1 
Cxcr4 
4 (2115) 
3 (1038) 
95 
115 
300 
300 
    
Let-7-a1-Cy5    
1 h post-injection 
2 h post-injection 
4 (240) 
4 (1000) 
45 
251  
50 
50 
4 h post-injection 4 (822) 295  50 
8 h post-injection 
32 h post-injection 
6 (484) 
4 (109) 
90 
21  
50 
50 
Fixed cell analysis 
Experiment  # cells (# particles) 
Let-7-a1, cxcr4 
Average # particles/cell # frames/video 
1 h post-injection 5 (1125), 5 (1414) 225 ± 121, 236 ± 71 300, 500 
2 h post-injection 4 (1509), 5 (1500) 377 ± 72, 300 ± 118 300, 500 
4 h post-injection 3 (940), 5 (1210) 313 ± 158, 242 ± 99 300, 500 
8 h post-injection 4 (1168), 7 (1825) 292 ± 166, 261 ± 187 300, 500 
32 h post-injection 8 (688), 9 (1294) 86 ± 34, 144 ± 49 300, 500 
MS2-Cy5 DNA 3 (702) 234 ± 125 300, 500 
*particles visible for greater than 9 frames 
Table 2.1. Number of cells and particles used in both live and fixed cell analysis.
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Figure 2.2. Single molecule high-resolution localization and tracking of miRNAs diffusing in living HeLa cells. Image of  
Cells microinjected with (A) let-7-a1-Cy3, (left, cytoplasmic injection; right, nuclear injection) and (B) let-7-a1-Cy5showing 
distinct particles of miRNA imaged 4 h and 2 h after microinjection respectively. Dashed and dotted lines indicate nuclear 
and cellular boundaries, respectively. Scale bar, 10 μm. Different types of diffusive motions exhibited by (C) let-7-a1-Cy3 
and (D) let-7-a1-Cy5 miRNAs. Scale bars, 0.5 μm. (E) MSD plots of the let-7-a1-Cy3 particles shown in panel C. Data 
were fit with equations representing biased (iv), corralled (ii), fast (iii) and very slow (i) Brownian diffusion. Diffusion  
coefficients as derived from the fits are: D(i) = 0.0001 μm2/s; D(ii) = 0.06 μm2/s (corral radius = 0.52 μm); 15 D(iii) = 0.062 
μm2/s; and D(iv) = 0.16 μm2/s (average velocity = 0.46 μm/s). (F) Distribution of diffusion coefficients calculated from 
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individual MSD plots of let-7-a1-Cy3 particles assuming Brownian diffusion. Cells were imaged 4 h after microinjection (n 
= 4 cells, Table 2.1). (G) Distribution of diffusion coefficients of let-7-a1-Cy5 at different time points after microinjection. 
Dotted lines represent demarcations of fast and slow particles to guide the eye, estimated based on segregation of the 
two Gaussian distributions 2 h after microinjection. Histograms represent data from multiple cells (n = 4, 4, 6 cells for data 
points corresponding to 2 h, 4 h and 8h, Table 2.1). 
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Figure 2.3.  Precision of single particle localization. Histogram depicting the 
displacement of formaldehyde-fixed let-7-a1-Cy5 particles about their origin (n = 
100 randomly selected particles). The location of each particle was tracked over 
time until it photobleached. The histogram was fit with a Gaussian function, which 
resulted in a mean of ~30 nm and a standard deviation of ~50 nm. Large jumps 
(>100 nm) were observed only when there were large fluctuations of intensity. 
Localization precision of immobilized beads (inset) was ~4 nm, largely owing to 
their higher signal-to-noise ratio (n = 100 randomly selected particles). 
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Figure 2.4. Intensity traces of particles undergoing diffusion in living cells. 
Intensity time trajectories of let-7-a1-Cy3 (green) and let-7-a1-Cy5 (red) particles 
are shown. Trajectories of both mobile and static particles are shown, as 
indicated in each trajectory. A significant proportion of particles had a relatively 
constant intensity during diffusion before disappearing. We infrequently observed 
large fluctuations in intensity as a particle was diffusing, possibly due to diffusion 
in the axial dimension (z-axis). We also occasionally observed stepwise changes 
in intensity of static particles, possibly due to photobleaching (see, for example, 
second trajectory from the top on the left side).  
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Figure 2.5. Intracellular diffusion of cxcr4 miRNA. (A) A DIC image and the 
corresponding (B) pseudocolored image of a cell microinjected with cxcr4-Cy3 
and imaged 4 h after injection. Scale bar, 10 μm. (C) Distribution of diffusion 
coefficients calculated from individual MSD plots of cxcr4-Cy3. We observed two 
major Gaussian distributions, with different fractional abundance but similar 
average diffusion coefficients to those obtained with let-7-a1-Cy3.  
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repression. Given that we showed our miRNAs to be functionally active, at least 
some of the observed particles thus must contain miRNAs bound to and actively 
repressing target mRNAs.  
The diffusion constants of miRNA containing RNPs increase over an 8-hour 
period. Next, we asked whether the diffusive properties of miRNA containing 
particles changed over time. Such changes may be expected for RISC-mediated 
loading of miRNAs onto mRNA targets and subsequent processing of the 
resulting mRNPs. To this end, we incubated let-7-a1-Cy5 microinjected cells for 
1, 2, 4, 8 and 32 h prior to imaging. After 1 h and 32 h, high background and 
large inter-frame displacements of individual particles, respectively, precluded 
accurate tracking and this observation is consistent with the presence of fast 
diffusing free miRNAs and smaller miRNA-protein complexes that become 
blurred at our 100-ms time resolution (camera integration time). To quantify this 
effect, the relative average background intensity (Fig. 2.6) was calculated for 
each time point and the resultant curve was fitted with a single exponential 
function, yielding a rate constant of 0.82 ± 0.18 h-1. The highest intensity is found 
at the 1 h time point, consistent with the notion that many miRNAs are not yet 
assembled into large and thus slowly diffusing RNPs, which become sufficiently 
localized to be visible at our 100-ms time resolution. We also determined the 
average number of particles visible for at least nine consecutive video frames for 
each time point, a threshold we used for our diffusion coefficient calculation. This 
criteria indirectly but faithfully reflects the number of large RNPs bearing a high 
molecular mass at each time point. The data fit well with a double exponential 
function with a rapid-rise phase characterized by a rate constant of 1.18 ± 0.62 h-
1, indicating assembly of miRNAs into larger RNPs (especially over the first 2 h of 
observation), and a slower decrease phase with a rate constant of 0.34 ± 0.13 h-
1, indicating an increase in RNP mobility of over the longer time frame (2 h – 32 
h). For the intermediate time points (2 h, 4 h and 8 h) we again clearly discerned 
diffusing particles within two distinct Gaussian distributions, whose average 
Brownian diffusion constants systematically increased over time (Fig.  
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Figure 2.6. Analysis of background intensity and the average number of nine 
consecutive-frame localizations. The relative average background intensity 
(black, solid) was calculated for each time point and the resultant curve was fitted 
with a single exponential function. The average number of particles visible for at 
least nine consecutive video frames at each time point (grey, dashed), a 
threshold we used for our diffusion coefficient calculation, was obtained using the 
number of ―trackable‖ particles in our single particle tracking experiments and the 
data fit well with a double exponential function. This trend (and rate constants) is 
very similar to that obtained in our fixed cell photobleaching analysis (Fig. 2.8E, 
black lines), further supporting our hypothesis that a relatively rapid initial 
assembly of miRNAs into large RNPs is followed by a slow disassembly at later 
times. Error bars, standard error of the mean.  
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Figure 2.7. Relative deviation analysis of diffusion coefficients over time. 
Histograms depict the distribution of RD values (Materials and methods) at 
different times after let-7-a1-Cy5 microinjection (2 h, 4 h and 8 h, as indicated). 
RD values were calculated using MSD values corresponding to the sixth 
localization point and diffusion coefficients extracted from the first three points of 
the MSD time course. Although the distributions differ slightly, there is no 
significant increase in the fraction of higher RD values which, if present, would 
predict an increase in the fraction of particles undergoing directed motion (n = 4 
cells for each, Table 2.1)  
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2.2G). This increase in mobility was not caused by an increase in the fraction of 
particles undergoing directed motion (Fig. 2.7), suggesting that, on average, the 
molecular weights of the RNPs decrease in the 2 to 8 h time frame.  
Intracellular fluorophores can be counted accurately by stepwise 
photobleaching. The goal of iSHiRLoC is to measure both diffusion properties 
and assembly states of individual small RNA containing particles. To assess 
assembly, we utilized the relatively rapid stepwise photobleaching (135, 173) of 
single Cy5 fluorophores to quantify the number of miRNA molecules per particle. 
HeLa cells microinjected with either let-7-a1-Cy5 or cxcr4-Cy5 were 
formaldehyde-fixed and continuously illuminated until all fluorescent particles had 
photobleached (Fig. 2.8A, B). By counting the number of photobleaching steps 
for many particles (Fig. 2.8C and Table 2.1), we were able to deduce the 
distribution of their assembly states (Fig. 2.8D). While close to 50% of all 
particles contained a single miRNA 2 h after microinjection, a significant fraction 
held up to seven miRNAs (Fig. 2.8C, D). To test for bias from ‗dark‘ 
(prebleached) Cy5, we microinjected a control DNA labeled with an average of 
3.45 Cy5 fluorophores per molecule and counted a majority of 3 and 4 
photobleaching steps in each particle (Fig. 2.9), as expected if prebleaching is 
negligible. In addition, we noted a strong overlap in the distribution of 
fluorescence intensities between particles observed in fixed and living cells (Fig. 
2.10), together suggesting that our counting results in fixed cells accurately 
reflect the miRNA assembly states in living cells.  
Time and mRNA dependent changes in miRNA assembly support a multiple 
target turnover model. Finally, we monitored miRNA assembly over time at the 
same time points as in our diffusion measurements. Similar to our observations 
in living cells, high background made it impossible to accurately localize single 
miRNA particles in cells that were fixed only 20 min after microinjection (Fig. 
2.11A). At later time points (1 h to 32 h), we found two distinct assembly phases 
for let-7-a1 miRNA that fit well with a double-exponential function, suggesting the 
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Figure 2.8. Counting of single miRNA molecules in fixed HeLa cells. (A) A pseudo-colored (background corrected) image 
of a formaldehyde-fixed HeLa cell showing the intracellular distribution of miRNAs 2 h after microinjection. Dashed and 
dotted lines indicate nuclear and cellular boundaries, respectively. Scale bar, 10 μm. (B) Sets of frames showing 
photobleaching of two different miRNA particles over the indicated time. The locations of the particles are labeled in panel 
A. Scale bar, 300 nm. (C) Representative stepwise photobleaching traces of individual miRNA particles within the cell 
shown in panel A. For some traces, the number of steps could not accurately be determined. These traces were further 
classified as either non-determinable multimer with indistinct steps (NM1); non-determinable multimer with initial peak 
intensity exceeding that expected from up to 7 fluorophores based on an average intensity of ~250 arbitrary units (A.U.) 
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per fluorophore bleaching step (NM2); or non-determinable as either monomer or multimer due to large fluctuations in 
intensity and rapid (< 3 frames) photobleaching (ND). (D) Distribution of miRNA photobleaching steps observed 2 h after 
microinjection (n = 4, Table 2.1). Error bars, standard deviation. (E) Change in the fraction of monomers (particles 
undergoing a single step of photobleaching, dotted line) and multimers (particles that bleach in two or more steps, solid 
line) of let-7-a1 (black) and cxcr4 (gray) miRNAs with time. Each data point is derived from multiple cells (nlet-7-a1 = 4, 4, 3, 
4, 8 cells and ncxcr4 = 5, 5, 5, 7, 9 cells for 1 h, 2 h, 4 h, 8 h and 32 h, respectively; Table 2.1). Error bars, standard 
deviation. 
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Figure 2.9. Stepwise photobleaching control. (A) Pseudo-colored, background 
subtracted image of cell microinjected with double-stranded DNA probe MS2 
labeled with ~3.45 Cy5s per molecule. Outline of the cell (dotted) and its nucleus 
(dashed) are also shown. Scale bar, 10 μm. (B) Different types of photobleaching 
traces. (C). Distribution of photobleaching steps for MS2-Cy5 injections (n = 3 
cells, Table 2.1).  
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Figure 2.10. Comparison of fluorescence intensities. Intensity of Cy5-labeled 
miRNA containing particles was compared between living (grey) and fixed cells 
(black), imaged 2 h after microinjection.  The intensity observed in the first frame 
of each video (100 ms exposure time) was used to create this histogram (n = 4 
cells each).  
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Figure 2.11. Fixed cell images from various time points. Representative images 
of fixed cells incubated for various amounts of time after microinjection and their 
corresponding stepwise photobleaching distributions. Shown are (from left to 
right) DIC, pseudo-colored, pseudo-colored/background-subtracted images and 
photobleaching step distributions of cells injected with let-7-a1-Cy5 and 
fluorescein dextran. Images and distributions were taken from cells fixed (A) 20 
min, (B) 1 h, (C) 2 h, (D) 4 h, (E) 8 h and (F) 32 h after microinjection 
(Supplementary Table 1). Scale bar, 10 μm. The background was very high in 
cells incubated for 20 min after microinjection, thus it was practically impossible 
to locate single molecules.  
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existence of two kinetic processes (Fig. 2.8E). The faster phase is characterized 
by a rate constant of 1.2 ± 0.2 h-1, during which the number of RNPs containing 
more than one miRNA increases; we note that this time evolution resembles that 
of the initial assembly of miRNAs into RNPs observed over the earliest (1-2 h) 
live cell time points. The slower phase with a rate constant of 0.14 ± 0.08 h-1 
leads to a modest increase in RNPs containing just a single miRNA and matches 
the timing of the increase in mobility of miRNA containing particles (Fig. 2.2G 
and Fig. 2.6) as well as that of miRNA-induced mRNA target degradation . Thus, 
our data support a multiple turnover model of miRNA-mediated gene repression, 
wherein miRNA:RISC (miRISC) complexes first assemble on their cognate 
mRNA targets, then associate with PBs where the mRNA is degraded and the 
miRNAs subsequently released back into the cytoplasm to bind additional mRNA 
targets (Fig 2.12). Consistent with this model, cells microinjected with the 
artificial cxcr4 miRNA, which is predicted to find 10-fold fewer mRNA target 
molecules in a HeLa cell, do not show these time dependent changes in the 
fractions of single and multiple miRNA containing particles (Fig 2.8E).  
 
2.4 Discussion 
Single miRNA molecules have been previously counted both in vitro  (191-193) 
and in situ (194) but neither in vivo nor in a form that allowed them to still be 
functional. All prior methods required the hybridization of microscopically-
detectable complementary oligonucleotides to miRNAs, after cell lysis or fixation, 
and were predominantly used to quantify endogenous miRNAs. Although efficient 
in understanding miRNA expression patterns, even at the single cell level (194), 
these methods cannot be used to visualize the intracellular assembly and 
transport of miRNA associated complexes, processes fundamental to their 
biological function. Here we report a novel method to visualize single, functional, 
fluorophore labeled miRNA molecules inside live as well as formaldehyde-fixed  
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Figure 2.12. Model illustrating intracellular miRNA assembly. Model consistent 
with our data, depicting the sequential assembly of miRNA into miRISC 
complexes that bind translationally active mRNA targets to form large RNPs, 
associate with PBs, and are finally released upon PB mediated mRNA 
degradation to engage in multiple turnover of targets. The indicated timeframes 
were derived from the kinetics measured in the current study. 
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human cells, a technique laying the foundation for understanding their 
intracellular localization, assembly and diffusion.  
Detection of single fluorophore labeled molecules inside living cells 
presents many challenges. Firstly, the concentration of the molecule under 
interrogation should be low enough to observe them as well isolated, diffraction-
limited spots. Hence, we turned to microinjection, instead of other intracellular 
delivery methods such as transfection, which has the inherent disadvantage of 
trapping molecules in lipid vesicles. Microinjection also comes with the added 
advantage that the amount injected can be precisely controlled and even varied 
between different cells on the same dish. Secondly, autofluorescence is a major 
challenge for intracellular microscopy. Signal from fluorescent probes should be 
high enough to be visible above the autofluorescent background, which can be 
difficult to achieve. Using an appropriate medium formulation (113) and mode of 
illumination (100), we achieved high enough signal-to-noise ratios to reach single 
molecule detection sensitivity. Thirdly, photobleaching of fluorescent probes 
limits the number of photons that can be collected for efficient localization of 
single molecules. Although impossible to prevent entirely, photobleaching was 
delayed in vivo by using certain medium additives. Our imaging medium contains 
both an oxygen scavenging system, which prevents photobleaching mediated by 
oxidation, and a triplet state quencher, which prevents the formation of long-lived 
non-fluorescent excited states prone to oxidation and hence photobleaching 
(Materials and methods).  
In our single particle tracking experiments, we typically observe brief 
sojourns of miRNAs in the imaging plane before they move out of focus or 
photobleach. Only few particles exhibited large variations in intensity along their 
trajectory (Fig. 2.4), potentially representing diffusion along the z-axis. In the 
case of random diffusion, all degrees of translational freedom are equivalent and 
movement along any two dimensions (2D) is a valid representation of the three-
dimensional (3D) movements (195). A 2D diffusion coefficient is thus a good 
estimate of the mobility of a three-dimensionally diffusing particle. Limited by our 
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time resolution (100 ms) we cannot, however, rule out the possibility that miRNA 
particles undergo undetected diffusion along the z-axis between successive 
frames of imaging. Since we predominantly estimate the relative changes in 
mobility rather than absolute molecular mass, 2D diffusion coefficients suffice.  
Schwille and coworkers (171) have previously characterized the 
localization and diffusion of fluorophore labeled silencing RNAs and EGFP 
labeled Ago2, an important component of RISC, in living cells using confocal 
microscopy and fluorescence cross correlation spectroscopy. They reported a 
cytoplasmic diffusion coefficient of ~5.4 µm2/s for RISC, which translates into an 
~3 MDa complex. We do not observe such particles possibly due to limits in our 
time resolution (100 ms) and/or since they may not be visible for 9 frames, our 
threshold for diffusion coefficient calculation. We have evidence for the notion 
that we may be losing rapidly diffusing particles from our analysis in the fact that 
the diffusion coefficient distribution measured 8 h after microinjection becomes 
visibly curtailed above a diffusion coefficient of ~2 μm2/s (Fig. 2.2G). The main 
particles we do observe, however, have diffusion coefficients commensurate with 
those of miRNAs bound to mRNAs or miRNA localized in PBs, key mechanistic 
intermediates of mRNA repression by miRNAs, as both complexes bear a much 
higher molecular mass than that of RISC.  We also note that the number of 
miRNAs we observe in the focal plane of a microinjected cell (~500 on average 
per fixed cell, considering both the number of distinct particles and their individual 
photobleaching steps; see Table 2.1 and Fig. 2.8D) correlates well with the 
volume fraction of the cell in focus multiplied with the total number of 
microinjected miRNAs (~18,000), suggesting that we can account for a significant 
fraction of the microinjected miRNAs. 
Based on our live and fixed cell data, we derive a model depicting the 
assembly of miRNAs into large RNPs (such as a miRISC bound to a ribosome-
decorated mRNA or PB), followed by their release from the complex. On the one 
hand, our live cell data show that miRNAs start out as fast-moving, blurred 
particles (until ~1 h after microinjection), assemble into observable slow-moving 
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RNPs (between 1 h and 2 h), and once again become faster (and thus lower in 
molecular mass) as their residence time in cells increases (2 h – 32 h, Fig. 2.2G 
and Fig. 2.6). On the other hand, our fixed cell data clearly show a sharp 
decrease in the number of single miRNA containing particles within the first 1-2 
hours, followed by a slow increase at later time points (Fig. 2.8E). This trend was 
not observed when cells were injected with the artificial cxcr4 miRNA, most likely 
due to its ~10 fold lower number of expressed mRNA target molecules as 
compared to let-7. As a result, the sharp decrease in monomeric miRNAs 
between 1 h and 2 h is expected to be ~10-fold smaller than that observed with 
let-7-a1 (down to ~2.5% from ~25%), thus making it indiscernible in our 
experiments (that have an estimated error in the decrease amplitude of ~±5%). 
Additionally, cells fixed 20 min after microinjection give rise to very high 
background fluorescence, which drastically decreases after 1 h (Fig. 2.11A). 
Based on these observations, we propose the following chronological model for 
miRNA assembly (Fig. 2.12): At initial time points, less than 1 h after 
microinjection, a majority of miRNAs remains free or unbound, thus contributing 
to a large background in our live and fixed cell experiments. Between 1 and 2 h, 
most miRNAs assemble into miRISC-mRNA complexes, thereby depleting the 
free miRNA population. This assembly leads to relatively slowly moving 
complexes in living cells and a corresponding decrease in the population of 
single miRNAs containing particles in fixed cells. As time proceeds, miRNA 
mediated mRNA degradation occurs, releasing miRISC complexes to possibly 
elicit further rounds of repression, which is represented by an increase in the 
mobility of miRNA particles in live cells and an increase in the population of 
monomeric miRNAs in fixed cells. Time dependent changes in miRNA assembly 
were not observed for cxcr4, consistent with the lesser number of mRNAs it 
targets. We also observe a decrease in the number of miRNA particles at long 
incubation times (32 h), which may represent miRNA degradation, cleavage of 
the fluorophore from the miRNA, and/or even efflux of labeled miRNAs from the 
cell. In addition, dilution of microinjected miRNA through cell division has to be 
considered. Overall, our observations for the first time reveal a stepwise 
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assembly of miRNA containing complexes involving mRNAs or PBs, followed by 
the release of miRISC complexes from them into the cytoplasm due to mRNA 
degradation, possibly accompanied by miRNA (or fluorophore) degradation.  
In conclusion, in iSHiRLoC we have developed a broadly applicable 
method that visualizes both diffusive properties and assembly states of functional 
small non-coding RNAs in cultured cells. We find that miRNAs exhibit different 
types of Brownian diffusion in living HeLa cells with (at least) two widely ranging 
Gaussian distributions of diffusion coefficients, representing two complexes of 
distinct molecular mass, consistent with messenger RNPs and processing 
bodies. Stepwise photobleaching revealed that the largest fraction of these 
particles contains single miRNA molecules. A still significant fraction of particles, 
however, contains multiple miRNA molecules, strongly invoking the formation of 
higher-order miRNA complexes either assembled on mRNA targets or 
associated with PBs. Time dependent changes in diffusion and assembly were 
observed in cells injected with let-7-a1 miRNA, supporting the multiple turnover 
model outlined in Fig. 2.12. In the future, iSHiRLoC can be extended by 
multicolor imaging (138, 172) to co-track a miRNA with its corresponding target 
mRNA, RISC or PB proteins and map the dynamic interaction network of RNAi, 
with the ultimate goal of understanding its mechanism through single molecule 
systems biology.  
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Chapter 3 
 
Quantitative Analysis of microRNA Localization within Processing Bodies 
at Single Molecule Sensitivity 
 
3.1 Introduction 
microRNA (miRNA) mediated gene regulation is an evolutionarily conserved 
cellular process wherein small RNAs, ~22 nt in length, typically repress 
eukaryotic protein expression post-transcriptionally (11, 12). miRNAs have been 
reported to employ several different mechanisms to elicit gene repression, 
however, these mechanisms are all under intense debate (47). Some data 
suggest that miRNAs interfere with initiation of messenger RNA (mRNA) 
translation (66, 70, 71), whereas others support the notion that repression occurs 
at post-initiation steps (74, 75, 196). More recent reports favor an mRNA 
destabilization model wherein miRNA induced silencing complexes (miRISCs), 
upon binding to the 3`UTR of mRNA targets, cause mRNA decay via 
deadenylation (78, 79). In contrast, Fabian et al. (197) had recently reported that 
miRNAs mediate target repression by a combination of both translational 
inhibition and mRNA decay. Their data suggest that miRNA mediated mRNA 
deadenylation and decay follow the initial inhibition of translation and thus alludes 
to the possibility for miRNA mediated mRNA decay to occur as a consequence of 
translational inhibition.  
In eukaryotes, deadenylation of mRNAs is either closely followed by or 
simultaneously occurs with 3`-to-5` or 5`-to-3` mRNA degradation (80). 
Deadenylation is mediated by the exosome (198), whereas the latter 
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predominantly mandates an initial decapping step (199), involving the removal of 
the canonical 7-methyl guanosine ‗cap‘ at the 5` end of mRNAs, followed by Xrn1 
mediated mRNA degradation (200). Cap removal irreversibly tags an mRNA for 
degradation and this process is tightly regulated both spatially and biochemically. 
Although spatial compartmentalization of 5`-to-3` mRNA degradation was initially 
based only on the localization of Xrn1 exonuclease (201), decapping enzymes 
(202) and several other RNA processing enzymes (203) to distinct cytoplasmic 
foci; it was later proven that both decapping and mRNA degradation can indeed 
occur in these discrete areas (204). Notably, these foci do not contain ribosomes 
and are hypothesized to only contain translationally inactive messenger 
ribonucleoprotein complexes (mRNPs) (205). These cytoplasmic foci are now 
widely known as processing bodies (PBs).  
PBs are dynamic structures, i.e. there is a continuous exchange of 
proteins and mRNAs between these foci and the cytoplasmic pool (189, 206). 
Additionally, the number (per cell) and size of PBs are cell cycle dependent 
(207). Previous research has shown that miRNAs and its associated proteins 
localize to PBs (67, 81, 173), and the inhibition of miRNA biogenesis or depletion 
of GW182 proteins, a central role player in miRNA mediated target repression 
(208, 209), causes the disappearance of PBs (210, 211). Conversely, depletion 
of certain PB components also prevented effective inhibition of mRNA targets 
(212). Moreover, a positive correlation exists between miRNA mediated mRNA 
repression and the accumulation of repressed mRNAs at PBs. As a specific 
example, cationic amino acid transporter (CAT-1) mRNA, a target of miR-122, 
localizes to PBs when Huh-7 hepatoma cells are enriched in miR-122 but exits 
PBs when repression is relieved either by stress or by the addition of miR-122 
anti-miRs (213), chemically modified oligonucleotides that inhibit miRNA function 
by binding with complete complementarity. More general examples entail the 
distribution of PBs during embryogenesis and organ development wherein global 
suppression of miRNA function and reduction in miRNA abundance is coincident 
with loss of microscopically visible PBs (214, 215). These observations led to the 
hypothesis of yet another mechanism for the regulation of gene expression by 
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miRNAs. According to this hypothesis, PB assembly complexes release miRISC 
bound mRNPs from polysomes and promote association with other repressed 
mRNPs (205), thereby either mediating the formation of a PB or targeting these 
large complexes to PBs (81, 212). Repressed mRNPs are then stored or 
degraded within these foci, leading to the possibility for the spatial organization of 
gene regulation. This idea is very similar in concept to that of Fabian et al. (197), 
wherein mRNA degradation occurs as a consequence of translational inhibition. 
However, it is still not clearly understood whether PBs are indispensible for 
repression or miRNA repressed mRNPs localize to PBs as a consequence of 
other modes of repression, for example translational inhibition mediated by 
mRNA deadenylation (83). Regardless, PBs play an important role in miRNA 
mediated mRNA repression by, at the very least, sequestering previously 
repressed mRNPs and subjecting them to (further) degradation. 
Not much is known about the distribution of miRNAs within PBs and the 
nature of miRNA:PB interactions in vivo. Previous work, based on ensemble 
intensity quantification, had estimated that only a very small proportion of cellular 
miRNAs and miRISC proteins localize to PBs (67, 189). In order to gain a deeper 
understanding on the dynamic and possibly heterogeneous nature of miRNA:PB 
interactions, and to more accurately quantify the distribution of miRNAs within 
PBs, we developed a method to observe single molecules of miRNAs (Chapter 
1) and colocalize them with single PB particles inside human cells. To this end, 
miRNAs and PBs were labeled with spectrally different fluorescent probes and 
single particles (and molecules) of miRNAs were localized and tracked with 
respect to single PBs in the same cell. We then used spatial mapping software to 
colocalize the spectrally distinct fluorescent probes with ~10 nm resolution. Our 
single molecule counting by stepwise photobleaching of fluorophores (Chapter 
1), performed subsequent to high-resolution colocalization of PBs and miRNAs, 
provides a robust quantification of miRNA distribution within PBs. With this added 
accuracy (in quantification) and resolution, we show that there is a 
heterogeneous distribution of miRNAs within PBs. We additionally show that 
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miRNAs interact either stably or transiently with PBs in live HeLa cells supporting 
the possibility for diversity in composition of miRNA complexes and PBs.  
 
3.2 Materials and methods 
Plasmids, DNA and RNA oligonucleotides. The EGFP ORF was PCR 
amplified from pEGFP-C1 (Clontech) using DNA primers bearing AgeI and XhoI 
restriction enzyme (RE) sites. Plasmid pEGFP-hDcp1a was created by removing 
the mRFP1 ORF from pmRFP1-hDcp1a (gift from Nancy Kedersha, Brigham 
Women‘s hospital) using AgeI and XhoI restriction enzyme digestion and 
replacing it with the PCR amplified, RE digested ORF of EGFP. pEGFP-hAgo2 
was received as a generous gift from Phillip Sharp (MIT). 
RNA oligonucleotides were purchased from the Keck Biotechnology 
Resource Laboratory at the Yale University School of Medicine with a 5‘ 
phosphate (P) and a 3‘ amino group on a C7 carbon linker. RNA was purified as 
described (177) and the 3‘ amine groups were labeled with Cy3 or Cy5 
succinimidyl ester as described (177, 178). RNA sequences were as follows: 
let-7-a1 guide: P-UGAGGUAGUAGGUUGUAUAGUU 
let-7-a1-passenger: P-CUAUACAAUCUACUGUCUUUCC 
Guide and passenger strands were heat-annealed in a 1:1 ratio, resulting in 
duplex miRNAs, and frozen for further use. 
Cell culture and transfection.  HeLa cells (CCL-2, ATCC) were cultured in 
DMEM (GIBCO, Invitrogen) supplemented with 10% (v/v) fetal bovine serum 
(FBS) and non-essential amino acids (NEAA) at 37 oC. For Ago2-Dcp1a 
colocalization experiments, 1.8 x 105 cells were seeded onto coverslip bottom 
dishes (Mat-tek) one day before transfection. Cells were transfected with pEGFP-
Ago2, pmRFP1-hDcp1a or a combination of both using lipofectamine 2000 
(Invitrogen) and imaged 24 h post transfection. Regular media was replaced with 
phenol red free growth media 4 h prior to imaging and cells were imaged in 
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phenol red free DMEM. For Dcp1a-miRNA colocalization and co-tracking 
experiments, 2.4 x 105 cells were reverse transfected with pEGFP-hDcp1a or 
pmRFP1-hDcp1a using Fugene HD (Roche) transfection reagent, in delta-T 
dishes (Bioptechs), one day before microinjection. Regular medium was replaced 
with phenol red-free medium 4 h prior to microinjection and subsequently with a 
minimal medium (HBS) immediately before microinjection. After microinjection, 
cells were washed several times with HBS and incubated in phenol red-free 
DMEM containing 2% (v/v) FBS and 1x NEAA and in the presence of a 5% CO2 
atmosphere for 2 h prior to imaging. Live cell and fixed cell imaging were done in 
HBS-OSS and PBS-OSS respectively (Chapter1, MATERIALS AND 
METHODS, live cell imaging and data analysis and Fixed cell imaging and 
data analysis). 
Microinjection. Microinjections were performed using a Femtojet pump 
(Eppendorf) and a microscope mounted Injectman NI2 micromanipulator 
(Eppendorf). Solutions to be microinjected were centrifuged at 16,000 x g for 15 
min at 4oC just prior to microinjection. The micropipette (Femtotips, Eppendorf) 
was loaded with 1.5 µM let-7-a1-Cy5 labeled miRNA and optionally with 0.05% 
10 kDa Fluorescein dextran or Alexa555-dextran (Invitrogen) in PBS. Fluorescein 
and Alexa555, spectrally distinct from Cy5, served as a markers to locate 
microinjected cells mainly because Cy5 photobleached relatively quickly (within 
~1.5 s). All microinjections were performed at 100 hPa microinjection pressure 
for 0.5 s with 20 hPa compensation pressure.  
Fluorescence microscopy.  Ensemble hAgo2-hDcp1a colocalization 
experiments were performed on a Nikon TE2000 microscope equipped with a 
Cool-SNAP HQ CCD camera (Photometrics). Cells were imaged using a 40x 
objective at 0.5 – 1s camera exposure time. Light from a mercury lamp was 
spectrally filtered using 470/40x and 575/50X excitation filters to specifically 
excite EGFP and mRFP1 respectively via wide-field epi-illumination. 
Fluorescence from EGFP was detected using a 400DCLP dichroic filter and 
460/50m emission filter; and that from mRFP1 was detected using a 605dxcru 
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dichroic filter and 625/30m emission filter. All filters were purchased from 
Chroma. 
Super-accuracy single particle tracking was performed as described 
(Chapter1, MATERIALS AND METHODS, Fluorescence microscopy). EGFP 
and mRFP1 were imaged using the fluorescein and Cy3 filter sets respectively. 
Ago2 and Dcp1a particle tracking was done at 92x, 120x or 192x magnification 
using lower laser power and different camera gain settings as compared to single 
miRNA particle tracking. Signal from different fluorophores were recorded on the 
same region of the camera, one after another (not simultaneously) for multi-color 
imaging. 
Data analysis. ImageJ (NIH) was used for image analysis in ensemble 
fluorescence microscopy. For single molecule microscopy, images from 
spectrally distinct fluorophores arising from the same particle were mapped onto 
one another using in-house MATLAB routines to correct for chromatic 
aberrations arising from the microscope optics. To this end, sparsely distributed 
(~100 beads per 68 x 68 µm2), non-specifically immobilized ~200 nm tetraspek 
beads (Invitrogen) bearing four spectrally distinct fluorochromes were imaged 
using 488nm, 532nm and 640nm lasers respectively. The intensity distribution 
from each fluorohpore on the same bead were then independently fit with a 2D 
Gaussian function and localized with ~5 nm spatial accuracy. Combining the 
location of all beads thus determined, a local weighted mean transformation 
(136) was calculated to map the entire field of view for different fluorophore 
emissions. The resultant map thus created was then used as a template to co-
localize EGFP/mRFP1 and Cy5 particles with ~10 nm spatial resolution. Single 
particle tracking and single molecule counting were done as described 
(Chapter1, MATERIALS AND METHODS, live cell imaging and data analysis 
and Fixed cell imaging and data analysis). Certain videos were deconvolved 
using a theoretical point spread function in AutoQuantX2 (MediaCybernetics) to 
artificially improve the signal to noise ratio.  
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 As we use only a finite observation window, small observation time 
coupled with fluorophore photobleaching, to measure the dwell time of miRNAs 
in PB, a systematic bias is introduced in the calculation of observed dwell times. 
This was corrected for by measuring the rate at which single Cy5 fluorophores 
photobleached (kphoto) and subtracting this value along with the reciprocal of the 
observation window (tw) from the observed rate (kobserved) (21): 
                            
 
  
 
 
3.3 Results 
Ago2 and miRNAs colocalize with processing bodies. Previous reports had 
suggested that miRISC-bound mRNA complexes localize to PBs under both 
normal and stressed conditions (67, 189, 213). To test whether ectopically 
expressed Ago2 and microinjected miRNAs, core components of miRISC, 
localize to PBs we performed multi-color ensemble fluorescence microscopy 
(Fig. 3.1). Dcp1a, a decapping protein that localizes to PBs, fused to mRFP1 
served as a PB marker. Under conditions of transient transfection, both EGFP-
Ago2 and mRFP1-Dcp1a localized to distinct foci in the cytoplasm of HeLa cells 
(Fig. 3.1A). The distributions of the number of Ago2 foci and PBs (Dcp1a foci) 
per cell (Fig. 3.1B, C) were similar to those present endogenously (81, 189, 190). 
Notably, only ~50% of Ago2-EGFP expressing cells contained punctate 
structures of Ago2, whereas all cells expressing Dcp1a-mRFP1 contained foci 
enriched in Dcp1a (Fig. 3.1B, C). A majority of Ago2 foci (~82%) in cells co-
expressing Ago2 and Dcp1a colocalized with Dcp1a foci, strongly suggesting that 
large punctae of Ago2 are themselves indicative of PBs. We additionally found 
that Cy5 labeled, microinjected miRNAs also formed punctate structures, which 
also colocalized (~72% of all Cy5 labeled punctuate structures respectively) with 
PBs (Fig. 3.1D). However, only ~15% of all Cy5 signal and ~10% of all EGFP 
signal, arising from miRNAs and Ago2 respectively, colocalized with PBs. These  
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Figure 3.1. Ago2 and miRNAs colocalize with PBs. (A) Pseudo-colored images 
depicting the colocalization (Merge, right) of ectopically expressed Ago2-EGFP 
(left) and Dcp1a-mRFP1 (middle). Arrows show representative foci containing 
both Ago2 and Dcp1a. Scale bar 10 µm. (B) and (C) Distribution of the number of 
Ago2 and Dcp1a foci in HeLa cells (n = 55 cells). (D) Pseudo-colored images 
depicting the colocalization (Merge, right) of ectopically expressed Dcp1a-EGFP 
(left) and microinjected let-7-a1-Cy5 miRNA (middle). Arrows show 
representative foci containing both Dcp1a and miRNA. Scale bar 10 µm. 
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data suggest that only a small fraction both miRNAs and Ago2, potentially in the 
form of miRISC bound mRNPs, localize to PBs. 
PBs diffuse much slower than micro-ribonucleoprotein complexes 
(miRNPs). Prior to performing multi-color tracking, we sought to understand the 
diffusive behavior of Dcp1a punctae in living HeLa cells. To this end, we 
transiently transfected HeLa cells with plasmids bearing Dcp1a tagged with a 
fluorescent protein (EGFP or mRFP1), and tracked the motion of individual 
fluorescent foci in live cells. Punctate structures were detected even at very low 
laser power and camera gain settings, as expected because each puncta should 
be composed of multiple Dcp1a molecules, and therefore fluorescent proteins. 
Particles were tracked for several minutes without observing significant 
photobleaching and diffusion coefficients of individual particles were determined 
using time-averaged mean squared displacement analysis (180). 
 We found that a majority of Dcp1a foci were either static (Fig. 3.2A, C) or 
exhibited confined motion; however, certain particles also demonstrated other 
types of diffusion (Fig. 3.2B, C). Diffusion coefficients of a majority of particles 
ranged between 10-2 and 10-4 µm2/s (Fig. 3.2D), consistent with those reported 
earlier (190), with good correlation between the size of punctae and their 
mobility. Based on our previous observations (Chapter 2, Fig. 2.2), a majority of 
diffusing miRNA particles, potentially in the form of miRNPs, bore diffusion 
coefficients ranging between 1 – 0.01 µm2/s. The relatively slow diffusion of 
Dcp1a foci, compared to miRNPs, led us to devise a discontinuous illumination 
scheme wherein PBs were imaged immediately before and after visualizing 
miRNPs in live HeLa cells. Using such a scheme enabled us to track miRNPs 
without compromising on time resolution, which would have been reduced if 
miRNAs and PBs were visualized by continuously alternating excitation. 
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Figure 3.2. Mobility of PBs are much slower than that of miRNPs. Representative PBs demonstrating confined (A) and 
Brownian motion (B) respectively. (C) MSD vs time plots of particles in A and B. Diffusion coefficients calculated from the 
plot were D(i) = 0.0007 µm2/s and D(ii) = 0.1 µm2/s respectively. (D) Distribution of diffusion coefficients of Dcp1a foci in 
live HeLa cells (n = 8 cells, 80 particles). 
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Heterogeneous distribution of labeled miRNAs in processing bodies. To 
better understand the distribution of miRNAs within PBs, we performed single 
molecule miRNA counting experiments as described (Chapter 1, Results, 
Intracellular single molecule counting). More specifically, EGFP or mRFP1 
and Cy5 fluorescence signal were mapped with ~10 nm spatial resolution and the 
intensity trajectories of Cy5 labeled miRNA particles, localized within ~300 nm 
from the periphery of PBs, were analyzed. Such a criterion was used to account 
for miRNAs that localized adjacent to PBs, which according to Pillai et al. (67) 
could potentially signify miRNA localization to distinct PB compartments. All 
localizations within (Fig. 3.3A) or adjacent (Fig. 3.3B) to PBs will be denoted by 
the term ‗colocalization‘ from this point forward. We found that only ~20% of 
EGFP or mRFP1 labeled punctuate structures (i.e., PBs) colocalized with Cy5 
labeled miRNA; and only ~10% of all miRNA molecules colocalized with PBs, 
consistent with earlier reports (67). Amongst the colocalized fraction, a majority 
of PBs (~83%) contained only 1 or 2 miRNA molecules (Fig. 3.3A – C and E) 
whereas the rest (~17%) contained three miRNA molecules or greater (Fig. 3.3D, 
E). We additionally found that PBs could either contain single (Fig. 3.3A, C) or 
multiple miRNA particles (Fig. 3.3B, D) suggestive of single or multiple miRISC-
bound mRNPs. These findings reveal a surprising heterogeneity in the 
distribution of miRNAs within PBs (Fig. 3.3F), a phenomenon that was not 
observed using traditional fluorescence microscopy.  
miRNPs localize to processing bodies stably or transiently. We further 
sought to understand the nature of the miRNP:PB interactions in live HeLa cells 
using single particle tracking microscopy. To this end, we injected Cy5 labeled 
miRNAs into HeLa cells expressing EGFP or mRFP-1 tagged Dcp1a and 
observed the mobility of each of these particles relative to one another. A 
discontinuous illumination scheme was employed; EGFP or mRFP-1 was imaged 
for 2 – 5 s before and after imaging Cy5 for 5 - 10 s, to track Dcp1a puncta and 
miRNA particles, respectively. We found that PBs, a majority of which were large 
particles with high molecular mass, moved very slowly (~100 – 150 nm) over the 
entire visualization period (9 – 20s) and thus were practically immobile during the 
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Figure 3.3. Heterogeneous distribution of miRNAs within PBs. (A - D) Pseudocolored images of EGFP labeled Dcp1a 
particles (left), Cy5 labeled miRNAs (middle) and their respective colocalized images (right), representing single mRNP 
bound by a single miRISC (A), two mRNPs bound by single miRISC each of which one is localized adjacent (iii) to the PB 
(B), single mRNP bound by two miRISCs (C) and two mRNPs each bound by two miRISCs (D) respectively. Scale bar, 
0.6 µm (A, B) and 0.8 µm (C, D) respectively. (E) Representative single molecule intensity trajectories of Cy5 labeled 
miRNAs corresponding to those present in A-D. (F) Distribution of miRNA molecules colocalized with PBs (n = 12 cells, 
110 particles). 
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miRNA visualization time. Only those miRNPs in the vicinity of large slowly 
moving PBs, whose displacements during miRNP imaging were less than 1 pixel 
(133 nm), were further analyzed. The EGFP/mRFP1 and Cy5 signals were 
mapped as described (Data Analysis), an average image of EGFP / mRFP1 
puncta was created from videos corresponding to both pre- and post-miRNA 
imaging, and the localization of Cy5 labeled miRNPs in the vicinity of PBs was 
analyzed.  
 We predominantly observed two different types of interactions; one where 
miRNPs associated with PBs for short intervals of time before diffusing back into 
the cytoplasm (Fig. 3.4A, B), referred as ‗transient‘ interactions from this point 
forward, and another where miRNPs remained colocalized with PBs until the Cy5 
fluorescent probe on the miRNA photobleached (Fig. 3.4C, D) or the miRNP 
floated off to a different focal plane, denoted as ‗stable‘ interactions. In the first 
type of interaction, a relatively fast moving cytoplasmic miRNP (~0.6 µm2/s)  
transiently associated with a PB for ~0.2 – 3 s, observed as a reduction in miRNP 
mobility in the event of colocalization (~0.15 µm2/s), and quickly dissociated to 
freely diffuse back into the cytoplasm (Fig. 3.3A). Transient interactions also 
included miRNPs that diffused away from PBs after being initially associated with 
one at the beginning of our observation window (Fig. 3.3B). In either case, we 
found that individual miRNPs interacted with the same PB multiple times. In 
contrast, stable colocalizations were observed as miRNPs associated with the 
periphery of a PB (Fig. 3.3C) or localized inside PBs (Fig. 3.3D). The average 
dwell time (or interaction times) of miRNPs in PBs, be it stable or transient 
associations, was ~ 0.62 ± 0.05 s, which after correcting for small observation 
time and photobleaching amounts to 1.18 ± 0.10 s. Upon further analysis, we 
found that miRNAs bind to PBs stably and transiently with equal probability, 
which in combination with the observations above, predicts diversity in 
composition of miRNPs and PBs. 
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Figure 3.4. Interaction of miRNPs with PBs in live cells. (A) and (B) 
Representative images of let-7-a1-Cy5 miRNPs transiently interacting with EGFP 
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labeled Dcp1a foci, i.e. PBs, with average interaction times of 2.2 ± 1.3 s and 1.5 
s respectively. The miRNP in (A) interacts multiple times with the PB before 
rapidly diffusing back into the cytoplasm (0.8s, 2.1s, 3.3s dwell times 
respectively). Scale bar, 0.5 µm. (C) and (D) Representative images of stable 
miRNP-PB interactions. The miRNP in (C) surveyed the periphery of the PB and 
that in (D) remained localized within the PB before photobleaching. Particles in 
(C) and (D) interacted with PBs for 8.4 s and 2 s respectively. Numbers in top 
right of each let-7-a1-Cy5 panels correspond to time since each particle was 
visible. Videos of let-7-a1-Cy5 in (A) and (C) were deconcolved. (E) Interaction 
(or dwell) time histogram of miRNPs (in) associating with PBs. Dotted line 
represents fit of the data to a single exponential function. (n = 8 cells, 108 
interactions). Grey box at ‘10 s‘ time indicates an artificial enrichment of this dwell 
time as contributed by our limited observation window (10 s). 
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3.4 Discussion 
Here we report on the distribution of miRNAs associated with PBs and the 
different modes of miRNA-PB interactions inside human cells with single 
molecule sensitivity. We find that majority of PBs contain very few fluorophore 
labeled miRNPs and that miRNPs can interact with PBs in stable or transient 
fashion. Taken together, these observations predict the existence of a diverse set 
of miRNA complxes and PBs varying in composition. Moreover, a stable 
miRNA:PB interaction may potentially require specific interacting proteins, such 
as GW182 (208, 209, 212, 216), whose presence either on the miRNP or the PB 
can strengthen the interaction. Additionally, our data clearly show the 
heterogeneity associated with molecular interactions, specifically in the context of 
a living cell, which are largely unobservable using ensemble biochemical and 
microscopic techniques.  
We initially performed control experiments to confirm the colocalization of 
microinjected miRNA and ectopically expressed Ago2 with PBs. Consistent with 
previous work (67, 189) we found that only a small fraction of the total miRNA 
and Ago2 cellular pool colocalized with microscopically visible PBs. It is possible 
that miRNA mediated target repression occurs via multiple mechanisms and only 
a small fraction of repressed mRNPs are channeled through PBs. However, it is 
still unclear whether PB localization of repressed mRNPs is the cause for 
repression or occurs as a consequence of other modes of repression. Thus, an 
alternate hypothesis is that a majority of repression occurs in the cytoplasm 
through other mechanisms and only a very small fraction of these already 
repressed mRNPs aggregate to form PBs or are transported to PBs for further 
processing. 
We also tracked the movements of single Ago2 and Dcp1a particles in live 
HeLa cells and found them to predominantly exhibit confined movements, as 
previously reported (190). Such restricted diffusion has been proposed to arise 
from the anchoring of PBs to certain cellular elements, like the cytoskeleton 
(190). Additionally, these particles diffused much slower than a majority of 
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miRNPs, largely owing to their high molecular mass. The large size and slow 
mobility of PBs enabled us to devise an illumination scheme to visualize both 
PBs and miRNPs, labeled with differently colored fluorescent probes, in the same 
region of a live cell. As a majority of miRNPs diffused at least an order of 
magnitude faster than PBs, it was absolutely necessary for us to image miRNPs 
at higher spatial and temporal resolution, which was easily achieved using our 
illumination and analysis methods. Continuous illumination schemes to image 
two fluorophores simultaneously (138) could potentially shed light on the 
interaction of miRNPs with fast moving PBs as well. 
Very few quantitative data exist on the distribution and dynamics of 
miRNAs and miRISC proteins within PBs. On the one hand, Pillai et al., using 
standard confocal microscopy, have shown that miRNAs can either localize 
within PBs or adjacent to PBs (67). This observation prompted them to 
hypothesize that miRNAs could potentially interact with PBs via different 
mechanisms, which were not resolvable by their visualization method. 
Photobleaching experiments, on the other hand, have shown that PB-localized 
miRISC components, especially Ago2, exchanged very slowly with their 
cytoplasmic pools compared to other PB components (189), strongly suggesting 
stable miRISC:PB interactions. These reports, upon comparing the signal 
intensity of fluorophore labeled miRNAs or Ago2 within PBs to the total 
fluorescent intensity within the cell have estimated that close to 20% of miRNAs 
and their associated mRNAs (67) and less than 2% of cellular Ago2 (189) 
localize to PBs. Quantifications such as these are often skewed by errors 
associated with ensemble intensity measurements arising due to fluorophore 
self-quenching (217), wherein the total intensity value of a particle with multiple 
fluorophores is not linearly related to that of a single fluorophore. To overcome 
these caveats, we used stepwise photobleaching of fluorescent probes for 
counting the number of miRNA molecules within PBs. This method does not rely 
on the absolute value of intensity per se, but uses the number of steps it takes for 
the intensity trajectory of an individual particle to reach background levels as a 
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direct count of the number of molecules within that spot, exploiting our single 
molecule sensitivity. 
Our stepwise photobleaching intensity analysis showed that miRNAs are 
not equally distributed within PBs and, as reported earlier (67), localized either 
within or adjacent to PBs (Fig. 3.3). Certain foci contained more miRNAs than 
others, but surprisingly a majority of PBs contained either 1 or 2 fluorophore 
labeled miRNAs. Additionally, PBs colocalized with single mRNPs (Fig. 3.3A, C) 
or multiple distinct mRNPs each associated with one or more miRISCs (Fig. 
3.3B, D). Notably, punctuate miRNA particles bearing greater than 6 miRNAs 
rarely colocalized with EGFP labeled PBs, possibly suggesting the presence of 
additional, unlabeled aggregates composed of different proteins that are 
undetectable in our experiments. Such heterogeneous distribution of miRNAs 
can potentially be explained by one or several of the following hypotheses; (i) 
depending on their composition and size, PBs can accommodate different 
numbers of miRNPs; (ii) based on their composition, miRNPs can interact with 
PBs to varying degrees; (iii) only punctuate structures of miRNAs are truly PB-
localized, whereas the rest, containing only one or two miRNA molecules, 
represent transient miRNP:PB interactions; or (iv) PBs associated with small 
numbers of miRNA molecules are nucleating centers for miRNP aggregation.  
Single molecule and particle tracking enabled us to clearly visualize the 
different modes of miRNP:PB interactions in live HeLa cells. We found that 
miRNPs either bound transiently or stably with PBs and those miRNPs that 
started out as freely diffusing particles in the cytoplasm were more likely to bind 
transiently than stably. These observations support the notion that miRNAs that 
localize adjacent to PBs in fixed cells represent either transient miRNP:PB 
interactions or miRNPs scanning over the surface of PBs to potentially locate a 
more stable docking site. As both stable and transient interactions, overall, were 
equally likely, our data strongly suggest a probabilistic miRNP:PB interaction 
model in which miRNPs do not show a constant (static) behavior, but can switch 
between being bound and unbound states, possibly depending on specific 
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biomolecular signals. This model coupled with the observed short dwell times, on 
the order of a few hundred milliseconds, of miRNPs in association with PBs 
suggests a transient role for PBs in mediating miRNA assisted gene repression. 
Alternatively, it may provide a more general explanation for the relatively low 
repression levels by miRNAs as opposed to silencing RNAs (siRNAs), which 
typically ‗knock-down‘ protein expression almost completely. miRNAs 
predominantly bind with incomplete complementarity to their cognate mRNA 
targets, reducing protein expression by only a small fraction. Thus, low binding 
energy, in contrast to siRNAs that bind with complete complementarity to their 
targets, in addition to a low interaction probability of miRNPs with PBs, enables 
miRNAs to fine-tune protein expression instead of acting as binary switches. To 
further test such a model, the affinity of miRNAs for mRNAs will need to be 
investigated. Overall, our data shed light on the interaction between miRNPs and 
PBs inside living cells at single molecule sensitivity, thus paving the way for 
investigating biomolecular interactions in their native environment, one molecule 
at a time and highlighting the importance of heterogeneity and transient events in 
biomolecular processes. 
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Chapter 4 
 
Elucidating microRNA:mRNA Interactions in vitro Using Single Molecule 
Fluorescence Microscopy 
 
4.1 Introduction 
microRNAs (miRNAs) are small non-coding RNAs, ~22 nucleotides (nt) in 
length, that base pair with 3`UTRs of protein-coding mRNAs to mediate post-
transcriptional repression (11, 12). The recognition of mRNAs by miRNAs is 
defined by a 6-8 nt region within the 5` end of the miRNA called the seed 
sequence (218-220). This sequence in the miRNA needs to be completely 
complementary to regions within the mRNA and this criterion, along with 
sequence conservation among organisms, has been traditionally used for the 
bioinformatic, genome-wide prediction of miRNA targets (219, 220). Reporter 
assays have suggested that seed pairing is not only important for recognition but, 
in some cases, is sufficient for efficient repression (64, 221). However, this does 
not hold true for all miRNA targets, and it has been shown that the degree of 
repression is highly variable in different UTR contexts (218). Such observations 
clearly suggest a role for mRNA structures and sequences outside of the seed 
region in target recognition and binding (218). 
A majority of bioinformatically predicted miRNA targets contain only one 
seed sequence for a given miRNA, however, certain messages, especially those 
coding for transcription factors (222-224), contain multiple seed matches. Of 
particular importance is the mRNA coding for high mobility group AT hook 2 
(HMGA2) proteins, a small, non-histone, chromatin architecture modulating 
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transcription factor. This mRNA contains seven seed matches for let-7, a miRNA 
that is evolutionarily conserved from the nematode C.elegans to humans, and the 
aberrant expression of this protein can lead to oncogenic transformation in mice 
(48, 222). Conversely, the 3` untranslated regions (UTRs) of several oncogenes, 
including HMGA2, are shortened in cancerous cells to evade miRNA mediated 
repression (225-227). These results suggest that mRNAs with long 3`UTRs are 
under evolutionary pressure for stringent regulation in order to evade cancer and 
that this is realized by the maintenance of multiple miRNA seed matches (226, 
227).  
Previous reports (48, 63, 64) have shown that all miRNA binding sites 
within a naturally occurring or artificial mRNA that contains multiple seed 
sequences are important in vivo (48, 63, 64); however, it is unclear whether: (i) 
all sites are occupied simultaneously; and (ii) ―allostery‖ and/or cooperativity 
connect multiple miRNA binding sites. To this end, we developed a single 
molecule assay to count the number of miRNAs bound per mRNA molecule in 
vitro. We found that a majority of mRNAs are either unbound or singly bound by 
miRNAs, using each two different miRNA-mRNA pairs and cell extracts. Contrary 
to previous observations (63, 64, 228), our data together with computational 
analysis of RNA structure and free energy calculations of miRNA binding suggest 
that multiple seed matches within mRNAs provide a greater probability for 
miRNA binding, but not necessarily binding of multiple miRNA, thus providing a 
molecular framework for the relatively modest repressive abilities of miRNAs. Our 
results also suggest that miRNAs bind seed sequences independently from one 
another, with certain sites bound preferentially over others. 
 
4.2 Materials and Methods 
Plasmids, DNA and RNA oligonucleotides. cDNA of mouse HMGA2 
containing a  5` untranslated region (UTR), coding sequence (CDS) and 3`UTR 
were removed from pcDNA-mH-2xwt plasmid bearing the cDNA of mouse 
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HMGA2 with two 3`UTRs (made by John Hoerter), using the BamHI and NotI 
restriction enzymes. The mouse HMGA2 cDNA was ligated into pEF6, which was 
also digested with the same restriction enzymes, downstream of the T7 promoter 
resulting in pEF6-mH. pRL-TK-cxcr4-6x (229), plasmid containing the renilla 
luciferase CDS and an artificial 3`UTR containing six binding sites for an artificial 
cxcr4 miRNA downstream of the T7 promoter, was purchased from Addgene ©. 
All RNA oligonucleotides were purchased from the Keck Biotechnology 
Resource Laboratory at the Yale University School of Medicine with a 5‘ 
phosphate (P) and, in the case of amine modified RNA, a 3‘ amino group on a C7 
carbon linker. RNA was purified as described (177) and the 3‘ amine groups 
were labeled with Cy3 or Cy5 succinimidyl ester as described (177, 178). RNA 
sequences were as follows: 
let-7-a1 guide: P-UGAGGUAGUAGGUUGUAUAGUU 
let-7-a1-passenger: P-CUAUACAAUCUACUGUCUUUCC 
cxcr4 guide: P-UGUUAGCUGGAGUGAAAACUU 
cxcr4 passenger: P-GUUUUCACAAAGCUAACACA 
Guide and passenger strands were heat-annealed in a 1:1 ratio, resulting in 
duplex miRNAs, and frozen for further use. 
 Control DNA, BDCcxcr4N, containing a 5` biotin and 3` amino group was 
purified and labeled as described (177). Sequence is as follows: 
BDCcxcr4N: AAAAAAAAGTTTTCACTCCAGCTAACATT 
mRNA synthesis and labeling.  Plasmids pEF6-mH and pRL-TK-cxcr4-6x were 
digested with NotI RE and purified by phenol-chlorofom extraction followed by 
ethanol precipitation. In vitro transcriptions were performed with 1 µg linearized 
plasmids using the MegaScript T7 kit (Ambion ©) according to manufacturer‘s 
protocol. Transcription reactions were then DNAse treated (turbo DNAse, 
Ambion ©) and the RNAs, mH or RL-cx6x transcribed from plasmids pEF6-mH 
and pRL-TK-cxcr4-6x respectively, were purified by LiCl precipitation. The RNAs 
were purified either from a 1.2% agarose gel, in the case of mH, or 5% urea poly-
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acrylamide gel electrophoresis (PAGE), for RL-cx6x. Gel extracted RNAs were 
then modified by 7-methyl-(3`O-Methyl)-G capping and polyadenylation using the 
ScriptCap capping and polyA tailing kits respectively (Epicentre ©). 3`OMethyl 
GTP was used instead of GTP for capping reactions (Fig. 4.2A) to prevent 
periodate mediated oxidation and the subsequent biotinylation of the cap in 
addition to the 3` end. To estimate the length of the polyA tail, RNAs were 
separated on a 1.2% formaldehyde agarose gel. Capped and tailed RNAs were 
purified by gel filtration (Roche© RNA columns), and their 3`ends were 
biotinylated after periodate oxidation as described (230). Briefly, 1-10 µM RNA 
was oxidized using 100mM sodium periodate in a 100mM sodium acetate buffer, 
pH 5.3, for 90 min on ice and room temperature (RT) respectively. The oxidized 
RNA, purified by gel filtration and ethanol precipitation, was then reacted either 
with saturated biotin hydrazide or biocytin hydrazide (Thermo Pierce©) for 5 h at 
RT and purified by gel filtration (Roche© RNA columns) followed by ethanol 
precipitation. Biotinlyation efficiency was tested by adding a known amount of 
either a positive control RNA, a negative control non-biotinylated RNA or the 
biotinylated RNA to streptavidin beads (MyOne-C1 Streptavidin beads, 
Invitrogen©) and measuring the amount of RNA bound (Fig. 4.2C). Briefly, 50 
pmol of biotinylated-let-7-a1 miRNA (+ve), capped and tailed RLcx6x mRNA (-ve) 
or capped, tailed, biotin tagged, Cy3 labeled,  RLcx6x mRNA (CRTBCy3), 
suspended in 10 mM Tris.Cl, 1M NaCl and 0.1% Tween-20 buffer, were added to 
streptavidin coated magnetic beads and incubated for 0.5 h at RT to allow for 
RNA binding. Beads containing RNA were separated from unbound RNA using a 
magnet and the amount of RNA left in the supernatant was measured by the 
absorbance value at 260 nm. Amount left in the supernatant subtracted from the 
amount added was used to estimate the amount of RNA bound to the beads. In 
the case of RL-cx6x, the capped, tailed and biotinylated (using biocytin 
hydrazide, which had an extra amine functional group) RNA was further labeled 
with a Cy3 dye at the 3` end, as described (177). This dye labeled RNA was 
purified by gel filtration (Roche© RNA columns), ethanol purification and was 
used in single molecule assays. 
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Computational analysis of secondary structure and miRNA hybridization 
energies. Mfold version 2.3 (http://mfold.rna.albany.edu) was used to create and 
analyze secondary structures of mRNAs. The RNAs were folded at RT with 1 M 
Na+ and no divalent ions. RNAhybrid was used to calculate the minimum free 
energy of hybridization between miRNAs and their corresponding seed 
sequences. 
 
miRISC assembly and in vitro translation. miRISCs were assembled in HeLa 
cytosolic (S100) cell extracts (Jena Biosciences) with minor modifications to the 
protocol described earlier (231). Briefly, 1 nM Cy5 labeled let-7-a1miRNA was 
typically incubated with 50% HeLa cell extract supplemented with lysis buffer 
[23.7 mM HEPES.KOH, pH 7.5, 79 mM potassium acetate, 1.58 mM magnesium 
acetate, 5mM DTT and 1 mg/mL Pefabloc SC (Roche©)], RNAi mix (125mM 
creatine phosphate, 5mM ATP and 25mM DTT), 2% creatine kinase and 10% 
RNAse inhibitor (Applied Biosystems©), for 2 h at 4 oC. 
 Repression reactions in nuclease treated rabbit reticulocyte lysate (RRL, 
Promega) were performed as described (71, 229, 232). Briefly, 150 fmol of Cy5 
labeled cxcr4 miRNA were mixed with 25 fmol of capped and tailed reporter 
mRNA (C-RLcx6x-T) and control luciferase RNA (firefly luciferase RNA, C-FL-T, 
Promega) to a total volume of 2.2 µL. The mixture was heated to 75 oC for 3 min, 
cooled to RT for 5 min and then added to ice to pre-anneal the miRNA with the 
reporter mRNA. 7.8 µL of a masrter mix containing 7 µL (70%) of RRL, 0.2 µL (4-
8 U) of RNasin (Promega), 0.2 µL (20 µM) amino acid mix and 0.4 µL of water 
was added to the RNA mix and incubated at 30 oC for 15 min. Dual luciferase 
assays were performed using dual luciferase assay reagents (Promega) 
according to manufacturers protocol to quantify repression.  
 
Single molecule microscopy. Slides and coverslips for single molecule 
microscopy were prepared as described (233). Briefly, clean quartz slides were 
functionalized using a commercially available aminosilane (Sigma) and reacted 
with a mixture of NHS-ester functionalized poly-ethylene glycol (PEG) and 
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biotinylated PEG (5000 MW, Laysan Biosciences). Coverslips were silanized and 
reacted only with PEG. Unreacted free amines on the slides and coverslips were 
then blocked with sulfo-DST (Laysan biosciences), thus creating a negatively 
charged surface that inhibits non-specific binding of negatively charges RNAs. 
Double sided tape was used to create a microfluidic channel between the 
coverslip and slide, which were then tightly glued together using epoxy.  
 For experiments with HeLa cell extracts, 50 – 350 pM capped, tailed and 
biotinylated mRNAs (C-mH-T-Bio or C-RLcx6x-T-Bio) were first immobilized on 
the streptavidin coated slides and assembled miRISC complexes (20 times more 
miRNA as compared to mRNA), as described above, were added to the 
immobilized mRNA. Complexes were allowed to bind to the mRNA, on the slide, 
at RT for 20 min and unbound complexes were washed off using a buffer 
containing the lysis buffer, RNAi mix, creatine kinase, RNAse inhibitor 
supplemented with an oxygen scavenging system (10 mM trolox, 100 mM 
protocatechuic acid and 1 µM protocatechuate-3,4-dioxygenase). Slides were 
imaged immediately after washing. 
 For experiments with RRL, repression reactions (described above) were 
assembled with capped and tailed biotinylated and Cy3 labeled reporter mRNA, 
(capped and tailed) control mRNA and the miRNA in the appropriate ratio. 
Repression reactions were then diluted 10-fold in the master mix (described 
above), added to streptavidin coated slides and incubated for 10-15 min at RT. 
Unbound complexes were washed using a buffer containing 50 mM 
HEPES.NaOH, pH 7.5, 80 mM potassium chloride, 20 mM sodium chloride, 1mM 
magnesium chloride and the oxygen scavenger system. Slides were imaged 
immediately after washing. Unfortunately, our attempts to image single miRNA 
molecules in the presence of cell extracts, both HeLa and RRL, within the 
microfluidic channel were marred by high background contributed by both the cell 
extract and unbound miRNAs. 
 Control experiments, to compute the percentage of bright fluorophores, 
were done by first annealing Cy3 labeled, biotin tagged DNA and Cy5 labeled 
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cxcr4 miRNA in a 1:10 ratio at 90 oC for 1 min, 75 oC for 3 min, and slow ramping 
of the temperature from 65 oC to 4 oC at 3oC / min. The annealed solution was 
added to streptavidin coated slides and incubated for 10 min. Unbound duplexes 
and excess miRNA were then washed away with the using a buffer containing 50 
mM HEPES.NaOH, pH 7.5, 80 mM potassium chloride, 20 mM sodium chloride, 
1mM magnesium chloride and the oxygen scavenger system. Slides were 
imaged immediately after washing. 
Imaging was done using a prism coupled total internal reflection 
fluorescence microscope based on an Olympus IX-71 microscope equipped with 
a 60x water immersion objective (Olympus) and a PentaMAX intensified CCD 
camera (Princeton Instruments). Cy3 and Cy5 fluorophores were excited using 
532 nm and 635 nm lasers respectively and their fluorescence emission were 
detected using HQ580/60 and HQ710/130 bandpass filters (Chroma) 
respectively. Emission from Cy3 and Cy5 were spectrally separated using a 
dichotic filter and projected onto different regions (channels) of the same CCD 
chip. Positions on the Cy3 and Cy5 channels were spatially mapped using 
fiduciary markers [Red microspheres (Invitrogen)] as described (Chapter 3). 
Particles were Images were collected for 100 – 500 s at 10 frames/s (fps) camera 
exposure time and intensity trajectories were analyzed using custom written 
MATLAB routines. The density of spots on our passivated surfaces were low 
enough (~ 0.05 spots/µm2) to be confident that single particles were visualized. 
 
4.3 Results 
mRNA secondary structure and thermodynamics of miRNA binding 
potentially play an important role in target recognition and binding. We first 
analyzed computationally predicted secondary structures of both C-mH-T and C-
RLcx6x-T (Fig. 4.1) to check if secondary structure of mRNAs affected miRNA 
seed sequence accessibility. As expected, both mRNAs were highly structured, 
especially in their 3`UTRs. Seed sequences of let-7 miRNA in the 3`UTR of 
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mouse HMGA2 were found to be distributed between unstructured loops, 
structured stems that were completely base-paired with a different region of the 
mRNA, or a combination of both, wherein only a few bases were paired (Fig. 
4.1A). Based purely on the general expectation that regions within loops are 
more accessible than ones that are base paired, we can immediately rank 
miRNA seed sequences with respect to their accessibility; seed sequence 5 is 
the most and seed sequences 2 and 6 are the least accessible. We also find that 
seed sequences 6 and 7, separated by just 13 nucleotides (nt), can potentially 
exhibit positive cooperativity, wherein binding of one miRNA melts the proximal 
structure of the mRNA, rendering the other miRNA binding site more accessible. 
All other binding sites are structurally well dispersed, inconsistent with synergistic 
miRNA binding. In contrast, all cxcr4 seed sequences within the relatively short 
3`UTR of RLcx6x are closely located, both structurally and by sequence 
(separated by just 4 nt from one another), with correspondingly high propensity 
for cooperative miRNA binding (Fig. 4.1B), especially between seed sequences 
2 and 6 as well as 3 and 5. Additionally, the lowest energy structure predicts that 
seed sequence 1 is the most accessible and the rest are equally of lower 
accessibility.  
By contrast, computational prediction of the duplex stability of the 
miRNA:target site hybrid suggests an anti-correlation between minimum free 
energy of miRNA binding and seed sequence accessibility for mHMGA2 mRNA 
(Fig. 4.1C). It is possible that seed sequence accessibility is of primary 
importance, but upon seed matching, hybridization of ~4 – 8 nt in the 5`region of 
the miRNA with the mRNA, the extent of complementarity between the miRNA 
and mRNA can dictate affinity of miRISC complexes. Thus, both secondary 
structure and miRNA binding energy potentially play important roles in target 
recognition and miRNA binding, respectively, in addition to opening up the 
possibility for cooperative miRNA binding. 
Synthesis of capped, tailed, biotinylated, dye labeled long mRNAs. To 
synthesize mRNAs with all the essential functionalities required for miRNA  
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Figure 4.1. mRNA secondary structure and miRNA binding energy analysis. (A and B) Mouse HMGA2 and RLcx6x 
mRNAs folded in mfold. Highlighted region in the core structure denotes 3`UTR. Boxed structures show zoomed in 
sections of miRNA binding sites. Highlighted sequences inside zoomed-in sections denote regions complementary to let-
7-a1 and cxcr4 miRNAs in mHMGA2 and RLcx6x mRNAs respectively. Regions circled in red represent seed sequences. 
(C) RNAhybrid results of mHMGA2 : let-7-a1 and RLcx6x : cxcr4, mRNA : miRNA pairs. Underlined numbers correspond 
to seed sequence numbers in (A) mHMGA2 and (B) RLcx6x mRNAs respectively. Sequences underlined in red denote 
seed pairing. Mfe denotes minimum free energy. 
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binding and single molecule visualization in vitro, we developed a multi-step 
mRNA synthesis and modification method. Based on previous reports (67, 229), 
which suggested the requirement for 5`caps and 3`tails on mRNAs for efficient 
miRNA mediated repression, we enzymatically capped (Fig. 4.2A) and tailed 
(Fig. 4.2B) our RNAs after in vitro transcription. These modified mRNAs were 
further functionalized with a biotin moiety, a requirement for surface 
immobilization in our single molecule assays; we used 3`end-specific, periodate-
mediated oxidation of the vicinal diols to react with biotin or biocytin hydrazide. In 
certain cases, mRNAs coupled with biocytin hydrazide were also labeled with a 
Cy3 dye, which was needed for the visualization of single mRNA molecules. As 
mRNAs capped with regular GTP would contain vicinal diols at the 5` end, which 
can also get oxidized by periodate, we decided to use 3`O-methyl GTP instead of 
GTP in our capping reactions. We first sought to test whether RNAs can be 
capped by 3`O-methyl GTP. To this end, we set up capping reactions of small 
(29 nt) RNA oligonucleotides with 3`O-methyl GTP and compared their 
electrophoretic mobility to those of both uncapped and GTP-capped RNAs on a 
20% denaturing PAGE that was capable of resolving RNAs differing in size by a 
single nt. As it would be impossible to resolve large RNAs (>100 nt) with single 
base sensitivity, we used a 29-nt RNA instead of mH or RLcx6x mRNA in these 
assays. Upon RNA staining and visualization, we found that these RNAs were 
capped by 3`O-methyl GTP with efficiencies similar to those capped by GTP 
(capping efficiency = ~90%) (Fig. 4.2A). We also systematically tested the 
mRNAs at the end of each step in our synthesis protocol to check for the 
presence of each modification and to quantify their respective efficiencies (Fig. 
4.2A - D). For instance, we found that ~100 – 200 A‘s were added to the mRNA 
in our tailing reactions (Fig. 4.2B) and our biotinylation efficiency was ~30 – 60% 
(Fig. 4.2C). Capped, tailed, biotinylated and, in certain cases, Cy3 labeled 
mRNAs that passed our quality controls were then used for single molecule 
experiments. 
mRNAs, containing multiple seed sequences for a particular miRNA, 
predominantly bind only one copy of the miRNA. Based on repression data
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Figure 4.2. Quality control assays. (A) 20% denaturing PAGE loaded with a 25-mer (1), uncapped 29-mer (2), uncapped 
29-mer with all components of capping reaction except for GTP (3), GTP-capped RNA (4), 3`OMethyl capped RNA (5). 
The RNA were stained with SYBR Gold nucleic acids stain (Invitrogen) and visualized under UV light. (B) 1.2% 
formaldehyde agarose gel stained with ethidium bromide and visualized under UV light. Samples correspond to, firefly 
luciferase RNA (FL, 1), capped and tailed FL (2), RNA ladder (Cat #G319A, Promega, 3), RLcx6x (4), capped and tailed 
RLcx6x (5), 3`OMethyl capped and tailed RLcx6x (6). (C) Quantification of biotinylation efficiency. Samples correspond to, 
biotinylated-let-7-a1 miRNA (+ve), capped and tailed RLcx6x mRNA (-ve) or capped-tailed-biotin tagged-Cy3 labeled 
RLcx6x mRNA (CRTBCy3). (D) 1.2% formaldehyde agarose gel loaded with Cy3 dye (1), RLcx6x mRNA (2), capped-
tailed-biotin tagged RLcx6x mRNA (3), RNA ladder (Cat #G319A, Promega, 4), capped-tailed-biotin tagged-Cy3 labeled 
RLcx6x mRNA (5). Top panel shows eithidium bromide staining followed by visualization using UV light. Bottom panel 
shows fluorescent scan illuminating the Cy3 fluorophore. 
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several groups (63, 64, 218, 225, 228) had predicted that miRNAs bind to 
mRNAs with positive cooperativity, especially when the mRNA contains multiple 
seed matches for that specific miRNA. Thus, under conditions of miRNA excess, 
it is highly likely for an mRNA to be bound by multiple miRNAs. To test this 
hypothesis, we developed a single molecule assay that utilizes the stepwise 
stochastic photobleaching of single fluorophores to quantify the number of 
miRNAs bound per mRNA target in cell extracts under conditions where gene 
repression is observed.  
 We first tested for the binding stoichiometry between miRNAs and their 
mRNA targets in RNAi competent cytosolic HeLa cell extracts (231). Pre-
assembled, Cy5 labeled miRISC complexes, assembled on let-7-a1 miRNAs, 
were incubated with surface-immobilized mH mRNAs (Fig. 4.3A, right) to allow 
for miRISC-mRNA complex assembly. As negative controls, miRISC complexes 
were also added to surfaces that either contained no mRNAs (negative, -ve) or 
were immobilized with a non-specific mRNA (RLcx6x, -veRNA) (Fig. 4.3A, left 
and middle). After washing the surface to remove any unbound miRISC 
complexes, the slide was illuminated until all the fluorophores had 
photobleached. By analyzing the number of photobleaching steps we were able 
to deduce the number of miRNA molecules within each particle. At first glance, 
miRISC bound mRNAs were visible as diffraction limited, well distributed 
particles in the field of view. We found (Fig. 4.3A, B) ~30 and ~5.5 fold more 
particles per field of view in slides immobilized with the specific mRNA (mH) 
compared to empty slides (-ve) and those immobilized with a non-specific (-
veRNA) mRNA, respectively, attesting to the specificity of the miRNA:mRNA 
interactions in HeLa cell extracts. Upon further analysis, we found that a majority 
of the particles, ~ 70% in the mH sample, photobleached in a single step (Fig. 
4.3C, D). Close to 30% of the particles, however, did contain anywhere between 
2 to 5 miRNA molecules. Although the mouse HMGA2 mRNA contains seven let-
7 seed sequences in its 3`UTR, we never observed any spots bleaching in seven 
steps, indicating the absence of fully loaded mRNAs. Thus, our observations  
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Figure 4.3. Single molecule miRNA counting experiments using HeLa cell extract. (A) Representative images of samples 
immobilized with no mRNA (-ve, left), a non-specific RLcx6x mRNA (-veRNA, middle) and a specific mouse HMGA2 
mRNA (mH, right). (B) Number of particles per field of view (FoV) in each of the samples indicated in (A). (n = 5 slides and 
one FoV each) (C) Representative intensity trajectories showing one, two and three step photobleaching respectively. (D) 
Histogram depicting the distribution of photobleaching steps in the mH sample (n = 1576 particles).  
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suggest that mRNAs bind miRNAs at sub-stoichiometric ratios, even if they 
contain several seed sequences for the same miRNA. 
 We further sought to understand whether our previous observations were 
cell extract specific or were a general phenomenon associated with miRNA 
mediated target repression. To this end, we conducted photobleaching 
experiments with a different miRNA-mRNA pair in another cell extract, the rabbit 
reticulocyte lysate (RRL), which has been shown to faithfully recapitulate miRNA 
effecter function (71, 229, 232). As RRL is also translationally viable, its use 
offered a functional assay to correlate the amount of repression with miRNA 
binding. Ensemble luciferase assays showed that a Cy5 labeled cxcr4 miRNA 
repressed its cognate RLcx6x mRNA target both specifically and effectively 
(~50% repression, Fig. 4.4A) when pre-annealed to the mRNA (compare ‗PA‘ to 
‗-ve‘ and ‗-‗ in Fig. 4.4A) at stoichiometric ratios. In fact, the RLcx6x mRNA, 
which contains six cxcr4 seed sequences, was maximally repressed only when 
the mRNA was annealed with the miRNA at a ratio of 1:6 (229, 232), not higher 
or lower. As described previously (229, 232), addition of the antisense (guide) 
strand only (AS) or the miRNA duplex (DS) to the repression reaction resulted in 
lower amounts of repression than observed when the miRNA was pre-annealed 
to the mRNA. We then performed single molecule experiments using the same 
conditions that resulted in maximal repression to compare the distribution of 
miRNA binding stoichiometry with the extent of protein reduction. To our surprise, 
we found that a majority of Cy3 labeled RLcx6x mRNAs (~75%) were not bound 
by any miRNA (Fig. 4.4B), even when close to 50% reduction in protein 
expression was achieved in our repression assay. We additionally found that a 
majority of miRNA-associated mRNAs (~95%) bound just one copy of the miRNA 
(Fig. 4.4C, D). Based on our control experiment testing for bias from prebleached 
fluorophores, we found that close to 70% of all Cy5 labeled RNAs were 
fluorescent, as expected if prebleaching is negligible (Fig. 4.4E). These 
observations, in combination with our miRNA counting data in HeLa cell extracts, 
support the notion that sub-stoichiometric miRNA binding to mRNAs is a general  
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Figure 4.4. Luciferase assay, single molecule miRNA counting experiments using RRL and control single molecule 
experiment. (A) Dual luciferase assay of repression reactions that contain capped and tailed RLcx6x and FL mRNAs 
respectively, and either no miRNA (-), non-specific let-7-a1 miRNA (-ve), cxcr4 miRNA pre-annealed to mRNAs in a 1:6 
miRNA:mRNA ratio (PA), anti-sense strand of cxcr4 miRNA (AS) or double stranded cxcr4 miRNA (DS). Renilla luciferase 
luminescence was normalized with that of firefly luciferase. All samples were normalized with respect to the no miRNA 
sample. Error bars, standard deviation (n = 6 independent trials). (B) Representative single-molecule image of Cy3 (left) 
and Cy5 (right) channels respectively. Arrows depict colocalized Cy3 and Cy5 spots. (C) Representative intensity 
trajectories showing single step photobleaching of both Cy3 (green) and Cy5 (red), which represents single mRNA 
molecules (green) bound by single miRNA molecules (red). (D) Histogram depicting the distribution of photobleaching 
steps in the RLcx6x sample (n = 694 particles). (E) Control experiment (Materials and Methods) to measure bias from 
dark fluorophores. Representative single-molecle image of Cy3 (left, green) and Cy5 (right, red) channels respectively. 
Arrows depict colocalized Cy3 and Cy5 spots.  
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phenomenon. Additionally, this notion potentially explains the relatively low 
repression potential of miRNAs as compared with silencing RNAs (siRNAs), a 
class of small RNAs that bind with complete complementarity to their mRNA 
targets to mediate mRNA cleavage.  
 
4.4 Discussion 
An ill-understood aspect of miRNA mediated mRNA repression is that of 
the binding stoichiometry between miRNAs and their mRNA targets, that is, to 
what extent any single binding site is occupied to affect mRNA regulation. 
Conversely, it is still unknown whether all binding sites within the 3`UTR of an 
mRNA containing multiple seed sequences are occupied by miRNAs 
simultaneously. To this end, we developed a single molecule assay that utilizes 
the stepwise photobleaching of single fluorophores to quantify the number of 
miRNAs bound per mRNA target in vitro. We first executed our assay in RNAi-
competent (yet translation-inactive) HeLa cytosolic S100 extract. Let-7-a1 
associated complexes were pre-assembled (Materials and Methods) and added 
to biotin-tagged mRNAs that were specifically immobilized on streptavidin coated 
surfaces. Surprisingly, a majority of mRNAs were bound by just one miRNA. In a 
complementary experiment, biotinylated and fluorophore labeled mRNAs were 
incubated with cell extracts that contained miRNAs labeled in a different color. 
miRNA-associated mRNAs were then immobilized on streptavidin coated quartz 
slides and the number of miRNAs bound per mRNA in rabbit reticulocyte lysate 
was deduced from the number of photobleaching steps of the miRNA fluorophore 
that colocalized with that of the mRNA. Our ability to fluorescently label large 
mRNAs allowed us to observe that a majority of mRNA molecules are either 
unoccupied or only singly occupied. Combining these results with in vitro 
repression assays, we conclude that repression indeed is achieved at sub-
stoichiometric binding of miRNAs to their cognate mRNA target sites, contrary to 
previous reports.  
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The hypothesis that miRNAs bind to mRNAs in a cooperative manner has 
been largely based on the observation that mRNAs with a single miRNA binding 
site are repressed to lower levels as compared to an mRNA with multiple seed 
sequences (63, 64). However, these conclusions were derived from indirect 
repression reporter assays that are capable of only measuring functional 
cooperativity (synergistic effects that can be mediated either by cooperative 
binding or, in contrast, by increased probability for binding due to the presence of 
multiple binding sites), not binding cooperativity. In contrast, we directly 
visualized miRNA-mRNA interactions and our results suggest a relatively low 
propensity for binding of multiple miRNA to a total of seven seed sequences, 
suggesting the absence of positive cooperativity. A recent report (225) had 
suggested the incapability of small RNAs loaded into Ago2, unlike those loaded 
into other Ago isoforms (Ago1, 3 and 4 in mammals), in demonstrating positive 
cooperativity for binding to mRNAs. It is thus possible that both cell extracts we 
used are enriched in Ago2 (234), which in turn would be expected to lead to 
independent, non-cooperative binding of miRISCs onto mRNAs. Alternatively, the 
washing step in our single molecule assays, used to remove unbound miRISCs, 
may possibly cause the dissociation of loosely bound miRISCs and thus 
introduce a bias towards the visualization of only high-affinity binding events. We 
are currently in the process of implementing experiments that involve photo-
induced cross-linking of miRISCs to mRNAs to further validate our conclusions.  
Another possible explanation for our observations derives from our 
secondary structure and hybridization energy predictions (Fig. 4.1). Highly 
structured regions within an mRNA may be refractory to miRNA binding, thus 
leading to the prediction that seed sequence accessibility is a key factor 
determining miRNA occupancy; however, the limited stability of miRNA:target 
site hybridization also cannot be discounted. In both mRNAs we analyzed, only 
one seed sequence (seed sequences 5 and 1 in mH and RLcx6x, respectively) 
are located in their entirety within unstructured loops. These regions may 
possibly be the only ones to which miRISC binds with high propensity, consistent 
with previous reports (235, 236) that had suggested the need for at least four 
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unpaired bases within the mRNA seed sequence for efficient target site 
recognition and repression. In contrast, binding site 6 within the mH mRNA, 
which is almost completely hybridized with another region of the mRNA, binds 
with maximum complementarity to let-7-a1 miRNA, representing the potentially 
most stable association. Due to its strong secondary structure this, however, may 
not be the most favorable site, in the light of previous evidence (237) that active 
RISC is unable to unfold highly structured RNAs.  Although it is still unclear 
whether the most accessible site or the most stably bound site is preferably 
occupied, it is likely that not all seed sequences within an mRNA can be bound 
with equal likelihood. Our finding that mRNAs containing multiple seed 
sequences are predominantly bound by just one miRNA, together with our 
computational analysis and previous reports thus may not only explain the 
relatively modest gene regulatory effect of miRNAs, but also why some mRNAs 
contain multiple (up to 7) redundant binding sites for the same miRNA; multiple 
miRNA binding sites simply provide a greater chance for effective miRNA 
engagement.  
In summary, we have developed a novel single molecule assay to 
visualize and quantify the number of miRNA molecules bound per mRNA in vitro. 
To the best of our knowledge our data represent the first reported observations of 
a physical interaction between miRNAs and mRNA at the single molecule level. 
We predominantly observe only singly miRNA bound mRNAs, consistent with a 
probabilistic model for miRNA binding. We additionally hypothesize that mRNA 
structure and low miRNA binding energy may lead to sub-stoichiometric binding 
of miRNAs to mRNAs, which in turn serves as a plausible explanation for the 
relatively low repressive power of miRNAs. Comparing the binding profiles not 
only between different miRNAs, but also between miRNAs and siRNAs, will help 
us understand how mRNA structure and the extent of complementarity between 
mRNA targets and repressor RNAs affect repression, thereby providing a basic 
understanding of the molecular mechanism by which small regulatory RNAs 
mediate transcriptome-wide gene repression. 
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Chapter 5 
 
Summary and Future Outlook 
 
5.1 Summary 
The recently discovered pervasive nature of non-coding RNAs (ncRNA) in 
biology has highlighted their involvement in all aspects of multi-cellular life (6, 7, 
9) and has prompted a fundamental reinterpretation of the central dogma of 
molecular biology. MicroRNAs are one such class of evolutionarily conserved 
small ncRNAs that act as master regulators of cellular gene expression (11, 12).  
Standard biochemical assays have provided a wealth of information about 
the miRNA pathway at the ensemble level (11, 12, 65). The cell, however, is a 
complex mixture of many single molecules, each bearing distinct properties and 
specifically interacting with its local environment. Thus, it is very important to 
understand, if possible, the distribution of properties and behaviors of every 
single molecule, rather than just their average. Single molecule microscopy has 
the potential to reveal heterogeneity within a sample appearing homogenous at 
the ensemble level, thereby unraveling key outliers, transient species, and rare 
events (94). Given that several mechanisms have been proposed for miRNA 
mediated gene regulation and it is still debated which repression mode(s) are at 
work (62, 65), miRNA research clearly calls for investigation using single 
molecule tools. Two such novel single-molecule tools have been described in this 
thesis that: (i) probe miRNA diffusion and assembly in cultured cells; and (ii) 
quantify the binding stoichiometry between miRNAs and their targets in vitro. 
Both of these approaches have the potential to resolve long-standing 
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unanswered questions in the RNA silencing field that has recently spawned a 
multi-billion dollar biotech industry. 
Chapter 2 describes a method to visualize miRNAs inside individual cells, 
with single molecule sensitivity. Previously reported methods of intracellular RNA 
observation, particularly an optimized illumination strategy (100), single particle 
tracking (SPT) and the probabilistic, step-wise photobleaching property of 
fluorescent probes (134, 135, 173), were all carefully ‗packaged‘ together with 
microinjection into one widely usable single-molecule tool to specifically 
investigate the intracellular diffusion and distribution of miRNAs. Microinjection 
allowed for the homogeneous, controlled delivery of miRNAs directly into cells in 
an efficient and non-invasive fashion. Ensemble luciferase and fluorescent 
reporter gene assays (Fig. 2.1) showed that fluorophore modification and 
microinjection do not affect miRNA function, attesting to the low invasiveness of 
the method. In this fashion, each cell functions as an individual reaction vessel 
into which fluorophore labeled miRNAs are introduced. One hour or more after 
microinjection, miRNAs could be visualized as well isolated, diffraction limited 
particles that diffused with a wide range of diffusion coefficients (~0.7–0.0001 
µm2/s) and demonstrated multifarious diffusive patterns (Brownian, corralled and 
directed) in living cells (Fig. 2.2). Diffusion coefficients of miRNA particles were 
distributed within (at least) two distinct Gaussian populations and were indicative 
of miRNA-bound mRNAs (87) and PBs (190) respectively, functional 
intermediates of miRNA mediated gene regulation. The different modes of 
diffusion were consistent with the expectation that intracellular miRNAs follow 
multiple pathways. The nature of the diffusing particles was further probed in 
formaldehyde-fixed cells. Fixing immobilized all particles so that the number of 
miRNA molecules within individual particles could be quantified using the 
quantized photobleaching of fluorescent probes (Fig. 2.8). The number of 
photobleaching steps was used to quantify the number of miRNA molecules 
assembled within each particle (134, 135, 173). With unprecedented sensitivity, 
this single molecule counting assay showed that a majority of particles contained 
individual miRNA molecules; however, significant fractions of particles also held 
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multiple molecules (up to seven). Additionally, fluorescence intensity analysis 
showed that our fixed cell analysis reflects the situation in live cells (Fig. 2.10). 
Finally, the temporal changes observed in mobility of particles in live cells and 
their assembly states in fixed cells support a miRNA-induced multiple-turnover 
model of target mRNAs (Fig. 2.12), consistent with previous reports (238). 
Notably, our method breaks the diffraction limit and reaches a super-accuracy of 
~30 nm for particle or molecule localization (Fig. 2.3) at a temporal resolution of 
100 ms. 
Transport of miRNA bound and suppressed mRNAs to processing bodies 
(PBs), cellular protein assemblies enriched in RNA processing enzymes (82), is 
considered one plausible mechanism by which miRNAs regulate protein 
expression (67, 81). Chapter 3 aimed (Chapter 2) to further quantify the extent of 
co-localization of miRNA-containing complexes and PBs, and thus estimate the 
fraction of miRNA bound mRNAs that are channeled though this pathway. To this 
end, high resolution (~10 nm) single molecule/particle tracking and single 
molecule counting were performed at two colors. Consistent with previous 
ensemble measurements (67) only a small fraction of miRNAs localized to PBs 
under conditions of cellular fixation. However, a surprising diversity in the number 
of miRNA molecules within individual PBs was observed (Fig. 3.3), strongly 
suggesting a heterogeneous composition of PBs and miRNA complexes and/or 
modes of miRNA-PB interaction. Further characterization of miRNA-PB 
interactions in live cells (Fig. 3.4) showed the presence of transient association, 
for on the order of a few hundred milliseconds, in addition to previously predicted 
stable association (189). Not only were such transient associations, hitherto 
unobserved, as frequent as the stable interactions, but individual miRNAs could 
switch between short and long residence times on the same PB. Taken together, 
our data suggests the presence of a diverse set of PB and miRNA complexes, 
and the potential role of an interacting protein or RNA partner that increases the 
affinity between the two complexes when present.  
Finally, the studies described in Chapter 4 found that miRNAs interact 
inefficiently with their cognate mRNAs under conditions of maximal repression. 
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The extent of miRNA binding to mRNAs bearing multiple miRNA binding sites 
were measured in vitro, using RNA interference (RNAi) competent mammalian 
cell extracts (229, 231, 232) at the single-molecule level. Stepwise 
photobleaching analysis was again used to count the number of miRNA 
molecules on individual immobilized mRNA targets that were either labeled or 
unlabeled, under conditions of maximal repression (as assayed separately, Fig. 
4.4A). In contrast to previous reports that had suggested positive cooperativity 
(35, 63, 64, 225), mRNAs with multiple seed sequences for a particular miRNA 
were predominantly bound by either no or just one miRNA (Fig. 4.3 and 4.4). 
The previous reports measured, however, functional cooperativity using reporter 
assays that indirectly quantify the increase in repression upon increasing miRNA 
concentration (35, 63, 64, 225). In contrast, our method visualizes actual 
association and has the potential to measure true binding cooperativity, if it 
exists. Furthermore, our observations are consistent different two cell extracts 
using two distinct miRNA:mRNA pairs. Our preliminary computational analysis of 
mRNA structure and miRNA binding energy coupled with previous reports (235-
237) seem to corroborate our single-molecule results; structured regions in 
mRNAs render a majority of binding sites inaccessible to miRNAs and the 
binding to these sites with incomplete complementarity further decreases the 
propensity for miRNA binding to mRNAs. Our results strongly suggest that a 
miRNA has a higher total probability for binding to an mRNA with multiple seed 
sequences as compared to one with lower number of binding sites and this effect 
alone leads to the higher repression of the former.  
Taken together, the data in both Chapters 3 and 4 offer a molecular 
understanding for the relatively modest repressive capability of miRNAs. Firstly, 
miRNAs bind with incomplete complementarity to their cognate mRNAs than their 
close cousins silencing RNAs (siRNAs) (12) that bind with higher 
complementarity to cause mRNA cleavage and thus stronger repression. 
Second, mRNA structure possibly renders a majority of miRNA binding sites 
inaccessible, thereby decreasing the propensity for miRNA binding. Conversely, 
siRNAs can better disrupt mRNA structure than miRNAs, which may further 
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enhance this effect. Finally, miRNA-bound mRNA complexes appear to bind to 
PBs with low affinity, decreasing the chance for the degradation of the target by 
PB components. This suggests that miRNAs work at the lower threshold of a 
multistep repression pathway, with low probabilities at each step, which 
culminates in a modest repressive ability that can quickly and substantially be 
ramped up if needed.   
 
5.2. Future Outlook 
Cell extracts provide the advantage of probing miRNA mediated 
repression events at much shorter time scales than transfection based cell 
culture assays, which can take hours or even days. Additionally, cell extracts 
offer ease of manipulation; it is relatively easy to add or remove specific 
molecular components at defined concentrations to observe dominant negative 
and loss-of-function phenotypes. In light of these advantages, future experiments 
to understand miRNA-mRNA interactions in vitro should include the addition of 
specific miRNA pathway proteins such as those of the Argonaute family, either in 
the form of their mRNA or as purified proteins. Such experiments can be used to 
verify whether miRNA association is modulated by titration of such proteins, 
which would indicate that they are limiting reagents. Additionally, experimental 
structure probing of mRNAs will be required to clearly predict the contribtion of 
mRNA structure and thus target site accessibility in miRNA binding. As binding of 
miRNAs to mRNAs is directly observed in our experiments, one can easily 
envision the determination of association and dissociation constants from such in 
vitro data, building a kinetic framework for miRNA mediated target repression.  
The methods presented in this thesis (especially in Chapters 2 and 3) 
only present a glimpse at their future possibilities. Our ability to visualize single 
molecules and complex assembly with exceptional spatiotemporal accuracy and 
resolution inside cells lets us envision the application of this method to several 
other molecular systems. The first and most logical extension of the method 
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presented in Chapter 2 would be to observe the diffusion and distribution of other 
miRNAs or siRNAs in multiple cell lines. It would be especially interesting to 
compare the intracellular localization, transport and complex assembly of 
miRNAs in cancerous cells and healthy cells, cultured from animal tissues, given 
that miRNA levels, expression profiles (239) and even function are different 
between them (John Androsavich, unpublished data). These differences may 
explain the diversity of modes of miRNA action proposed based on a plethora of 
experimental approaches, and our tools promise to shed light on the relative 
importance of these pathways. 
 Based on our repression data (Fig. 2.1) it is highly likely that a significant 
proportion of our observed particles are functional, actively repressing miRISC-
mRNA complexes. Further characterization of all particles by dual color tracking 
and colocalization, similar to that presented in Chapter 3, will aid in 
understanding the exact number of functional miRNAs. We can microinject 
miRNAs fluorescently labeled on both strands of the duplex and quantify the ratio 
of double-stranded to single-stranded miRNA. As only one strand of the miRNA 
duplex (guide) is preferentially retained in active RISC (Fig. 1.2), this experiment 
would serve to measure duplex unwinding and strand selection.  As we can now 
also label and visualize single mRNA molecules (Appendix 2), it would be 
relatively easy to find the exact percentage of target bound miRNAs, and similar 
to the method presented in Chapter 4, find the number of miRNAs bound per 
mRNA target inside cells (as opposed to cell extracts). Furthermore, we may 
even be able to compare the intracellular activity of fluorophore labeled pre-
miRNAs and mature miRNAs, as there is evidence for greater repressive 
capabilities of the former. We can, additionally, microinject pre-miRNAs 
specifically into the nucleus to monitor their nuclear export kinetics and 
investigate the effect of this step on pathway progression.  
Apart from the canonical pathway, miRNAs can act as substrates of 
several other cellular pathways (47). For instance, certain miRNAs undergo 
degradation mediated by terminal uridyl transferase (TUT) (240, 241), whereas 
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still others have their sequences modified by adenosine deaminase acting on 
RNA (ADAR) (242). The latter, especially editing within seed sequences, can 
have an important impact on the targeting specificity of edited miRNAs (243). 
Using dual-color experiments (Chapter 3) we can exactly count the number of 
miRNA molecules within these off-(RNAi)-pathways. In this fashion, we will be 
able to monitor the progress of miRNAs though every step of the RNAi and other, 
competing cellular pathways at single molecule sensitivity, with the ultimate goal 
of understanding the RNAi mechanism through a novel single molecule systems 
biology.  
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Appendix 1 
 
Purification and Functional Reconstitution of Monomeric µ-Opioid 
Receptors: Allosteric Modulation of Agonist Binding by Gi2
2 
 
A1.1 Introduction 
Opioid receptors are members of the G protein-coupled receptor (GPCR) 
superfamily and are clinical mainstays for inducing analgesia. Three isoforms of 
opioid receptors, µ, δ, and κ, have been cloned and are known to couple to Gi/o 
proteins to regulate adenylyl cyclase and K+/Ca+ ion channels (244-246). An ever 
growing amount of data suggests that many GPCRs oligomerize (247, 248), and 
several studies have suggested that µ-opioid receptors (MORs) and δ-opioid 
receptors heterodimerize to form unique ligand binding and G protein-activating 
units (249-253). Although intriguing, these studies utilize cellular overexpression 
systems where it is difficult to know the exact nature of protein complexes formed 
between the receptors. 
 To study the function of isolated GPCRs, our laboratory and others have 
utilized a novel phospholipid bilayer reconstitution method (254-259). In this 
approach purified GPCRs are reconstituted into the phospholipid bilayer of a high 
density lipoprotein (HDL) particle. The reconstituted HDL (rHDL) particles are 
monodispersed, uniform in size, and preferentially incorporate a GPCR monomer 
(258, 259). Previous work in our lab has shown that rhodopsin, a class A GPCR 
                                                          
2 Adapted with permission from Kuszak, A.J., Pitchiaya, S., Anand, J.P., Mosberg, H.I., Walter, 
N.G., and Sunahara, R.K., Journal of Biological Chemistry, 284: 26732–26741. © 2009 by The 
American Society for Biochemistry and Molecular Biology, Inc. Sethuramasundaram Pitchiaya 
carried out the single-molecule assays and the ensuing analysis. 
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previously proposed to function as a dimer (260-262), is fully capable of 
activating its G protein when reconstituted as a monomer in the rHDL lipid bilayer 
(259). Moreover, we have demonstrated that agonist binding to a monomeric β2-
adrenergic receptor, another class A GPCR, can be allosterically regulated by G 
proteins (258). This led us to determine whether a monomer of MOR, a class A 
GPCR that endogenously binds peptide ligands, is the minimal functional unit 
required to activate coupled G proteins. We additionally investigated whether 
agonist binding to monomeric MOR is allosterically regulated by inhibitory G 
protein heterotrimer.  
 To study the function of monomeric MOR we have purified a modified 
version of the receptor to near homogeneity. A yellow fluorescent protein was 
fused to the N terminus of MOR, and this construct (YMOR) was expressed in 
insect cells for purification. After reconstitution of purified YMOR into rHDL 
particles, single-molecule imaging of Cy3-labeled and Cy5-labeled YMOR 
determined that the rHDL particles contained one receptor. This monomeric 
YMOR sample binds ligands with affinities nearly equivalent to those observed in 
plasma membrane preparations. Monomeric YMOR efficiently stimulates GTPγS 
binding to Gi2 heterotrimeric G protein. Gi2 allosteric regulation of agonist binding 
to rHDL●YMOR was also observed. Single-particle imaging of binding of [Lys7, 
Cys8]dermorphin-Cy3, a fluorophore-labeled agonist, to rHDL●YMOR supports 
the notion that the rHDL particles contain a single YMOR. Taken together, these 
results suggest that a monomeric MOR is the minimal functional unit for ligand 
binding and G protein activation and illustrate a novel method for imaging ligand 
binding to opioid receptors. 
 
A1.2 Materials and methods 
Materials. G protein baculoviruses encoding rat Gαi2, His6-Gβ1, and Gγ2were 
provided by Dr. Alfred G. Gilman (University of Texas Southwestern, Dallas, TX). 
DNA encoding human -opioid receptor (NM 000914.2) was provided by Dr. John 
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R. Traynor (University of Michigan, Ann Arbor, MI). Expired serum was 
generously provided by Dr. Bert La Du (University of Michigan, Ann Arbor, MI). 
Spodoptera frugiperda (Sf9) and Trichoplusia ni (HighFiveTM) cells, pFastBacTM 
baculovirus expression vectors and Sf900TM serum-free medium were from 
Invitrogen. InsectExpressTM medium was purchased from Lonza (Allendale, NJ). 
N-Dodecyl-β-D-maltoside was from Dojindo (Rockville, MD). All of the lipids were 
from Avanti Polar Lipids (Alabaster, AL). [3H]diprenorphine (DPN, 54.9 Ci/mmol) 
and [35S]GTPγS (1250 Ci/mmol) were obtained from PerkinElmer Life Sciences. 
EZLinkTM NHS-Biotin reagent was from Pierce. Ovomucoid trypsin inhibitor was 
purchased from United States Biological (Swampscott, MA). GF/B and BA85 
filters, Cy3 and Cy5 NHSester mono-reactive dyes, Cy3-maleimide dye, and 
Source 15Q and Superdex 200 chromatography resins were from GE 
Healthcare. TalonTM resin was from Clontech. Bio-BeadsTM SM-2 absorbant resin 
was from Bio-Rad. Chromatography columns were run using a BioLogic Duo-
Flow protein purification system from Bio-Rad. Amicon Ultra centrifugation filters 
were from Millipore (Billerica, MA). Amino acids for ligand synthesis were 
obtained from Advanced ChemTech (Louisville, KY) or Sigma-Aldrich. All other 
chemicals and ligands were from either Sigma-Aldrich or Fisher Scientific. 
YFP-µ-Opioid Receptor Fusion Protein Expression and Purification. 
Baculoviruses were created using transfer vectors (pFastBacTM) that encoded a 
fusion protein of an N-terminal cleavable hemagglutinin signal sequence 
(MKTIIALSYIFCLVF), a FLAG epitope (DYKDDDD), a decahistidine tag, the 
monomeric and enhanced yellow fluorescent protein (Clontech), and the human 
MOR. High titer viruses (107–108 plaque-forming units/ml) were used to infect Sf9 
or HighFiveTM suspension cultures at a multiplicity of infection of 0.25 to 1. FLAG-
His10-mEYFP-MOR (YMOR) was expressed for 48 –52 h in the presence of 1 µM 
naltrexone (NTX). The cells were resuspended in Buffer A (50 mM Tris●HCl, pH 
8.0, 50 mM NaCl, 100 nM NTX, and protease inhibitors (3.2 μg/ml leupeptin, 3.2 
µg/ml ovomucoid trypsin inhibitor, 17.5 µg/ml phenylmethanesulfonyl fluoride, 16 
µg/ml tosyl-L-lysine-chloromethyl ketone (TLCK), 16 µg/ml tosyl-L-phenylalanine 
chloromethyl ketone (TPCK)) and lysed by nitrogen cavitation. Supernatants from 
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a 500 x g spin were then subjected to 125,000 x g spin for 35 min, and pellets 
containing membrane fractions were resuspended in Buffer A and either stored 
at -80 °C for later binding assays or further processed to purify receptor. 
 All of the purification steps were performed sequentially and at 4 °C or on 
ice. Membrane preparations were diluted to 5 mg/ml in Buffer A plus 1% DDM 
(w/v) and 0.01% cholesteryl hemisuccinate (CHS) (w/v) and gently stirred for 1 h 
to solubilize YMOR out of the membrane. Detergent extracted YMOR was 
enriched via TalonTM metal affinity chromatography resin (Clontech) in Buffer A 
plus 0.1% DDM and 0.01% CHS and eluted with Buffer A plus 0.1% DDM, 0.01% 
CHS, and 150 mM imidazole. Fractions containing YMOR (based on Coomassie 
staining after SDS-PAGE separation) were pooled, diluted 5-fold in Buffer B (20 
mM Hepes, pH 8.0, 5 mM MgCl2 , 0.1% DDM, 0.01% CHS, 100 nM NTX, and 
phenylmethanesulfonyl fluoride-TLCK-TPCK protease inhibitors), and eluted from 
a 1-ml Source 15Q strong anion exchange column with a 50 –300 mM NaCl 
linear gradient. Peak fractions were identified by radioligand binding assays 
using [3H]DPN (2–4 nM). Peak fractions were then pooled and concentrated on 
Amicon Ultra centrifugation filters (10-kDa molecular mass cut-off). As a final 
purification step this YMOR sample was resolved based on size using a 
Superdex 200 gel filtration column (GE Healthcare) in Buffer C (20 mM Hepes, 
pH 8.0, 100 mM NaCl, 0.1% DDM, 0.01% CHS, 100 nM NTX, and protease 
inhibitors). Coomassie staining after SDS-PAGE was used to identify fractions 
containing YMOR, which were pooled and concentrated to ~1–2 µM. Glycerol 
was added to a final concentration of 10% (v/v), and the samples were flash-
frozen in liquid nitrogen and then stored at -80 °C until further use. 
ApolipoproteinA-1 Purification. Wild type human apoA-1 was purified from 
expired serum as previously described (258). A recombinant apoA-1 with an N-
terminal 43-amino acid deletion and a histidine tag (Δ(1–43)-His6 -ApoA-1) was 
expressed using a pET15b vector to transform competent Escherichia coli cells 
(BL21). The cells were resuspended and lysed by gentle vortexing in 10 mM 
Tris●HCl, pH 8.0, 100 mM NaH2PO4, 6 M guanidine hydrochloride, 1% Triton X-
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100. Lysate was fractionated by centrifugation at 10,000 x g, and the supernatant 
was loaded onto a nickel-nitrilotriacetic acid column by gravity flow. The column 
was washed with 10 mM Tris●HCl, pH 8.0, 100 mM NaH2PO4, 6 M guanidine 
hydrochloride, 1% Triton X-100 and then with 50 mM NaH2PO4, pH 8.0, 300 mM 
NaCl, 1% Triton X-100. Bound Δ(1–43)-His6-apoA-1 was eluted with 50mM 
NaH2PO4 , pH 8.0, 300 mM NaCl, 250 mM imidazole, 1%Triton X-100. Peak 
fractions were further purified on a Superdex 75 gel filtration chromatography 
column in 20 mM Hepes, pH 8.0, 100 mM NaCl, 1 mM EDTA, 20 mM sodium 
cholate. Pooled apoA-1 was then dialyzed against 20 mM Hepes, pH 8.0, 100 
mM NaCl, 1 mM EDTA, 5 mM sodium cholate. Purified apoA-1 was concentrated 
to 10 mg/ml and stored at -80 °C until use. 
In Vitro HDL Reconstitution. HDL particles were reconstituted according to 
previously reported protocols (258). Briefly, 21 mM sodium cholate, 7 mM lipids 
(1-palmitoyl-2-oleoyl-snglycero-3-phosphocholine (POPC) and 1-palmitoyl-2-
oleoylsn-glycero-3-[phospho-rac-(1-glycerol)] (POPG) at a molar ratio of 3:2), 
purified YMOR (DDM-solubilized), and 100 µM purified apoA-1 were solubilized 
in 20 mM Hepes, pH 8.0, 100 mM NaCl, 1 mM EDTA, 50 mM sodium cholate. 
The final concentration of YMOR varied from 0.2 to 0.4 µM, but YMOR always 
comprised 20% of the total reconstitution volume. In some reconstitutions the 
lipid component was modified such that porcine polar brain lipid extract (Avanti 
Polar Lipids) was used in addition to POPC and POPG for a final concentration 
of 7 mM lipids at a molar ratio of 1.07:1.5:1 brain lipid: POPC: POPG. Following 
incubation on ice (1.5–2 h), the samples were added to Bio-BeadsTM (Bio-Rad, 
0.05 mg/ml of reconstitution volume) to remove detergent and to form HDL 
particles. Particles containing YMOR were purified via M1 anti-FLAG 
immunoaffinity chromatography resin (Sigma) and eluted with 1 mM EDTA plus 
200 µg/ml FLAG peptide. To assess the efficiency of HDL reconstitution, the total 
protein concentration of rHDL●YMOR was compared with the concentration of 
active reconstituted YMOR. FLAG affinity column-purified rHDL●YMOR was 
resolved from BSA and FLAG peptide on a Superdex 200 gel filtration column, 
and the peak fraction was analyzed for protein content with Amido Black staining 
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(263), whereas [3H]DPN saturation assays were used to measure active YMOR 
content. YMOR reconstituted into HDL was stored on ice until further use. 
G Protein Addition to rHDL●YMOR Particles. Gi2 heterotrimer (Gαi2- His6Gβ1- 
Gγ2) was expressed in Sf9 cells and purified as previously described (264). The 
concentration of active G protein was determined by filter binding of 20 μM 
[35S]GTPγS (isotopically diluted) in 30 mM NaHepes, pH 8.0, 100 mM NaCl, 50 
mM MgCl2, 1 mM EDTA, 0.05% C12E10, and 1 mM dithiothreitol after 1 h of 
incubation at room temperature. Purified G protein heterotrimer was added to 
preformed, FLAG-purified rHDL●YMOR particles at a molar ratio of 1:10 receptor 
to G protein. Gi2 was purified in 0.7% CHAPS, and the final volume of G protein 
added to rHDL●YMOR was such that the final CHAPS concentration was well 
below its critical micelle concentration. Reconstituted receptor and G protein 
samples were then incubated in Bio-BeadsTM for 30 –45 min at 4 °C to remove 
residual detergent.  
[3H]DPN Saturation and Agonist Competition Binding Assays. Binding 
reactions were performed in 100-µl volumes. Membrane fractions prepared from 
Sf9 or HighFiveTM cells expressing YMOR (0.5–5 µg total protein, prepared as 
above) were incubated with [3H]DPN (0.25 to 4 nM; 54.9 Ci/mmol) for 1 h at room 
temperature in 25 mM Tris●HCl, pH 7.7, 136 mM NaCl, 2.7 mM KCl (Tris-
buffered saline) buffer. Nonspecific binding was determined in the presence of 20 
µM NTX. Bound [3H]DPN was separated from free by rapid filtration through 
GF/B filters and three 200-µl washes of ice-cold Tris-buffered saline. [3H]DPN 
saturation binding reactions on YMOR incorporated into rHDL particles were 
prepared in Tris-buffered saline, pH 7.7, plus 0.1% BSA, and Sephadex G-50 
Fine (GE Healthcare) gravity flow columns were used to separate bound from 
free [3H]DPN. Agonist competition assays in insect membranes and rHDL 
particles were performed in 25 mM Tris●HCl, pH 7.7, 6 –7 mM NaCl. Competition 
assays in rHDL particles also included 0.1% BSA. [3H]DPN binding assays on 
detergent solubilized YMOR were performed in 50 mM Tris●HCl, pH 7.7, 136 
mM NaCl, 0.1% DDM, 0.01% CHS and separated on Sephadex G-50 gravity flow 
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columns. For agonist competition assays, receptor samples were incubated with 
0.5–1 nM [3H]DPN and increasing concentrations of agonist (1 pM to 1mM) in the 
absence or presence of 10 µM GTPγS. The samples were measured for 
radioactivity on a liquid scintillation counter, and the data were fit with one-site 
saturation, one-site competition, or two-site competition binding models using 
Prism 5.0 (GraphPad, San Diego, CA).  
[35S]GTPγS Binding Assay. 100-µl volume reactions were prepared containing 
1 µg of total membrane protein from YMOR expressing HighFiveTM cells or ~50 –
60 fmol of YMOR incorporated into rHDL particles in 30 mM Tris●HCl, pH 7.4, 
100 mM NaCl, 5 mM MgCl2 , 0.1 mM dithiothreitol, 10 or 1 µM GDP (membranes 
or HDL particles), and 0.1% BSA. Membrane assays and rHDL assays were 
incubated with 10 nM isotopically diluted [35S]GTPγS (12.5 Ci/mmol). YMOR 
samples were incubated with increasing concentrations of agonists (1 pM to 1 
mM) for 1 h at room temperature, then rapidly filtered through GF/B (membrane 
samples) or BA85 filters (HDL samples), and washed three times with 2 ml of ice-
cold 30 mM Tris●HCl, pH 7.4, 100 mM NaCl, 5 mM MgCl2. The samples were 
measured for radioactivity on a liquid scintillation counter, and the data were fit 
with a log dose-response model using Prism 5.0.  
Single-molecule Imaging of Reconstituted Cy3- and Cy5-YMOR. Purified 
YMOR (~200 pmol) was incubated with NHS-ester Cy3 or Cy5 mono-reactive 
dye (GE Healthcare) in 20 mM Hepes, pH 8.0, 100 mM NaCl, 5 mM MgCl2 , 6 
mM EDTA, 0.1% DDM, 0.01% CHS, 100 nM NTX for 30 min at 25 °C and then 1 
h at 4 °C. Conjugation reactions were quenched by the addition of Tris●HCl, pH 
7.7 buffer (10 mM final). Cy-labeled YMOR was then separated from free dye 
using a 12-cm Sephadex G-50 column. The final dye to protein molar ratio was 
3.8:1 for Cy3-YMOR and 3.7:1 for Cy5-YMOR, determined by absorbance at 280 
nm for total protein, 550 nm for Cy3 dye, and 650 nm for Cy5 dye as measured 
on a NanoDrop ND-1000 spectrophotometer. A separate aliquot of YMOR was 
co-labeled with both Cy3 and Cy5 for final molar ratios of 2:1 Cy3: YMOR and 
1.8:1 Cy5: YMOR. HDL reconstitutions of Cy3- YMOR alone, Cy5-YMOR alone, 
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a mixture of Cy3- and Cy5-YMOR, and Cy3-Cy5-YMOR were then performed. 
Reconstitutions were performed as previously described, using apoA-1 that had 
been biotinylated at a 3:1 molar ratio using EZ-Link NHS-Biotin according to the 
manufacturer‘s protocol (Pierce). Reconstituted samples were diluted 5000-fold 
in 25 mM Tris●HCl, pH 7.7, and injected into a microfluidic channel on a quartz 
slide that was previously coated with biotinylated polyethylene glycol and treated 
with 0.2 mg/ml streptavidin to generate a surface density of ~0.05 
molecules/µm2. An oxygen scavenging system of 10 mM Trolox (Sigma-Aldrich), 
100 mM protocatechuic acid, and 1 µM protocatechuate-3,4-dioxygenase was 
included in the sample dilution (265). Following a 10-min incubation to allow 
binding of the biotin-HDL●CyYMOR complex to the streptavidin-coated slide, the 
channel was washed with ice-cold 25 mM Tris●HCl, pH 7.7, containing the 
oxygen scavenging system. An Olympus IX71 inverted microscope configured for 
prism-based total internal reflection fluorescence (TIRF) and coupled to an 
intensified CCD camera was used to image Cy3 and Cy5 fluorophores 
(CrystaLaser, 532 nm; Coherent CUBE laser, 638 nm; Chroma band pass filters 
HQ580/60 and HQ710/130 nm). Fluorophore intensity time traces were collected 
for 30 –100 s at 10 frames/s. Time traces were analyzed for photobleaching with 
in-house software (MatLab 7.0). 
Synthesis of [Lys7, Cys8]Dermorphin and Labeling with Cy3 Dye. [Lys7, 
Cys8]dermorphin (Tyr-D-Ala-Phe-Gly-Tyr-ProLys-Cys-NH2) was synthesized on 
Rink resin (solid support) using an Applied Biosystems 431A peptide synthesizer 
and standard Fmoc (N-(9-fluorenyl)methoxycarbonyl) chemistry. The samples 
were characterized on a Waters reverse phase HPLC using a Vydac C18 
(Protein and Peptide) 10-micron column. The samples were run on a linear 
gradient of 0 –45% acetonitrile in an aqueous phase containing 0.1% 
trifluoroacetic acid at 35 °C and monitored at 254 and 230 nm (Fig. A1.1). 
Peptides were similarly purified on a Waters semipreparative reverse phase 
HPLC using a Vydac C18 10-micron column at room temperature. The purified 
peptide was labeled with Cy3-maleimide (GE Healthcare) according to the 
manufacturer‘s instructions using a ratio of 1.5:1 peptide to fluorophore and  
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Figure A1.1. Synthesis and Purification of Lys7, Cys8]dermorphin. [Lys7, 
Cys8]dermorphin was synthesized on Rink resin using an Applied Biosystems 
Peptide Synthesizer and Fmoc chemistry. Samples were resolved on a Waters 
reverse phase HPLC using a Vydac C18 10 micron column, run on a linear 
gradient of 0 to 45% acetonitrile containing 0.1% TFA in an aqueous phase 
containing 0.1% TFA at 35oC. Samples were monitored at 254 nm. 
[Lys7,Cys8]dermorphin  (A) has a retention time of 25.9 min and was determined 
to be 98% pure before labeling. [Lys7,Cys8]dermorphin was labeled with Cy3-
maleimide dye (GE Healthcare) at a ratio of 1.5:1 peptide:fluorophore. 
[Lys7,Cys8]dermorphin-Cy3  (B) has a retention time of 29.2 min and was 
determined to be 91% pure before use in binding assays and imaging 
experiments. A mixture and co-elution profile (C) shows that the two compounds 
are well separated.   
 131 
 
repurified by HPLC as before. The labeled peptide was further purified via semi-
preparative HPLC using a 5-micron Vydac C18 column as described above. The 
potency and efficacy of [Lys7, Cys8]dermorphin-Cy3 at MOR were confirmed in 
radiolabeled [3H]DPN competition and [35S]GTPγS binding assays. 
Prism-based Single-molecule TIRF and Step Photobleaching Analysis of 
[Lys7, Cys8]Dermorphin-Cy3 Binding to rHDL●YMOR + Gi2. Purified 
recombinant apoA-1 was biotinylated at a 3:1 molar ratio of biotin: apoA-1. 
Purified YMOR was then reconstituted with biotin-apoA-1, POPC, POPG, and 
brain lipid extract as above. Purified Gi2 heterotrimer was added to reconstituted 
receptor as above, and coupling was confirmed by observing high affinity 
competition of [3H]DPN binding by the agonist DAMGO. Five nanomolar biotin-
HDL●YMOR+Gi2 was then incubated with 5 µM [Lys7, Cys8]-dermorphin-Cy3 for 
45 min at 25 °C in 25 mM Tris●HCl, pH 7.7. The samples were diluted 100-fold in 
25 mM Tris●HCl, pH 7.7, and imaged as described above with a surface density 
of ~0.25 molecules/µm2. Fluorophore intensity time traces were collected for 30 –
100 s at 10 frames/s and analyzed for photobleaching with in-house software 
(MatLab 7.0). 
 
A1.3 Results 
Expression of a Functional µ-Opioid Receptor Fusion Protein in Insect 
Cells. Human YMOR (Fig. A1.2A) expressed in Sf9 and HighFiveTM insect cells 
bound the nonspecific opioid antagonist [3H]diprenorphine ([3H]DPN) with high 
affinity in a saturable manner (Kd = 0.6 ± 0.1 nM; Fig. A1.2B). Maximal receptor 
levels of 12–40 pmol/mg were routinely observed.  
The µ-selective agonist DAMGO ([D-Ala2, N-MePhe4, Gly5-ol]enkephalin) 
stimulated [35S]GTPγS binding to membranes co-expressing YMOR and Gαi2- 
His6Gβ1-Gγ2 G protein heterotrimer (Gi2) in a concentration-dependent manner 
(Fig. A1.2C). DAMGO elicited strong activation of Gi2, stimulating [
35S]GTPγS  
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Figure A1.2. Functional expression of a modified MOR in insect cells. (A) 
schematic representation of the modified µ-opioid receptor expressed in insect 
cells. N-terminal modifications included a hemagglutinin signal sequence (HA), 
FLAG epitope, His10,and a YFP. This construct, termed YMOR, was expressed in 
Sf9 and HighFiveTM insect cells using a recombinant Baculovirus system. (B) 
YMOR expressed in insect cells exhibits high affinity ligand binding. Plasma 
membrane preparations (5 µg) of HighFiveTM cells expressing YMOR were used 
in [3H]diprenorphine saturation binding assays. YMOR bound [3H]DPN with a 
Bmaxof ~40 pmol/mg and a Kd of 0.6 ± 0.1 nM. (C) YMOR couples to G protein in 
insect cell membranes. Membrane preparations (2 µg) of HighFiveTM cells co-
expressing YMOR and Gi2 heterotrimer were incubated with increasing 
concentrations of the µ-opioid agonist DAMGO in the presence of 10 nM 
[35S]GTPγS (isotopically diluted). DAMGO stimulated [35S]GTPγS exchange on 
Gαi2 with an EC50 of 36 ± 0.1 nM. D, agonist binding to YMOR expressed in 
insect cells is allosterically regulated by G proteins. YMOR/Gi2 membrane 
preparations (2–3 µg) were incubated with 0.8 nM [3H]DPN and increasing 
concentrations of DAMGO in the absence or presence of 10 µM GTPγS. A high 
affinity binding site for DAMGO (●, Ki hi =~2.9 nM) was disrupted in the absence 
of G protein coupling (with GTPγS, ■, Ki = ~300 nM). DAMGO also displayed low 
affinity binding to membranes not expressing Gi2 (YMOR,▲, Ki =~580 nM; and 
YMOR + GTPγS, ▼, Ki=~800 nM). Binding data were normalized to the curve fit 
maximum. For all panels the data are representative of at least two experiments 
performed in duplicate, and the error bars represent the standard error of the 
mean.   
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binding nearly 4-fold over basal levels with an EC50 of 36 ± 0.1 nM. The potency 
and efficacy of DAMGO at insect cell expressed YMOR is well in line with its 
observed pharmacological characteristics in mammalian cell expression systems 
(266-268). Allosteric regulation of agonist binding to opioid receptors by G 
proteins has been well established in plasma membrane preparations of brain 
homogenates and overexpression systems (269-273) and was also observed for 
YMOR expressed in insect cells. In the absence of Gi2, DAMGO competed 
[3H]DPN (0.5 nM) binding in a concentration-dependent manner with a Ki of ~580 
nM (Fig. A1.2D). In membranes expressing both YMOR and Gi2, DAMGO 
exhibited a biphasic mode of inhibition of [3H]DPN binding with a Ki hi of ~2.9 nM 
and a Ki lo of ~1.5 µM (fraction of Ki hi ~0.53). The addition of 10 µM GTPγS to the 
YMOR + Gi2 membranes eliminated the high affinity DAMGO-binding site (Ki = 
~300 nM), illustrating that YMOR is allosterically regulated by G proteins. 
Therefore, YMOR expressed in HighFiveTM cells proved fully functional in regards 
to G protein coupling.  
YMOR Purification. The capacity of a variety of detergents (zwitterionic, polar, 
and nonionic detergents such as Triton X-100, digitonin, Nonidet P-40, CHAPS, 
C12E10, and n-octyl-β-glucoside) to solubilize YMOR from insect cell membranes 
was assessed by anti-FLAG Western blot analysis. Extraction of YMOR with 
DDM proved to be most efficient (data not shown). The addition of CHS (0.01% 
w/v) improved the stability of the solubilized receptor as measured by [3H]DPN 
binding, consistent with the stabilizing effects of cholesterol moieties observed for 
solubilized β2AR (274) (Fig. A1.3). The expression levels of YMOR and the 
efficiency of DDM solubilization, assessed by [3H]DPN binding and anti-FLAG 
Western blots, were enhanced in the presence of naltrexone. Therefore this 
antagonist was present (100 nM) during all subsequent purification steps.  
DDM-extracted YMOR was purified through a series of chromatographic 
steps including metal chelate (TalonTM), anion exchange (Source 15Q), and size 
exclusion (Superdex 200) chromatography columns. Peak fractions from each 
column were determined by Coomassie staining, anti-FLAG antibody Western  
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Figure A1.3. The inclusion of cholesteryl hemisuccinate (CHS) during n-dodecyl-
β-D-maltoside (DDM) solubilization stabilizes YMOR. YMOR was solubilized from 
the plasma membranes of Sf9 cells with 1% DDM in the presence or absence of 
0.01% CHS and then enriched on a TalonTM IMAC column in either 0.1% DDM or 
0.1% DDM plus 0.01% CHS. [3H]DPN binding to these detergent solubilized 
YMOR samples was then measured in the absence (total) or presence (NS) of 
20 µM naltrexone. Addition of CHS to solubilized YMOR increased [3H]DPN ~3.8-
fold, suggesting an improvement in the amount of receptor in an active 
conformation. Error bars represent the Standard Error of the Mean of two 
experiments performed in duplicate. *P<0.05, significantly different from DDM 
total as calculated by a Student‘s t-test.  
 135 
 
 
Figure A1.4. Purification of YMOR from HighFiveTM insect cells and 
reconstitution into HDL particles. (A) YMOR was extracted from membranes in 
the presence of 100 nM naltrexone with 1% n-dodecyl-β-D-maltoside and 0.01% 
cholesteryl hemisuccinate and enriched on a TalonTM metal affinity column. The 
TalonTM pool containing YMOR (predicted 73-kDa molecular mass) was applied 
to a Source 15Q anion exchange column followed by a size exclusion gel 
filtration column (Superdex 200). Samples of the purification steps were resolved 
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by SDS-PAGE and silver-stained. YMOR was enriched to ~95% purity (GF 
peak). (B) purified YMOR was reconstituted into HDL particles (see 
―Experimental Procedures‖) and resolved by size exclusion chromatography 
(Superdex 200). Fractions were analyzed for total protein content (UV 
absorbance), active YMOR ([3H]DPN binding), and YFP fluorescence. UV 
absorbance showed a major peak corresponding to rHDL particles (stokes 
diameter of ~10.5 nm). The elution volume of active YMOR corresponded with 
the rising slope of the rHDL peak. YFP fluorescence eluted as two peaks, 
corresponding to the active YMOR and a larger YMOR aggregate that was not 
incorporated into rHDL particles. This aggregated YMOR was not active based 
on [3H]DPN binding. The data were normalized such that the maximal value for 
each parameter was set to 100%. [3H]DPN binding measurements were 
performed in duplicate, and the error bars are omitted for clarity. (C) high affinity 
[3H]DPN binding to YMOR is disrupted in detergent micelles but restored 
following reconstitution into rHDL particles. [3H]DPN binding to YMOR in insect 
cell membranes (●, Kd=~0.5 nM), purified in DDM micelles (■, Kd=~4.1 nM), and 
in rHDL particles (▲, Kd=~0.4 nM). The data are representative of at least three 
experiments performed in duplicate, and the error bars represent the standard 
error of the mean. The binding data were normalized to the maximal binding level 
(Bmax) as calculated by a one-site saturation curve fit (Prism 5.0,GraphPad). 
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blotting, and [3H]DPN binding. Fractions displaying the highest [3H]DPN binding 
capacity and appropriate molecular weight were pooled and subjected to the next 
chromatographic step. Superdex 200 peak fractions were pooled, concentrated, 
flash-frozen in liquid N2 , and then stored at -80 °C until later use. A 
representative silver-stained SDSPAGE separation of each enrichment step is 
shown in Fig. A1.4A. Yields of YMOR were typically ~50 µg of >95% pure 
receptor/liter of insect culture. YMOR, deemed pure based on silver staining, 
bound [3H]DPN at ~20% of the predicted binding sites calculated from the 
molecular mass. This loss of activity is likely due to the detrimental freeze/thaw 
process. 
Reconstitution of YMOR into High Density Lipoprotein Particles. The 
reconstitution of YMOR into high density lipoprotein (rHDL) particles was 
performed with a 500-fold molar excess of apoA-1 to YMOR (250-fold excess of 
rHDL) to favor reconstitution of a single YMOR molecule/rHDL particle. 
Resolution of rHDL particles containing YMOR (rHDL●YMOR) with size 
exclusion chromatography (SEC) suggested an apparent Stokes diameter of 
10.5 nm (Fig. A1.4B). [3H]DPN binding to the SEC fractions confirmed the 
presence of functional YMOR in particles that eluted slightly earlier than the main 
UV absorbance peak (Stokes diameter of ~10.3 nm), indicating the slightly larger 
size of rHDL●YMOR compared with rHDL. The YFP fluorescence of the SEC 
fractions indicated an additional peak that elutes near in the Superdex 200 void 
volume, suggestive of aggregated YMOR. Because these fractions did not bind 
[3H]DPN, we surmised that this receptor population was inactive. This 
aggregated and inactive receptor is consistent with the previous observation that 
~80% of the purified YMOR is inactive post freeze/thaw and prior to 
reconstitution into HDL.  
The effectiveness of YMOR reconstitution into HDL is clear when 
comparing [3H]DPN binding between detergent-solubilized receptor and 
rHDL●YMOR particles. Prior to reconstitution into HDL, DDM-soluble YMOR 
bound [3H]DPN with a Kd of ~4.1 nM, whereas reconstituted YMOR bound 
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[3H]DPN with a Kd of ~0.4 nM (Fig. A1.4C). This significant disruption of high 
affinity ligand binding for the soluble receptor is not surprising, because 
detergents are known to decrease the ligand affinity of opioid receptors (275) and 
disrupt GPCRs in general (276). Replacement of detergents with phospholipids 
reverses the deleterious effects of the detergent and restores YMOR 
conformation to one that binds [3H]DPN with native, membrane-bound affinity.  
YMOR Is Monomeric When Incorporated into rHDL. To determine the number 
of YMOR molecules present in each rHDL particle, we assessed the degree of 
receptor co-localization between Cy3- and Cy5-labeled YMOR using single-
particle imaging. Purified YMOR was labeled with Cy3- or Cy5- reactive 
fluorescent dyes and reconstituted into HDL using biotinylated Δ(1–43)- His6 -
apoA-1. This biotin-rHDL●CyYMOR complex was then incubated on a 
streptavidin-coated microfluidic slide and excited with 532- and 638-nm lasers. 
Fluorescence emission was detected using prism-based SM-TIRF. Reconstituted 
Cy3-YMOR and Cy5-YMOR were visualized as mono-disperse fluorescent foci 
(Fig. A1.5A and B). When Cy3-YMOR and Cy5-YMOR were mixed prior to 
reconstitution (Cy3-YMOR+Cy5-YMOR), a low level of co-localization of the two 
fluorophores (3.4%) was observed (Fig. A1.5C and E). A false-positive co-
localization signal of 2.8 and 2.2% was observed for the Cy3-YMOR and Cy5-
YMOR samples, respectively (Fig. A1.5E). As a positive control, co-localization 
for YMOR labeled with both Cy3 and Cy5 was also measured (Fig. A1.5D). 
Considering that our method does not allow for the differentiation between 
YMOR labeled with multiple Cy probes of the same fluorophore versus co-
localization of multiple YMORs labeled with the same Cy probe, we may 
underestimate colocalization by as much as a factor of 2. Thus we estimate an 
upper limit for co-localization, i.e. incorporation of two or more YMORs into a 
single rHDL particle, of ~1.8% ((3.4% x 2) - (2.8% + 2.2%)). These data suggest 
that HDL reconstitution resulted in a sample containing mostly monomeric 
YMOR. Therefore the ligand binding and G protein coupling characteristics of the 
HDL-reconstituted YMOR presented here are indicative of the properties of a 
monomeric receptor.  
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Figure A1.5. YMOR is monomeric when reconstituted into HDL particles. 
Purified YMOR was labeled with Cy3 or Cy5 fluorescent dyes and reconstituted 
separately or together into biotin-labeled rHDL. The particles were imaged using 
single-molecule total internal reflection fluorescence microscopy on quartz slides 
coated with streptavidin. Representative overlay images of reconstituted 
rHDL●Cy3-YMOR (A), rHDL●Cy5-YMOR (B), rHDL●(Cy3-YMOR  Cy5-YMOR) 
(C), and rHDL●Cy3-Cy5-YMOR (D) are shown. Quantification of Cy3 and Cy5 
co-localization (E) showed that when both Cy3-YMOR and Cy5-YMOR were 
mixed together prior to reconstitution (mixture, 4c), only ~3.4% of rHDL particles 
contained two labeled receptors, compared with a false-positive co-localization 
signal of 2.8 and 2.2% observed for the rHDL●Cy3-YMOR and rHDL●Cy5-YMOR 
samples. YMOR co-labeled with both Cy3 and Cy5 was also imaged as a 
positive control for co-localization. Approximately 24% of rHDL●Cy3-Cy5-YMOR 
particles (co-labeled, 4d) exhibited colocalization, indicating that not all YMOR 
received a secondary fluorescent dye under the labeling conditions.  
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To assess the amount of active versus inactive YMOR incorporated into 
rHDL, we compared the total protein concentration of purified rHDL●YMOR 
particles to the maximal concentration of YMOR based on [3H]DPN saturation 
binding assays. Reconstituted YMOR was purified using FLAG affinity resin and 
resolved by SEC into a sample containing only apoA-1 and YMOR (based on 
SDS-PAGE and Coomassie staining). Amido Black staining of these peak 
fractions indicated a protein concentration of ~5.2 µg/ml. Considering that the 
protein sample consists of two apoA-1 molecules (molecular mass, ~25,500 Da) 
and one YMOR (molecular mass, ~73,500 Da), the rHDL●YMOR sample has a 
total molecular mass of 124,500 Da and therefore a molar concentration of ~42 
nM. Saturation binding assays on the rHDL●YMOR SEC peak indicated a molar 
concentration of ~31 nM for YMOR which bound ligand. Given the inherent 
limitations of protein detection assays at the low concentration of our samples, 
these data suggest that at least 75% of the YMOR in rHDL is active based on 
[3H]DPN binding.  
Monomeric YMOR Binds Antagonists with High Affinity. Reconstituted and 
monomeric YMOR binds antagonists with affinities similar to those observed in 
the plasma membrane. The antagonists naloxone and naltrexone and the µ-
specific peptide CTAP (D-Phe-Cys-Tyr-D-Trp-Arg-Thr-Pen-ThrNH2) compete 
[3H]DPN binding in similar fashion when in HighFiveTM cell membrane 
preparations or in reconstituted HDL particles (Fig. A1.6A). Therefore 
reconstitution into HDL allows YMOR to adopt a conformation that appears 
identical to receptor in plasma membranes in terms of high affinity antagonist 
binding.  
Monomeric YMOR Functionally Couples Inhibitory G Proteins. We next 
analyzed the capacity of monomeric YMOR to functionally couple to 
heterotrimeric G protein. Functional measurements included allosteric regulation 
of agonist binding (Fig. A1.6B) and agonist-mediated stimulation of [35S]GTPγS 
binding (Fig. A1.6C). Anti-FLAG affinity column purification of rHDL●YMOR was 
performed to remove ―empty‖ rHDL particles, and purified Gi2 heterotrimer was  
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Figure A1.6. Monomeric YMOR binds ligands with high affinity and functionally 
couples to Gi2 heterotrimer. (A) opioid antagonists bind YMOR in rHDL with 
affinities equivalent to those observed in membrane preparations. Competition 
binding assays were performed using plasma membranes of HighFiveTM cells 
expressing YMOR and Gi2 heterotrimer (dotted lines, open symbols) or 
rHDL●YMOR (solid lines, closed symbols). For CTAP binding assays in rHDL, 
YMOR was coupled to Gi2 heterotrimer. Increasing concentrations of naloxone, 
naltrexone, or CTAP competed the binding of 1 nM [3H]DPN in the rHDL system 
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or 0.5 nM [3H]DPN in membrane preparations. The observed binding constants 
were: naloxone Ki mem = ~19 nM, Ki rHDL = ~7.8 nM; naltrexone Ki mem = ~4.3 nM, Ki 
rHDL = ~3.3 nM; CTAP Ki mem = ~7.1 nM, Ki rHDL =~7.6 nM. (B) binding of morphine 
to rHDL●YMOR is allosterically regulated by G proteins. Purified Gi2 heterotrimer 
was added to rHDL●YMOR at a molar ratio of 10:1, G protein to receptor. 
DAMGO and morphine bound rHDL●YMOR with high affinity, competing the 
binding of 0.75 nM [3H]DPN in a biphasic manner (DAMGO (■), Ki hi = ~7.6 nM, Ki 
lo = ~1.8 µM; morphine (●), Ki hi = ~1.7 nM, Ki lo = ~320 nM). High affinity agonist 
binding was lost with the addition of 10 µM GTPγS (DAMGO (□), Ki GTPγS = ~1 
µM; morphine (○), Ki GTPγS = ~1 µM). In both A and B, data were normalized to 
the maximal binding level as calculated by a one- or two-site competition curve fit 
(Prism 5.0, GraphPad). © HDL-reconstituted YMOR activates Gi2 in response to 
agonist binding. YMOR (an estimated 50 – 60 fmol) and associated Gi2 
heterotrimer were incubated with 10 nM [35S]GTPγS (isotopically diluted) in the 
presence of increasing concentrations of DAMGO. DAMGO activated Gi2 with an 
EC50 of 29 ± 1.4 nM, stimulating ~40 fmol of [
35S]GTPγS binding to Gαi2 over 
basal levels, suggesting approximately a 1:0.7 coupling between YMOR and G 
protein. These results correlate with the estimated 53% high state observed in B. 
The data are representative of three experiments performed in duplicate. The 
error bars represent the standard error of the mean.  
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added at a 10:1 Gi2:rHDL●YMOR molar ratio. The concentration of purified G 
protein was determined by [35S]GTPγS binding assays, and receptor 
concentration was measured with [3H]DPN saturation assays of rHDL●YMOR 
samples. Gi2 addition results in high affinity agonist binding (Fig. A1.6B). 
Morphine competed [3H]DPN binding with a Ki hi of ~1.7 nM and a Ki lo of ~320 
nM, whereas DAMGO inhibited with a Ki hi of ~7.6 nM and a Ki lo of ~1.8 µM. As in 
membranes the addition of 10 µM GTPγS to the monomeric rHDL●YMOR+Gi2 
uncouples the G protein and results in a single-site, low affinity agonist 
competition curve. Similarly, when rHDL●YMOR was not coupled to Gi2, DAMGO 
competed [3H]DPN binding with micromolar affinity (Fig. A1.7).   
Just as YMOR membrane preparations displayed DAMGO induced 
[35S]GTPγS binding to Gi2, monomeric YMOR in rHDL particles showed strong 
DAMGO stimulation of nucleotide exchange (~4.7-fold stimulation with an EC50 of 
31 ± 2.2 nM; Fig. A1.6C). A fluorescently labeled agonist, [Lys7,Cys8]dermorphin-
Cy3, was also tested and showed concentration-dependent stimulation of 
[35S]GTPγS binding to Gi2 by monomeric YMOR (EC50 of 32 ± 9.1 nM; Fig. 
A1.8B).  
Although Gi2 was added to rHDL●YMOR at a 10:1 molar ratio in these 
reconstitutions, the observed high and low agonist affinities illustrate that not all 
YMOR was coupled to Gi2. In fact, the agonist competition assays indicate that 
~54% of the receptor was coupled to Gi2. These data are consistent with 
previous studies on the β2 AR where the addition of purified G protein 
heterotrimer to rHDL particles in the absence of detergents resulted in 90 –95% 
G protein loss, largely because of aggregation (258). Indeed, SEC analysis of 
rHDL●YMOR before and after Gi2 addition confirmed that a large amount of the 
heterotrimer aggregates during its addition (data not shown). As such, the two 
populations of ~54% coupled and ~46% uncoupled YMOR correspond well with 
the expected final G protein to YMOR ratio of 0.5–1:1.  
Single-particle Visualization of Agonist Binding to rHDL●YMOR. [Lys7, 
Cys8]dermorphin was used as an agonist probe to visualize binding to  
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Figure A1.7. DAMGO displays low affinity binding to rHDL•YMOR. An estimated 
15 fmoles of rHDL•YMOR was incubated with 1 nM [3H]DPN and increasing 
concentrations of DAMGO in 25 mM Tris•HCl, pH 7.7, 100 mM NaCl, 0.1% BSA. 
DAMGO competed [3H]DPN binding with a Ki of ~1.9  µM, indicating that in the 
absence of G  protein heterotrimer coupling DAMGO binds YMOR with low 
affinity. These data corroborate those in Fig. A1.2D and 6B, which illustrated 
that DAMGO binds YMOR with low affinity when Gi2 heterotrimer is uncoupled 
from the receptor by the addition of 10  µM GTPγS. Data is representative of 
three experiments performed in duplicate. Error bars represent the Standard 
Error of the Mean. 
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Figure A1.8. A Cy3-labeled [Lys7, Cys8]dermorphin retains agonist properties at 
YMOR. Approximately 50 fmoles of receptor in HDL particles were coupled to 
purified Gi2 heterotrimer at a ratio of 30:1 G protein:YMOR.  (A) [Lys
7, 
Cys8]dermorphin-Cy3 binds rHDL•YMOR+Gi2 with high affinity, displaying a Ki of 
3.3 nM in competition assays against 0.75 nM [3H]DPN. The single high affinity 
binding site suggested by the monophasic competition curve is due to the high 
molar ratio of G protein addition to YMOR, which results in nearly all of the 
receptor being coupled to Gi2 heterotrimer. Data is normalized to the maximal 
binding level as calculated by a one-site competition curve fit (Prism 5.0, 
GraphPad).  (B) [Lys7, Cys8]dermorphin-Cy3 stimulated [35S]GTPγS binding to 
rHDL•YMOR+Gi2 with an EC50 of 23.05 nM. Approximately 52 fmoles of 
[35S]GTPγS binding was stimulated, suggesting a 1:1 YMOR:Gi2 coupling, 
confirming the fact that adding Gi2 at a 30:1 molar ration results in complete 
coupling of YMOR. Data are representative of three experiments performed in 
duplicate are shown. Error bars represent the Standard Error of the Mean.  
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Figure A1.9. Single-molecule imaging of Cy3-labeled agonist binding to rHDL●YMOR + Gi2 confirms that the majority of 
YMOR is monomeric when reconstituted into HDL. Binding of [Lys7, Cys8]dermorphin-Cy3, a fluorescently labeled MOR-
specific agonist, to rHDL●YMOR+Gi2 was observed with prism-based total internal reflection fluorescence microscopy. 
YMOR was reconstituted into HDL particles using biotinylated apoA-1, followed by Gi2 heterotrimer addition at a 30:1 G 
protein to receptor molar ratio. Reconstituted HDL (A) or rHDL●YMOR+Gi2 (B) were then incubated with a saturating 
concentration (500 nM) of [Lys7, Cys8]dermorphin-Cy3, adhered to a streptavidin-coated quartz slide, and washed with 
ice-cold 25 mM Tris●HCl, pH 7.7 buffer. Bound [Lys7, Cys8]dermorphin-Cy3 was continuously excited at 532 nm to 
observe photobleaching of the fluorophore. C, representative fluorescence intensity traces for a one- and two-step 
photobleach event are shown. The arrows indicate photobleach events. D and E, quantification of photobleaching showed 
that ~95% of the bound [Lys7, Cys8]dermorphin-Cy3 bleached in a single step, suggesting that 95% of rHDL particles 
contained monomeric YMOR. [Lys7, Cys8]dermorphin-Cy3 binding was reversible, as shown the addition of 5 µM NTX. A 
minimum of four slide regions and 200 fluorescent spots were counted for each sample.
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monomeric YMOR in rHDL at the single-molecule level with TIRF (Fig. A1.9). 
[Lys7, Cys8]-dermorphin was labeled with a Cy3 fluorophore (Fig. A1.1), and its 
ability to bind reconstituted YMOR with high affinity and stimulate [35S]GTPγS 
binding to Gαi2 was confirmed (Fig. A1.8). YMOR was reconstituted with 
biotinylated Δ(1–43)-His6 -apoA-1 (b-rHDL●YMOR), enriched on a FLAG affinity 
column, and added to Gi2 heterotrimer at a 30:1 Gi2:YMOR molar ratio to ensure 
complete receptor coupling to G protein. Binding of a saturating concentration 
(500 nM) of [Lys7, Cys8]dermorphin-Cy3 to b-rHDL●YMOR+Gi2 was then imaged 
with SM-TIRF. Fifty picomolar b-rHDL or b-rHDL●YMOR+Gi2 (Fig. A1.9A and B) 
samples were continuously excited at 532 nm and fluorescence intensity traces 
(Fig. A1.9C) were analyzed for step photobleaching. Approximately 95% of the 
b-rHDL●YMOR+Gi2 fluorescence traces exhibited single-step photobleaching, 
suggesting that a single [Lys7,Cys8]dermorphin-Cy3 was localized within each 
fluorescent spot (Fig. A1.9D and E). Having shown that rHDL particles contain a 
single receptor, these photobleaching data indicate that only one dermorphin 
bound per receptor.  
 
A1.4 Discussion 
Intense research over the past decade has focused on the existence and 
functional consequences of GPCR oligomerization. Recently, our laboratory and 
others have taken advantage of a unique phospholipid bilayer platform in the 
form of rHDL particles (254, 255, 258, 259). Using this system we previously 
demonstrated the functional reconstitution of two prototypical GPCRs, rhodopsin 
and β2AR (258, 259). Having illustrated that these receptors are monomeric 
following reconstitution, we observed complete functional coupling to their 
respective G proteins. For the β2AR, agonist binding to monomeric receptor is 
allosterically regulated by the stimulatory heterotrimeric G protein Gαsβγ. 
Therefore GPCR dimerization is not required for functional G protein coupling in 
the prototypical class A GPCRs rhodopsin and β2AR.  
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 In contrast, the accumulation of considerable biochemical and biophysical 
evidence suggests that the µ-, δ-, and κ-opioid receptors may function in a 
fashion that is dependent on their oligomerization. Analysis of receptor 
overexpression in co-transfected cells suggested the existence of δ-δ 
homodimers (277) and demonstrated unique pharmacology resulting from µ-δ (6, 
7, 10) and δ-κ heterodimers (278). Bioluminescence resonance energy transfer 
studies have shown that homo- and heterodimers can be formed by all three 
opioid receptor isoforms (253). These findings have promoted the notion that 
opioid receptor oligomerization is important for function (279, 280). However, with 
co-transfection systems the final profiles of µ and δ monomers, homodimers, and 
heterodimers are unknown. In light of these reports, we rationalized that it was 
vital to determine whether the monomeric form of the MOR behaves in a 
pharmacologically similar manner as the native, membrane-bound form.  
 The HDL reconstitution system was used to investigate the function of 
monomeric MOR. Reconstitution of MOR required the purification of active 
receptor in large enough quantities for subsequent biochemical manipulation and 
analysis. Previous reports of MOR purification from endogenous or recombinant 
sources have yielded either low quantities (281-285) or poor agonist binding 
affinities (286-288). Several aspects were key to the expression and purification 
of YFP-MOR (YMOR): a cleavable hemagglutinin signal sequence at the N 
terminus of the receptor (289), the presence of naltrexone during expression, and 
the inclusion of cholesteryl hemisuccinate and naltrexone during the entire 
purification process. These modifications contributed to the stabilization of 
YMOR, leading to an increase in yields during the chromatography process as 
well as increasing the specific activity of the detergent solubilized receptor. 
Reconstitution into HDL facilitated the isolation of a monomeric form of YMOR 
that couples to and activates heterotrimeric G proteins. Furthermore, we illustrate 
that the inhibitory G protein Gαiβγ can allosterically regulate agonist binding to 
monomeric MOR. These results suggest that G protein regulation of monomeric 
receptors is likely a phenomenon common to all G proteins and class A GPCRs. 
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The capacity of MOR to couple to various isoforms of Gi/o heterotrimers in a 
differential manner are currently under investigation in our laboratory. 
 Taken together our results demonstrate the functionality of monomeric 
MOR, illustrating that the opioid GPCR does not require dimerization to bind 
ligands and signal to G proteins. However, these data do not refute the existence 
of opioid receptor oligomerization in cells. It remains possible that homo- and 
heterodimerization create unique ligand binding entities that may be subject to 
differential regulation, desensitization, and internalization. One of our future goals 
is to isolate various oligomeric states of opioid receptors and other GPCRs in 
rHDL particles and compare their activities toward ligands and signaling partners 
directly. A major technical obstacle is the formation of ―anti-parallel‖ receptor 
dimers, where the N termini for the reconstituted GPCRs in the oligomer are on 
opposite sides of the phospholipid bilayer. Indeed, reconstitution of two GPCRs 
in a single rHDL particle has been previously demonstrated for rhodopsin (254, 
255, 258, 259), but a detailed analysis by nanogold labeling and single-particle 
electron microscopy of the reconstituted ―dimers‖ reveals that a significant 
fraction were anti-parallel (254). It is plausible, and even likely, that an 
antiparallel GPCR dimer will result in suboptimal or disrupted G protein coupling. 
The development of approaches to ensure parallel GPCR dimer incorporation 
into rHDL particles to confidently study the functional relevance of opioid receptor 
dimerization is currently a major priority in the laboratory.  
 HDL reconstitution of YMOR also provided a platform for analysis of ligand 
binding using single-molecule microscopy. In this study we examined the 
reversible binding of a µ-opioid receptor specific agonist [Lys7, Cys8]dermorphin  
with SM-TIRF. To the best of our knowledge these data represent the first 
reported observation of a peptide agonist binding to an isolated GPCR in a lipid 
bilayer using single-particle imaging. We are currently refining our methods to 
resolve the kinetics of ligand binding to YMOR, as well as visualizing ligand 
binding to opioid receptors in intact cells. Peptide receptors such as the opioid 
family are particularly amenable to fluorescence spectroscopy because the 
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relatively large ligand size can tolerate the incorporation of fluorophores without 
drastically impairing binding affinities. This single-molecule visual approach of 
studying ligand binding to opioid receptors, utilizing labeled agonists and 
antagonists with unique binding affinities toward receptor homo- and 
heterodimers, may potentially address opioid receptor oligomerization in 
physiologically relevant tissue preparations.  
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Appendix 2 
 
Single mRNA Tracking in Human Cells 
 
A2.1 Introduction 
To exactly quantify the number of mRNA bound miRNA particles that were 
observed in Chapter 2, it was essential to label mRNAs with a complementary 
fluorescent probe. We validated the previously reported MS2-MCP system for 
this purpose (87, 138). 
 
A2.2 Materials and methods 
Plasmids, DNA and RNA oligonucleotides. pMCP-EGFP, plasmid bearing the 
ORF of MS2 coat protein fused to EGFP and SV-40 nuclear localization signal 
(NLS), and pSL-MS2_24x, plasmid bearing 24 copies of the MS2 stem loops, 
were received as gifts from Robert Singer (Yeshiva) (87). Luciferase reporter 
plasmids bearing the MS2 stem loops were created in two steps. First, the ORF 
of IF2, PCR amplified using a forward primer bearing SbfI and EcoRI RE sites 
and a reverse primer bearing NotI RE site, was cloned into the corresponding 
SbfI and NotI RE sites in the pmG (pmiR-GLO, Promega) or pmG-mH3UM 
plasmids. The latter plasmid contained the mutated 3`UTR of mouse HMGA2 
which was unrepressed by wild-type let-7-a1 miRNAs but could be silenced by a 
mutant let-7-a1 miRNA. 24 copies of the MS2 stem loops (from pSL-MS2_24x) 
was then cloned into the EcoRI-NotI RE sites of the resultant plasmids, pmG-IF2 
and pmG-mH3UM-IF2, to generate pmG-MS2 and pmG-mH3UM-MS2 
respectively. We had to resort to this two step method because linearized 
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plasmids containing the MS2 stem loops often recombined with the genome of 
the bacterial competent cells we were using, thus resulting in clones bearing 
smaller plasmids. Clones containing the MS2 stem loops were created in SURE2 
(Stratagene) bacterial cells to minimize recombination of the MS2 repeats with 
the bacterial genome. Negative control siRNA used in transfection experiments 
was purchased from Ambion. All other RNA oligonucleotides were purchased 
from the Keck Biotechnology Resource Laboratory at the Yale University School 
of Medicine with a 5‘ phosphate (P)  and were purified as described . RNA 
sequences were as follows: 
let-7-a1 guide: P-UGAGGUAGUAGGUUGUAUAGUU 
let-7-a1-passenger: P-CUAUACAAUCUACUGUCUUUCC 
let-7-a1 mut guide: P-UGCGUUAGUAGGUUGUAUAGUU 
let-7-a1 mut passenger: P-CUAUACAAUCUACUGUCGUUCC 
siLuc2 guide: GAAGUGCUCGUCCUCGUCCUU 
siLuc2 passenger: GGACGAGGACGAGCACUUCUU 
Guide and passenger strands were heat-annealed in a 1:1 ratio, resulting in 
duplex miRNAs, and frozen until used. 
Repression assay. 24 h prior to transfection, 100 µL of 15,000 HeLa cells were 
seeded per well of a 96 well plate. Cells were transfected with 60 ng of the 
indicated plasmid, 10 nM of the indicated dsRNA, 0.4 µL of Lipofectamine 2000 
(Invitrogen) and 50 μL of OptiMEM (GIBCO). 6 h after transfection the growth 
medium was replaced with fresh medium. 24 h after transfection, medium was 
replaced with phenol red-free DMEM. Dual luciferase assays were performed 
using the Dual-Glo luciferase assay reagents (Promega) as per the 
manufacturer‘s protocol and luminescence was detected using a Genios Pro 
(Tecan) plate reader. 
Transfection, imaging and data analysis. 2.4 x 105 HeLa cells were reverse 
transfected by directly adding transfection complexes, containing 2 µg of the 
appropriate plasmid set and 7 µL of Fugene HD transfection reagent (Roche), to 
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trypsinzed cells. The 2 µg of total plasmid contained 1:1 molar ratio of the pMCP-
GFP and either pmG, pmG-MS2 or pmG-mH3UM-MS2. Cells were grown on a 
DeltaT dish (Bioptech) for 24 h at 37 oC under conditions of 5% CO2. The cells 
were then trypsinized and re-seeded onto DeltaT dishes in a 1:1 ratio of cells : 
growth media and re-grown for another 24 h. Regular medium was replaced with 
phenol red-free medium 4 h prior to imaging and subsequently with a minimal 
medium (HBS), without serum and vitamins, but containing 20 mM HEPES-KOH 
pH 7.4, 135 mM NaCl, 5 mM KCl, 1 mM MgCl2, 1.8 mM CaCl2 and 5.6 mM 
glucose, 0.3 U/mL Oxyfluor (Oxyrase), 20 mM sodium succinate, 2 mg/mL 
ascorbic acid and 200 µM trolox (HBS-OSS) immediately before imaging. Single 
particle tracking was performed as previously described (Chapter 2, 
Fluorescence microscopy) using the 488nm laser for GFP excitation and a 
dual band filter cube, consisting of a z491/639rpc dichroic filter (Chroma) and 
z491/639m emission filter (Chroma), for the detection of GFP fluorescence. Data 
analysis was done as previously described (Chapter 2, Live cell imaging and 
data analysis) with a minor modification of computing ensemble diffusion 
coefficients from mean squared displacement of all trajectories with a sample. 
A2.3 Results and Discussion 
Intracellular mobility of mRNAs as a good measure to predict 3`UTR 
‘loading’. Ensemble reporter assays were first performed to validate the ability of 
MS2 tagged transcripts to undergo miRNA mediated gene silencing. We found 
that the transcript without the mutant HMGA2 3`UTR (compare all A’s, Fig. 
A2.1A) was not repressed by any miRNA whereas transcripts with the UTR 
(compare all B’s Fig. A2.1A) were specifically and effectively repressed (Fig. 
A2.1A). We then performed single particle tracking (SPT) in HeLa cells co-
transfected with the EGFP-MS2-NLS fusion protein containing plasmid and either 
a control plasmid containing no MS2 sequences (-ve, Fig. A2.1B), the pmG-MS2 
plasmid (luc2-MS2, Fig. A2.1B) or the pmG-mH3UM-MS2 plasmid (luc2-
mH3UM-MS2, Fig. A2.1B). In the absence of MS2 stem loops only the nucleus  
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Figure A2.1. Establishment of the MS2-MCP system for dual-color intracellular 
single molecule microscopy. (A) Dual luciferase assay. Samples correspond to 
cells cotransfected with, pmG-MS2 and negative control siRNA (A-), pmG-MS2 
and mutant let-7-a1 miRNA (Amut), pmG-MS2 and wild-type let-7-a1 miRNA 
(Awt), pmG-mH3UM-MS2 and negative control siRNA (B-), pmG-mH3UM-MS2 
and mutant let-7-a1 miRNA (Bmut), pmG-mH3UM-MS2 and wild-type let-7-a1 
miRNA (Bwt). (B) Pseudo-colored images of HeLa cells cotransfected with 
pMCP-EGFP and either pmG (-ve), pmG-MS2 (luc2-MS2) or pmG-mH3UM-MS2 
(luc2-mH3UM-MS2). Arrows show representative cytoplasmic particles. (C) 
Ensemble diffusion coefficients of luc2-MS2 and luc2-mH3UM-MS2 transcripts. 
Velocity is calculated from particles moving in a biased fashion.  
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was fluorescent, representative of EGFP-MS2-NLS nuclear localization, and no 
cytoplasmic particles were seen. On the other hand cytoplasmic particles were 
seen for both of the latter two conditions. This was indicative of transcripts 
labeled with multiple copies of EGFP via the MS2 – MS2 stem loop interaction. 
Moreover, the ensemble diffusion coefficient of transcripts containing no UTR 
was almost ~7-fold larger than that with the UTR, even when the former was only 
2-fold smaller than the latter (Fig. A2.1C). This data suggests that the molecular 
mass of the UTR containing transcripts are ~300 fold more than the ones without. 
Such a scenario is only possible if the UTR was bound by other protein factors. 
Consistent with this hypothesis, the mouse HMGA2 3`UTR contains several 
miRNA binding sites which could potentially be occupied by host miRNA induced 
silencing complexes (miRISC). These experiments, thus, open up the possibility 
for indirectly quantifying 3`UTR ‗loading‘. In this way, we can also express 
transcripts containing the wild-type 3`UTR of HMGA2 in let-7 rich HeLa cells and 
use the difference in mobility between mutant UTR transcripts and wild-type UTR 
plasmids as a measure of let-7-RISC loading. This measurement could further be 
used to quantify the number of let-7 miRNAs bound per mRNA target, indirectly. 
We can additionally use this labeling method in dual-color tracking and 
colocalization experiments, similar to that in Chapter 3, to find the extent of 
miRNA binding to mRNAs. 
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Appendix 3 
 
Amenability of F9 Teratocarcinoma Cells for the Expression of Long 
3`UTRs and Gene Repression Mediated by Modified microRNA 
 
A3.1 Introduction 
To shed light on the mechanism of microRNA (miRNA) action inside living 
cells (Chapter 2), we first sought to investigate the diffusive motions of miRNA 
bound messenger RNA (mRNA) complexes, assembled post-microinjection, in 
F9 teratocarcinoma cells. These cells were ideal for our experiments and were 
our initial cell line of choice due to their lack of endogenous let-7 miRNA. Thus, 
the cellular pool of let-7 miRNAs in these cells would be dictated by the amount 
that we microinject. A couple of reports (48, 290) had shown that the uncontrolled 
expression of the High Mobility Group AT-hook 2 (HMGA2) gene, which is the 
case in F9 cells, leads to several cancers in mouse and that let-7 miRNA can act 
as a tumor suppressor by repressing HMGA2, creating a strong need to 
understand the intracellular interaction between these two molecules. These 
findings along with the fact that the 3`UTR of HMGA2 has seven let-7-a1 miRNA 
binding sites (seed sequences) and that HMGA2 was shown to be repressed by 
let-7-a1 (48, 290) motivated us to choose HMGA2 mRNA as a preferred mRNA 
target and let-7-a1 miRNA as our probe. Our experiment was based on the 
assumption that upon microinjection, binding of several (up to seven) Cy3-
labeled let-7-a1 miRNAs to a single HMGA2 mRNA would result in an inherent 
fluorescence amplification and will aid in tracking the particle. To further enhance 
the signal from a single mRNA, a target with more than seven let-7 seed 
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sequences was created by engineering two 3`untranslated regions (UTRs) of 
HMGA2 in tandem, downstream of its 5`UTR and coding sequence (CDS). 
Reverse Transcription followed by polymerase chain reaction (RTPCR) and 
Northern blotting indicated the presence of the endogenous HMGA2 mRNA, but 
an absence of our desired construct, i.e. the mRNA target containing tandem 
3`UTRs. We, thus, decided to exploit endogenously expressed HMGA2 
transcripts, ~ 8 – 80 copies / cell (based on absolute quantitative real-time PCR), 
as our mRNA target in single particle tracking (SPT) experiments. Unfortunately, 
control experiments (western blotting and dual luciferase assays) performed to 
test the repressive ability of fluorophore modified miRNAs showed that F9 cells, 
unlike HeLa cells, were incapable of using modified miRNAs for mRNA 
repression. Our observations can be explained either by technical issues related 
to transfection, wherein transfection efficiency or the intracellular availability 
(post-transfection) of modified miRNAs are different from those of un-modified 
miRNAs in F9 cells, or by a genuine difference in the molecular mechanism by 
which F9 cells (mouse) and HeLa cells (human) assemble miRNAs into 
repressive complexes. 
 
A3.2 Materials and methods 
Plasmids and DNA and RNA oligonucleotides. The coding sequence (CDS) of 
HMGA2 and two copies of its 3`-untranslated region (3`UTR) were cloned in 
tandem into the pcDNA4/TO/myc-His B plasmid (to yield pcDNA-mH-2xwt). 
pcDNA6/TR and the above plasmid were stably transfected into F9 
teratocarcinoma cells. Together the two plasmids constitute the Tetracycline 
expression system (T-Rex, Invitrogen) wherein the gene in the pcDNA4 plasmid 
is under the inducible control of the tetracycline repressor (Tet-R), which is 
constitutively expressed by the pcDNA6 plasmid. Nine clones were generated 
and each was tested for expression of an mRNA bearing the CDS of HMGA2 
followed by two copies of its 3`UTR, mH-2x-3`UTR. The above plasmids and 
clones were constructed by John Hoerter and Christine Mayr respectively. 
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Luciferase reporter plasmids pmG-mH3U was engineered by inserting the 
wild-type mouse HMGA2 3‘ UTR sequence downstream of the firefly luciferase 
ORF in the pmirGLO dual-luciferase expression vector (Promega). The wild-type 
3‘ UTR was PCR amplified from plasmid templates received as a gift from David 
Bartel (Whitehead Institute, MIT) (48) using primers containing at their 5‘ ends  
XhoI and NotI restriction sequences, respectively. Following restriction digestion, 
the amplicon insert was ligated to complementary ends in the pmirGLO vector. 
 All DNA oligos were purchased from Invitrogen©. Cartridge-purified oligos 
were directly suspended in water and used for PCRs. For northern blotting, DNA 
oligos were size-selected and extracted from a 20% denaturing PAGE. DNA 
sequences are as follows, 
Primers 175bp: Forward primer (FW-HMGA2),  
CCACAGAAGCGAGGACGCGGC and reverse primer (RV-HMGA2),  
CCTAGGTCTGCCTCTTGGCCG 
Primers 282bp: Forward primer (FW-HMGA2-UTI),  
GCAGATATCCAGCACAGTGG and reverse primer (RV-HMGA2-3UTR),  
GTCCCCCGTGTTTACAGCAG 
Probe1: Same sequence as RV-HMGA2 
Probe2: CCACTGTGCTGGATATCTGC 
Negative control siRNA used in transfection experiments was purchased 
from Ambion. SiLuc2 siRNA, a positive control siRNA, was designed towards the 
coding sequence of the firefly luciferase gene (luc2) and purchased from 
Dharmacon as a duplex.  All other RNA oligonucleotides were purchased from 
the Keck Biotechnology Resource Laboratory at the Yale University School of 
Medicine with a 5‘ phosphate (P) and, in the case of amine modified RNA, a 3‘ 
amino group on a C7 carbon linker. RNA was purified as described (177) and the 
3‘ amine groups were labeled with Cy3 or Cy5 succinimidyl ester as described 
(177, 178). RNA sequences were as follows: 
 159 
 
let-7-a1 guide: P-UGAGGUAGUAGGUUGUAUAGUU 
let-7-a1-passenger: P-CUAUACAAUCUACUGUCUUUCC 
let-7-a1 mut guide: P-UGCGUUAGUAGGUUGUAUAGUU 
let-7-a1 mut passenger: P-CUAUACAAUCUACUGUCGUUCC 
siLuc2 guide: GAAGUGCUCGUCCUCGUCCUU 
siLuc2 passenger: GGACGAGGACGAGCACUUCUU 
Guide and passenger strands were heat-annealed in a 1:1 ratio, resulting in 
duplex miRNAs, and frozen for further use. 
RT-PCR and northern blotting. Total RNA was extracted from both un-induced 
and doxycycline induced (0.2 – 1 µg/mL) stably transfected (tandem 3`UTRs) F9 
cells using the QIAGEN RNeasy kit (QIAGEN). Reverse transcription and PCR 
were performed using the Taqman reverse transcription reagents (Applied 
Biosystems) and the SYBR green PCR mastermix (Applied Biosystems) 
respectively, according to manufacturer‘s protocol. DNA products after RT-PCR 
were resolved on a 2% Agarose gel. DNA was visualized by ethidium bromide 
staining and visualization under UV light.  
 For northern blotting, total RNA were separated on a 1.2% formaldehyde 
agarose gel along with an RNA ladder (Promega). The lane containing the RNA 
ladder was cut off the rest of the gel post-electrophoresis and was stained with 
SYBR gold (Invitrogen). RNA from rest of the gel was then transferred to a nylon 
membrane by capillary action. After oven-drying, the RNA was cross linked to the 
membrane by UV exposure. Transfer was confirmed by staining the RNA on a 
replicate membrane using a buffer containing 0.5 M acetic acid, pH 5.2 and 
0.04% methylene blue (MB) for 10mins at room temperature. After multiple wash-
steps and pre-hybridization, the membrane was then treated with 32P labeled 
probe1 or probe2 and incubated at 55oC for 24 h. After multiple wash steps the 
probe labeled RNA were visualized by exposing the radio-labeled RNA bands to 
a phosphor screen. The SYBR gold stained RNA marker as then used to 
estimate size of RNA bands. 
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Western blotting and luciferase assays. F9 cells were transfected either with 
no miRNA (No RNA), a negative control siRNA (-ve), let-7-a1 miRNA with an 
amine modification in the 3`end (let-7-a1 amine) or a mutant let-7-a1 miRNA with 
an amine modification in the 3`end (let-7-a1 mut amine) using lipofectamine 2000 
(Invitrogen). miRNAs were added at a concentration of ~2 – 20nM. 24 h post-
transfection cells were lysed using a RIPA buffer (50 mM Tris-HCl, pH 8.0, with 
150 mM sodium chloride, 1.0% NP-40, 0.5% sodium deoxycholate, and 0.1% 
sodium dodecyl sulfate) and loaded onto a novex 16% tris-glycine pre-cast gel 
(Invitrogen). Size separated proteins were then transferred onto a polyvinylidene 
fluoride membrane (Millipore). Membranes were then probed with goat-anti-
HMGIC polyclonal and mouse-anti-βactin monoclonal primary antibodies 
respectively. Rabbit-antigoat-HRP and goat-antimouse-Cy3 were used as 
secondary antibodies. Chemifluorescence, mediated by HRP and its substrate 
(ECL plus, GE Healtcare), was used to visualize HMGA2 and Cy3 fluorescene 
was used to visualize actin. Typhoon 9410 Variable Mode Imager (GE 
Healthcare Life Sciences) was used for imaging the membrane. 
 24 h prior to transfection, 100 µL of 15,000 HeLa cells were seeded per 
well of a 96 well plate. Cells were transfected with 60 ng of pmG-mH3U, 10 nM of 
the indicated dsRNA, 0.4 µL of Lipofectamine 2000 (Invitrogen) and 50 μL of 
OptiMEM (GIBCO). 6 h after transfection the growth medium was replaced with 
fresh medium. 24 h after transfection, medium was replaced with phenol red-free 
DMEM. Dual luciferase assays were performed using the Dual-Glo luciferase 
assay reagents (Promega) as per the manufacturer‘s protocol and luminescence 
was detected using a Genios Pro (Tecan) plate reader. 
  
A3.3 Results and Discussion 
Long 3`UTR containing transcripts were not efficiently expressed in F9 
cells. We first performed RT-PCRs to test for the expression of transcripts 
containing the HMGA2 CDS with tandem 3`UTRs. Primer pairs were created to 
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amplify either a 175 base pair (bp) (Primers 175bp) or 282 bp (Primers 282bp) 
DNA sequence within the CDS or second 3`UTR of HMGA2, respectively (Fig. 
A3.1A). The former amplicon can result either from endogenous HMGA2 
transcripts or those that contain two copies of the 3`UTR whereas the latter is 
specific to the tandem 3`UTR construct; the forward primer binds to a region in 
between the two 3`UTRs, unique to the mH-2x-3UTR cDNA, and the reverse 
primer binds within the 3`UTR of HMGA2. Even after doxycycline mediated 
induction, only the 175 bp DNA product was seen, the 282 bp product was not, 
suggesting the absence of tandem 3`UTR containing transcripts (Fig. A3.1B, C). 
To confirm the above results, we also performed northern blots with probes that 
either targets both endogenous and mH-2x-3UTR transcripts. Consistent with our 
previous observation, we only observed endogenous HMGA2 transcripts (Fig. 
A3.1B, D). These findings are in agreement with other recent work (226, 227), 
which have suggested the shortening of 3`UTRs in proliferating cells.  
Modified miRNAs are non-functional in F9 cells. We then explored the 
possibility of utilizing the endogenous HMGA2 transcript for our SPT experiments 
in F9 cells. To test whether modified let-7-a1 miRNAs mediate repression of 
endogenous HMGA2, we first performed western blots. Surprisingly, amine 
modified let-7-a1 was incapable of repressing HMGA2 (compare, ‗no RNA‘, ‗-ve‘, 
‗let-7-a1 amine‘ and ‗let-7-a1 mut‘ in  Fig. A3.2A). We performed luciferase 
reporter assays to confirm our previous observation. Similar to the western blots, 
modified miRNAs (‗let-7-a1 amine‘, ‗let-7-a1 Cy3‘, ‗let-7-a1 Cy5‘, ‗let-7-a1 bio‘) 
failed to elicit repression of a reporter gene that contained the 3`UTR of HMGA2 
(Fig. A3.2B). In contrast, an unmodified siRNA (siLuc2) or miRNA (let-7-a1) were 
functional. These findings can be reconciled by two explanations, (i) transfection 
efficiency of modified miRNAs is much less than those of un-modified miRNAs, 
or (ii) modified miRNAs are incapable of being incorporated into the miRNA 
pathway. HeLa human cervical cancer cells, however, utilized modified miRNAs 
effectively to elicit repression (Chapter 2, Fig. 2.1) under similar conditions. This 
opens up the possibility that differences in the RNA interference machinery  
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Figure A3.1. Tandem 3`UTR containing transcripts were not expressed in F9 
cells. (A) Diagram depicting the transcript architecture of endogenous mouse 
HMGA2 (mHMGA2) and tandem 3`UTR containing mRNA (Tandem mH3U) 
respectively. Locations of PCR primers and northern blotting probes are shown 
using black and gray arrows. (B) Outline of our experiment. (C) 2% Agarose gel 
stained with ethidium bromide and visualized under UV. Samples separated on 
gel were, 100 bp ladder (NEB, lane 1), RT-PCR products amplified by primers 
specific to the tandem 3`UTR construct (lanes 2, 3) and products amplified by 
primers to the HMGA2 CDS (lanes 4, 5). (D) Northern blot showing RNAs 
detected with probe1 (left), which binds both endogenous and cloned transcripts, 
and probe2 (right), which is specific to the tandem 3`UTR construct. 
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Figure A3.2. Modified miRNAs are repression incompetent in F9 cells. (A) 
Western blot of lysates from F9 cells, which were transfected with no miRNA (no 
RNA), ambion negative control siRNA (-ve), a specific amine modified let-7-a1 
miRNA (let-7-a1 amine) or a mutated amine modified let-7-a1 that has been 
proven to not repress HMGA2 (let-7-a1 mut). Top panel shows actin and the 
bottom panel shows HMGA2. Numbers below represent quantification of bands, 
which was done in Image-quant©. Intensity of bands, used in quantification, were 
background subtracted and subsequently normalized to ‗–ve‘. (B) Dual luciferase 
assay of F9 cells transfected with pmG-mH3U plasmid and any of the mentioned 
miRNAs. Firefly luciferase luminescence was normalized to that of renilla 
luciferase in all samples. Comparative activity of all samples were then 
normalized with that ‗–ve‘. Error bars, standard deviation. (n = 6). 
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between humans and mice could mediate this effect; miRNA recognition and 
processing are different in these two cell lines (or even species) and therefore 
modified miRNAs are repression competent in one type of cells and not the 
other. Consistent with the above hypothesis, human and mouse Dicer, core 
components of the miRNA pathway with > 80% homology between two species, 
bear differences in their helicase domain, which has been implicated to unwind 
miRNA duplexes. It is highly possible that modified miRNAs are not efficiently 
unwound and thus are not functional in F9 cells. This claim can be confirmed by 
either incorporating compensatory mutations in the mouse dicer gene on trying to 
rescue miRNA mediated repression by overexpressing human Dicer in F9 cells. 
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Appendix 4 
 
miRNA Pulldown and Sequencing (miP-Seq): A High-throughput Method to 
Experimentally Validate miRNA Targets 
 
A4.1 Introduction 
Existing methods of miRNA target identification rely heavily on tools from 
bioinformatics, i.e., computational prediction (291).  The predicted 
complementary binding or ―seed‖ sequences within a 3‘ untranslated region 
(3‘UTR), or potentially other segments, of an mRNA are then typically validated 
on an individual basis by experimental methods such as luciferase reporter gene 
assays that require cloning of the 3‘UTR behind the reporter gene, co-
transfection with the miRNA into a eukaryotic cell line, and careful comparison 
with control experiments (218).  Such labor-intensive experimental tools have 
begun to unequivocally underscore the importance of matching seed sequences 
between a miRNAs and a specific mRNA target, however, they also have a 
number of severe drawbacks.  We sought to overcome this caveat by developing 
a high-throughput technique that experimentally validates and quantifies all 
mRNA interactions of a given miRNA.   
We will essentially combine HITS-CLIP (high-throughput sequencing of 
RNA isolated by crosslinking immunoprecipitation) (292) with an approach 
reported by Lund and co-workers to biochemically purify mRNA targets using a 
biotinylated miRNA ―bait‖ (293, 294). The affinity purification of RNA-protein 
complexes in the protocol reported by Lund et al. (293, 294) is performed 
immediately after cell lysis without UV crosslinking, with the drawback that many 
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complexes will get lost during subsequent wash and dilution steps.  Several other 
miRNA target isolation protocols have been published where either RISC 
proteins (e.g., Ago2) are used to immunoprecipitate the miRNA and the target 
mRNA (295, 296) or the miRNA itself is used as a primer for reverse transcription 
of the target mRNA (297).  The former method is based on the assumption that 
the protein is associated to the target via the miRNA; although this is mostly the 
case, protein-mRNA interactions that are not miRNA mediated cannot be 
discounted.  The latter method is inefficient in cases where the very 3` end of the 
miRNA does not canonically base-pair with its target. 
Our miRNA Pull-down–deep-Sequencing approach (in short miP-Seq) will 
include CLIP (292), miRNA-mRNA complex purification, and deep-sequencing of 
RNA transcriptomes (Fig. A4.1). More specifically, A 3‘ biotin moiety will be 
attached to the guide strand of a miRNA duplex, leaving the functionally 
important 5‘ phosphate intact.  The modified miRNA will be tested for its efficacy 
in RNAi using standard luciferase assays and Western blotting of the native 
HMGA2 target.  F9 cells will then be transfected with the biotinylated miRNA 
duplex and subjected to brief UV irradiation (3 times 400 mJ/cm2 at 254 nm) on 
ice to form covalent bonds between RNA and any bound proteins (298).  Proteins 
of RISC will form covalent bonds with both the bound miRNA and mRNA, 
covalently coupling the two.  Alternatively, we will perform chemical crosslinking 
with formaldehyde or glutaraldehyde, but UV irradiation has the advantage that 
non-specific protein-protein and RNA-RNA crosslinking will be minimal.  Cells will 
then be harvested, lysed, and streptavidin-coated magnetic beads will be used to 
affinity purify all miRNA-mRNA-protein complexes from the lysate.  All RNA 
processing steps post-lysis and prior to cDNA synthesis will be done on-bead.  
Bound complexes will be partially digested with RNases (RNase A, RNase T1, 
etc.) dephosphorylated and ligated to a 3‘ RNA linker (3‘RA).  The RNA will then 
be 5‘ phosphorylated with polynucleotide kinase (PNK) to allow for the 
subsequent ligation of a second RNA adapter (5`RA) to the 5` end, essentially as 
described (292, 298).  Bound complexes will then be eluted and covalently 
attached proteins will be removed from the adapter ligated RNA using proteinase 
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K.  A DNA oligonucleotide (3`RDA) complementary to the 3` adapter will be used 
to reverse transcribe the RNA, and the resulting cDNA will be PCR amplified and 
subjected to high-throughput sequencing to generate several million sequence 
reads that will be assembled into an unbiased, genome-wide map of miRNA-
associated RNAs.  The frequency with which a particular sequence is found 
provides a quantitative measure of its occupancy potential. 
Our proposed miP-Seq approach advances current miRNA target validation 
protocols in several important aspects: 
1.) UV crosslinking will be used to covalently attach the miRNA to any proteins 
and to any mRNA target, ensuring that we will retain even transiently formed 
complexes through the purification procedure. 
2.) Through affinity purification using the miRNA, a clear link is established 
between a specific miRNA and its RNA targets; this assignment is lost when 
immunoprecipitation is performed through a mediating protein component of 
RISC such as Ago2. 
3.) High-throughput (deep) sequencing will be used to validate and annotate 
RNA targets, a technique that is more time efficient, sensitive and quantitative 
than competing techniques. 
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Figure A4.1. Schematic of miP-Seq.   
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So far, we have performed control experiments to (i) show that biotin 
tagged let-7-a1 miRNA maintain repressive abilities in HeLa cells and (ii) validate 
specificity of miRNA bound mRNA pulldown. Current members of the Walter Lab 
will be pursuing this approach in more detail to map all the mRNA targets of let-7-
a1 in HeLa cells. 
 
A4.2 Materials and Methods 
Plasmids and RNA oligonucleotides. Luciferase reporter plasmids pmG-mH3U 
was engineered by inserting the wild-type mouse HMGA2 3‘ UTR sequence 
downstream of the firefly luciferase ORF in the pmirGLO dual-luciferase 
expression vector (Promega). The wild-type 3‘ UTR was PCR amplified from 
plasmid templates received as a gift from David Bartel (Whitehead Institute, MIT)  
(48) using primers containing at their 5‘ ends  XhoI and NotI restriction 
sequences, respectively. Following restriction digestion, the amplicon insert was 
ligated to complementary ends in the pmirGLO vector. 
Negative control siRNA used in transfection experiments was purchased 
from Ambion. SiLuc2 siRNA, a positive control siRNA, was designed towards the 
coding sequence of the firefly luciferase gene (luc2) and purchased from 
Dharmacon as a duplex.  All other RNA oligonucleotides were purchased from 
the Keck Biotechnology Resource Laboratory at the Yale University School of 
Medicine with a 5‘ phosphate (P) and, in the case of biotin tagged RNA, a 3‘ 
biotin moiety on a C12 carbon linker. RNA was purified as described (177). RNA 
sequences were as follows: 
let-7-a1 guide: P-UGAGGUAGUAGGUUGUAUAGUU 
let-7-a1-passenger: P-CUAUACAAUCUACUGUCUUUCC 
let-7-a1 mut guide: P-UGCGUUAGUAGGUUGUAUAGUU 
let-7-a1 mut passenger: P-CUAUACAAUCUACUGUCGUUCC 
siLuc2 guide: GAAGUGCUCGUCCUCGUCCUU 
siLuc2 passenger: GGACGAGGACGAGCACUUCUU 
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Guide and passenger strands were heat-annealed in a 1:1 ratio, resulting in 
duplex miRNAs, and frozen for further use. 
Luciferase assays. For transfection repression assays 24 h prior to transfection, 
100 µL of 15,000 HeLa cells were seeded per well of a 96 well plate. Cells were 
transfected with 60 ng of pmG-mH3U, 10 - 30 nM of the indicated dsRNA, 0.4 µL 
of Lipofectamine 2000 (Invitrogen) and 50 μL of OptiMEM (GIBCO). 6 h after 
transfection the growth medium was replaced with fresh medium. 24 h after 
transfection, medium was replaced with phenol red-free DMEM. Dual luciferase 
assays were performed using the Dual-Glo luciferase assay reagents (Promega) 
as per the manufacturer‘s protocol and luminescence was detected using a 
Genios Pro (Tecan) plate reader. 
Transfection, pull-down and RT-PCR. A schematic of the steps performed is 
shown in Fig. A4.2A. Cells were seeded onto 15 cm dishes ~2 days prior to 
transfections. 11 µg of the pmG plasmid, without any UTR, or 15 µg of pmG-
mH3U were transfected along with 25nM of biotin tagged let-7-a1 miRNA using 
lipofectamine 2000 (Invitrogen). 6 h after transfection the growth medium was 
replaced with fresh medium. 24 h after transfection, cells were washed three 
times and suspended in cold phosphate buffered saline (PBS). UV cross-linking 
was performed by placing a hand-held UV illuminator (254nm), 1.5 cm above the 
dish surface for 15 min on ice. PBS was then replaced with cold lysis buffer (20 
mM Tris.Cl pH7.5, 500 mM NaCl, 2.5 mM MgCl2, 0.05% NP-40, 60 U/mL 
Superase.In, 1x Roche© protease inhibitor capsule-EDTA free, 1mM DTT) and 
cells were scraped onto a tube using a rubber policeman (BD, Falcon). The tube 
was placed on ice for 10 min with intermittent vortexing, every 2.5 min. Lysates 
were then centrifuged at 10,000 x g for 15 min 4 oC and the supernatants, 
containing all the miRNA-mRNA complexes, were immediately used.  
100 µL of streptavidin beads, washed with the lysis buffer, were blocked 
with 100 µg yeast tRNAs (Sigma) and 100 µg bovine serum albumin for 2 h at 4 
oC. Beads were then washed multiple times with the lysis buffer. Lysates were 
added to blocked beads at a 1:1 ratio (vol:vol) and incubated for 4 h at 4 oC to 
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allow for binding of biotin tagged miRNA-mRNA complexes. Unbound complexes 
were washed using the lysis buffer and the beads, containing bound complexes, 
were DNAse (Turbo DNAse, Ambion) and proteinase K treated for 20 min each 
at 37 oC. This treated sample was then phenol-chlorofom extracted and the 
RNAs were ethanol precipitated. RNA pellets were dissolved in nuclease free 
water. 
Reverse transcription and PCR were performed using the Taqman reverse 
transcription reagents (Applied Biosystems) and the SYBR green PCR 
mastermix (Applied Biosystems) respectively, according to manufacturer‘s 
protocol. DNA products after RT-PCR were resolved on a 2% Agarose gel. DNA 
was visualized by ethidium bromide staining and visualization under UV light.  
 
A4.3 Results and Discussion 
Proof of specific pulldown marred by DNA contamination. We, first, 
performed luciferase assays to test the repressive activity of biotin tagged let-7-
a1. To this end HeLa cells were cotransfected with the pmG-mH3U plasmid and 
either a non-specific dsRNA (-ve), an un-modified let-7-a1 miRNA (WT), a biotin 
tagged let-7-a1 miRNA (WT1), a mutated let-7-a1 miRNA incapable of repressing 
let-7-a1 targets (let-7-a1 mut) or a specific siRNA (siRNA). As expected, the 
biotin tagged miRNA was capable of repressing its target (compare WT, WT1 
and MUT), but to a slightly lower extent than the un-modified let-7-a1 (Fig. 
A4.2B).  
 To test whether we pulled down specific mRNA targets via the biotin 
tagged miRNA, we performed control experiments using plasmid encoded, 
validated let-7-a1 targets. Hela cells were transfected either with a plasmid 
encoding for an mRNA with no let-7 seed sequence (pmG) or a plasmid 
containing a valid target of let-7 (pmG-mH3U) along with the biotin lagged let-7-
a1 miRNA. pmG-mH3U co-transfected with no miRNA was also included in our 
experiment to account for non-specific binding of mRNA targets to the beads. We  
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Figure A4.2. Validating biotin tagged miRNA function and its ability to pull-down 
specific targets. (A) Schematic of steps performed. (B) Dual luciferase assay of 
HeLa cells transfected with pmG-mH3U plasmid and any of the mentioned 
miRNAs. Firefly luciferase luminescence was normalized to that of renilla 
luciferase in all samples. Comparative activity of all samples were then 
normalized with that ‗–ve‘. Error bars, standard deviation. (n = 6). (C) 2% 
Agarose gel loaded with RT-PCR products, stained with ethidium bromide and 
visualized under UV light. Samples correspond to no template control (NT, lane 
1), no reverse transcriptase control and the actual RT-PCR sample from cells 
transfected with pmG-mH3U and no miRNA (NRT- and -, lanes 2 and 3), no 
reverse transcriptase control and the actual RT-PCR sample from cells 
transfected with pmG-mH3U and biotin tagged let-7-a1 miRNA (NRT-bio and bio, 
lanes 4 and 5), no reverse transcriptase control and the actual RT-PCR sample 
from cells transfected with pmG (NRT-ve and -ve, lanes 6 and 7), positive control 
for PCR, where PCR was set with DNA template, showing correct size of 
amplicon (+ve, lane 8) and 100 bp ladder (NEB, L).  
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then performed all the steps outlined in Fig. A4.2A. After RT-PCR, the DNA 
amplicons were separated on a 2% Agarose gel, stained with ethidium bromide 
and visualized under UV light. We did not detect any non-specific binding of 
mRNAs to the beads (lane 3, Fig. A4.2C) or non-specific pulldown by biotin 
tagged let-7-a1 (lane 7, Fig. A4.2C), but could clearly visualize the pulldown of a 
specific product (lane 5, Fig. A4.2C), which is indicative of efficient pulldown. 
However, we also detected a DNA band of the same molecular weight in the 
reverse transcription control sample, which does not contain any reverse 
transcriptase (lane 4, Fig. A4.2C). As no cDNA should be present in the absence 
of the reverse transcriptase, this band cold potentially arise from plasmid DNA 
contamination in our pull-down fraction, which could also serve as a template in 
the PCR reaction. This trend was present even after multiple rounds of DNAse 
treatment. Future experiments can include the RT-PCR of an endogenous target, 
which would not require the transfection of a plasmid DNA, and thus could 
potentially help in alleviating this problem. Alternatively, incomplete DNA 
digestion on-bead could potentially be the problem and the pull-down protocol 
can be tweaked to remove this step such that DNA digestion happens in solution. 
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